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According to the World Health Organization, over 200 infectious diseases in humans 
originate from animals (zoonoses), posing significant threats to human health. 
Zoonotic agents account for the majority of emerging and re-emerging pathogens. The 
human-animal interface has been recognised as an important risk factor that facilitates 
viruses to cross the species barrier and establish infection in humans. This indicates a 
need to perform surveillance of human populations who are at high risk of zoonotic 
infection due to their frequent contact with animals, together with the animals to which 
humans are exposed. The VIZIONS (Vietnam Initiative on Zoonotic Infections) has 
been conducted to directly respond to that need. 
The large virus family Picornaviridae include known emerging pathogens that have 
major impacts on the economies and human and animal health (e.g. foot-and-mouth 
disease virus, hand foot and mouth disease virus). Some enteroviruses (EVs) and 
parechoviruses in this family have been shown to be able to infect both humans and 
animals while a number of new picornaviruses (new EV variants, cosaviruses, 
cardioviruses, hunniviruses) with unknown pathogenicity and zoonotic potential have 
been discovered. This thesis, as part of VIZIONS, hopes to address the following gaps 
in our knowledge of such viruses in six genera (Enterovirus, Parechovirus, Cosavirus, 
Cardiovirus, Kobuvirus and Hunnivirus) of the family Picornaviridae: 
1)  The prevalence and genetic diversity of picornaviruses in studied samples 
2)  The epidemiology and disease association of the identified viruses 
3)  The overlaps (if any) of picornaviruses circulating in animals and humans 
4)  Possible animal sources of picornavirus infections in humans 
In order to do that, over 2,000 faecal samples collected from a wide range of hosts 
(pigs, rats, bamboo rats, shrews, bats, chickens, ducks, boars, civets, porcupines, 
monkeys and humans) were screened for picornaviruses by nested PCR and real-time 
PCR assays. Detection frequencies varied between viruses and sample origins with 
kobuvirus as the most commonly detected virus, followed by EV, cardiovirus and 




Comparison of detection frequencies of viruses infecting pigs revealed a disease 
(diarrhoea) association with porcine kobuvirus (PKV) but not EV infections. However, 
differences in PKV viral loads between diarrhoeic and non-diarrhoeic pigs were not 
statistically significant (p = 0.22). In addition, the PKV VP1 sequences from the two 
pig categories were not phylogenetically distinct. EV VP1 sequences obtained from 
pigs and boars showed high genetic diversity with four previously known types and 
nine new types (EV-G8 to -G16). Analyses of complete genome sequences of two new 
EV types provided evidence for inter-type recombination with a putative breakpoint 
in the 2A coding region. 
Similarly, study on samples from monkeys showed endemic infection of EV but no 
overlap with EV variants in humans was observed. The majority of EV detected in 
monkeys were novel with evidence for chimeric genomes and putative recombination 
breakpoints in the 2A region. New criteria for the classification of EV were 
additionally proposed. 
Characterization by sequencing of VP4/VP2 and VP1 regions or complete genomes of 
picornaviruses in rats and bamboo rats also showed relatively high genetic diversity. 
While these viruses can infect different species of rats, they were again genetically 
different from viruses detected in the studied human populations. 
In summary, studies in this thesis provide substantial new information on the 
prevalence, genetic diversity and disease association of picornaviruses in the studied 
populations. However, picornaviruses detected from animals were consistently 
separate from those found in humans, consistent with a relatively limited zoonotic 






This thesis has been completed with great support from many people. 
First of all, I would like to express deep gratitude to my supervisors – Professors Peter 
Simmonds and Mark Woolhouse – for giving me the opportunity to work in the 
wonderful groups, for their unending patience, enthusiasm, dedication and valuable 
suggestions over the last three years. 
I am grateful to my thesis committee members – Professor Paul Digard and Doctor 
Colin Sharp – for support and advice in keeping my progress on schedule. 
I extend special thanks to Doctor Heli Harvala for the initial lab training and 
troubleshooting, and Doctor Darren Shaw for valuable training on statistics. 
Support provided by the Director Boards of OUCRU and Hospital for Tropical 
Diseases in Ho Chi Minh City was greatly appreciated. My special thanks go to 
Doctors Stephen Baker, Juliet Bryant, Rogier van Doorn, Tran Tinh Hien, Ngo Thi 
Hoa, Ngo Tri Tue, Ms. Pham Hong Anh, Tran My Phuc, Pham Thi Thanh Tam, Ha 
Thanh Tuyen, Mr. Nguyen Van Cuong, Voong Vinh Phat, Nguyen Van Nghia. 
I would also like to thank my colleagues – Sinead Lyons, Donald Smith, Jeroen 
Witteveldt, Eleanor Gaunt, Nicky Atkinson, Bill Gregory and Julius Paddy – for 
sharing with me their invaluable lab experience, knowledge, tips and skills. 
To the cake club members – Jeroen Witteveldt, Eleanor Gaunt, Nicky Atkinson, Bill 
Gregory, Colin Sharp, David Walker, Katherine Dulwich, Katie Nightingale, Jon 
Pavelin, Inga Dry, Dominique Mccormick, Nikki Smith and Jack Ferguson. Their 
cakes and stories have brightened my days and widened my social knowledge.  
I wish to acknowledge the help provided by my friends – Shoko Nishiyama, Geoffrey 
Mainda, Stephen Chiweshe, Kethusegile Raphaka, Aya Masuda, Amr Bayomi, Cam 
Tu. 
Finally, I wish to thank my family, especially my wife, for their support and 




List of the published papers that are included in the thesis 
 
Nguyen, D. V., Anh, P. H., Van Cuong, N., Hoa, N. T., Carrique-Mas, J., Hien, V. 
B., Campbell, J., Baker, S., Farrar, J., Woolhouse, M. E., Bryant, J. E. & 
Simmonds, P. (2014a). Prevalence, genetic diversity and recombination of species G 
enteroviruses infecting pigs in Vietnam. Journal of General Virology 95, 549-556. 
 
Nguyen, D. V., Harvala, H., Ngole, E. M., Delaporte, E., Woolhouse, M. E. J., 
Peeters, M. & Simmonds, P. (2014b). High Rates of Infection with Novel 
Enterovirus Variants in Wild Populations of Mandrills and Other Old World Monkey 
Species. Journal of Virology 88, 5967-5976. 
 
Nguyen, D. V., Anh, P. H., Cuong, N. V., Hoa, N. T., Carrique-Mas, J., Hien, V. 
B., Sharp, C., Rabaa, M., Berto, A., Campbell, J., Baker, S., Farrar, J., 
Woolhouse, M. E., Bryant, J. E. & Simmonds, P. (2015 [Epub ahead of print]). 
Large-scale screening and characterization of enteroviruses and kobuviruses infecting 
pigs in Vietnam. Journal of General Virology 97(2):378-88. 
 
Oral presentation at the 18th International Picornavirus meeting: High rates of 
infection with novel enterovirus variants in wild populations of mandrills and other 






BLAST Basic Local Alignment Search Tool 
bp base pair 
cDNA complementary deoxyribonucleic acid 
Ct threshold cycle 
CV coxsackievirus 
DAF decay accelerating factor 
DNA  deoxyribonucleic acid 
dNTP  deoxynucleotide triphosphates 
DTT Dithiothreitol 
E. coli  Escherichia coli 
EAV equine arterivirus 
EMCV  encephalomyocarditis virus  
ENc effective number of codons  
ERAV  equine rhinitis A virus 
ERBV  equine rhinitis B virus 
EV  enterovirus 
FMDV foot and mouth disease virus 
GI  gastrointestinal 
HAV-cr1 Hepatitis A virus cellular receptor 1 
HCoV  human coronavirus 
HFMD hand, foot and mouth disease 
HIV human immunodeficiency virus 
HPeV human parechovirus 
HRV human rhinovirus 
HuV hunnivirus 
ICAM-1 intercellular adhesion molecule 1 
ICTV  International Committee on the Taxonomy of Viruses 
IPTG isopropyl β-D-1-thiogalactopyranoside 
IRES  internal ribosomal entry site 
kb  kilobase 




LDLR low density lipoprotein receptor 
LV Ljungan virus 
MEGA Molecular Evolutionary Genetics Analysis 
MGPs magnetic glass particles  
ML maximum likelihood 
mRNA messenger RNA 
mtDNA mitochondrial DNA  
NCBI National Center for Biotechnology Information 
NHPs non-human primates 
NJ  neighbour joining 
nt  nucleotide 
OUCRU Oxford University Clinical Research Unit  
OWMs Old World Monkeys 
PBS  phosphate buffered saline 
PCR  polymerase chain reaction 
PhD doctor of philosophy 
PKV porcine kobuvirus 
PV  poliovirus 
RF  recombinant form 
RNA  ribonucleic acid 
RNP ribonucleoprotein 
rpm  rounds per minute 
RT  reverse transcription 
RT-PCR  reverse transcription polymerase chain reaction 
SAFV Saffold virus 
SARS severe acute respiratory syndrome 
SOPs standard operating procedures  
SVDV swine vesicular disease virus  
TAE Tris-acetate-EDTA 
Tm  melting temperature 
TMEV Theiler's murine encephalomyelitis virus 
























UK United Kingdom 
US United States 
UTR  untranslated region 
UV  Ultraviolet 
VCAM-1 vascular cell adhesion molecular 1  
VHEV Vilyuisk human encephalomyelitis virus 
VPg  viral protein genome linked 




List of Figures 
Chapter 1 
Figure 1.1. Comparison of mutation rates in viruses ........................................... 5 
Figure 1.2. The pathogen pyramid ....................................................................... 9   
Figure 1.3. Genome organisation, polyprotein processing cascade and capsid 
architecture of enterovirus .................................................................................. 15 
Figure 1.4. The structure of human rhinovirus virions ...................................... 16 
Figure 1.5. Summary of the picornavirus life cycle ........................................... 18 
Chapter 2 
Figure 2.1. Sampling sites in Vietnam and sample numbers ............................. 36 
Figure 2.2. The flowchart of key steps and methods used in this thesis ............ 41 
Chapter 4 
Paper 1: Prevalence, genetic diversity and recombination of species G 
enteroviruses infecting pigs in Vietnam 
Figure 1. Phylogenetic comparisons of sequences from VP4/VP2 region (nt 810 
– 1250) (a) and VP1 (nt 2469 – 3317) (b) from study samples and available 
sequences of other EV-G variants from GenBank .............................................. 81 
Figure 2. Amino acid sequence divergence across the genome of EV-G types 1 – 
6 ........................................................................................................................... 83 
Figure 3. Phylogenetic comparisons of sequences from 3Dpol (nt 6585 – 7121) 
(a) and 5’UTR (nt 196 – 470) (b) from the study samples and available sequences 
of other EV-G variants from GenBank ............................................................... 84 
Paper 2: Large-scale screening and characterization of enteroviruses and 
kobuviruses infecting pigs in Vietnam 
Figure 1. Box plot of log10 EV RNA copies/ml of EV-G screen positive sample 
suspensions from healthy and diarrhoeic pigs .................................................... 99 
Figure 2. Log10 PKV RNA copies/ml of pig sample suspensions in different age 
groups (a) and in healthy or diarrhoeic sows/boars (b) ..................................... 100 
Figure 3. Phylogenetic comparisons of VP1 sequences from study samples and 
available sequences of other EV-G variants from GenBank ............................ 101 
Figure 4. Box plot of EV types by pig ages ..................................................... 102 
List of Figures 
x 
 
Figure 5. Phylogenetic comparisons of VP1 sequences (nt 3005 – 3838) from 
study samples and available sequences of other PKV variants from GenBank
.......................................................................................................................... .103 
Figure 6. Phylogenetic comparisons of sequences from 5’UTR (nt 107 – 809) (a), 
VP4/VP2 (nt 810 – 1752) (b), VP1 (nt 2469 – 3317) (c), and 3D (nt 5934 – 7316) 
(d) from the study samples and available sequences of other EV-G variants from 
GenBank ........................................................................................................... 104 
Figure 7. (a) Nucleotide sequence divergence within EV-G9 and between EV-G9 
sequences and other EV-G types. (b) Group Scan analysis of the sequence 
734087-G9 ........................................................................................................ 105 
Chapter 5 
Figure 1. Collection sites in Cameroon of samples used in the current study…128 
Figure 2. Comparison of Ct values of EV RNA detected by real-time PCR in 
faecal samples collected from mandrills with those in human samples ........... 128 
Figure 3. Maximum likelihood analysis (GTR plus γ plus I model) of VP4/partial 
VP2 region (A) and whole VP1 (positions 743 to 1168 and 2477 to 3376, 
respectively, numbered using the PV3 reference sequence) (B) ...................... 130 
Figure 4. (A) Distributions of pairwise amino acid distances in P1 (positions 743 
to 3376) and 3CD regions (positions 5429 to 7360) between representative 
human-derived sequences within EV-A, EV-B, and EV-C. (B) Pairwise distances 
between three representative mandrill sequences with EV species A to D, J, and 
H ........................................................................................................................ 133 
Figure 5. Amino acid sequence divergence between mandrill sequences and A1 
and A2 subgroups in EV-A, human variants in species B to D (A) and simian 
viruses in species A, B, J, and H (B) ................................................................ 135 
Figure 6. Phylogenetic analysis of parts of 5’UTR (A), 3CD (B), and 3’UTR (C)
 ........................................................................................................................... 137 
Chapter 6 
Figure 6.1. Direct contact during handling of rats without protection measures 
puts handlers at risks of acquiring zoonotic infections ..................................... 149 
Figure 6.2. Schematic diagram of the HuV genome and amplified fragments (in 
parentheses) with numbers indicating the positions of each fragment for complete 
genome of novel types ...................................................................................... 151 
Figure 6.3. Prevalence of the screened picornaviruses by hosts ...................... 152 
List of Figures 
xi 
 
Figure 6.4. Phylogentic relationships between cardioviruses detected in 
Vietnamese rats (highlighted in bold) and reference sequences in the regions (a) 
and (b) VP4 (nt 1295 – 1583) and (c) VP1 (nt 3005 – 3832) ........................... 154 
Figure 6.5. Phylogenetic relationships between kobuvirus VP1 (nt 3005 – 3838) 
sequences detected in Vietnamese rats and a civet (highlighted in bold) and 
reference sequences........................................................................................... 155 
Figure 6.6. Phylogenetic relationships between HuV VP1 (nt 2597 – 3298) 
sequences detected in Vietnamese rats (highlighted in bold) and reference 
sequences .......................................................................................................... 156 
Figure 6.7. Amino acid distance scan across the coding region of (a) Vietnamese 
HuVs against reference sequences and (b) between Vietnamese HuVs ........... 157 
Chapter 7 
Figure 7.1. Phylogenetic analysis of a) cardiovirus VP4/VP2 region (nt 1295 – 
1583), b) kobuvirus VP1 region (nt 2991 – 3821), c) and d) EV VP1 region (nt 
2477 – 3376) ..................................................................................................... 167
xii 
 
List of Tables 
 
 
Chapter 1  
Table 1.1. Members of the family Picornaviridae and their natural hosts.... 12 
Table 1.2. Receptors used by selected picornaviruses .................................. 19 
Chapter 2 
Table 2.1. Origin and sampling periods of samples used in this thesis ......... 35 
Table 2.2. Species of rats and shrews ............................................................ 38 
Table 2.3. Species of the trapped bats ........................................................... 39 
Table 2.4. RT master mix .............................................................................. 43 
Table 2.5. Codes for nucleotides used in primer design ............................... 44 
Table 2.6. Reagents used in PCR reactions ................................................... 45 
Table 2.7. List of primers and probes ............................................................ 47 
Table 2.8. Reagents used in transcription ...................................................... 55 
Table 2.9. Reagents used in real-time PCR for EVs, parechovirus and PKV
 ....................................................................................................................... .56 
Table 2.10. Reagents used in one step RT-PCR ............................................ 56 
Table 2.11. Cycling conditions in one step RT-PCR .................................... 57 
Table 2.12. Reagents used in SequalPrep long PCR ..................................... 57 
Table 2.13. Cycling conditions for SequalPrep™ long PCR ........................ 58 
Table 2.14. Summary of methods commonly used for phylogenetic tree 
construction .................................................................................................... 61 
Chapter 3 
Table 3.1. Detection of picornavirus RNA in screened samples ................... 68 
Chapter 4 
Paper 1: Prevalence, genetic diversity and recombination of species G 
enteroviruses infecting pigs in Vietnam 
Table 1. Detection of EV RNA in pig faecal samples ................................... 80 
Table 2. Clinical characteristics of EV-infected pigs .................................... 82 
Paper 2: Large-scale screening and characterization of enteroviruses and 
kobuviruses infecting pigs in Vietnam 
List of Tables 
xiii 
 
Table 1. Detection of EV and PKV in pigs ................................................... 98 
Chapter 5 
Table 1. Detection frequencies in study samples using primers from different 
genome regions ............................................................................................ 128 
Table 2. P1, 3CD, and whole-genome amino acid sequence distances between 
mandrill variants and other species .............................................................. 131 
Chapter 6 
Table 6.1. Viral pathogens that may be transmitted by rodents to humans…147 
Chapter 7 
Table 7.1. Number of human samples by occupation category ................... 164 
Table 7.2. Characteristics of 10 cases from high risk cohort infected with 









Abstract ................................................................................................................................... ii 
Acknowledgements ............................................................................................................... iv 
Abbreviations ........................................................................................................................ vi 
List of Figures ........................................................................................................................ ix 
List of Tables ......................................................................................................................... ix 
Chapter 1. Introduction ......................................................................................................... 1 
1.1. Introduction .................................................................................................................... 1 
1.2. Zoonoses.......................................................................................................................... 2 
1.2.1. Introduction ............................................................................................................... 2 
1.2.2. Factors underlying the emergence of zoonotic pathogens ........................................ 3 
1.3. Pathogen pyramid .......................................................................................................... 9 
1.4. Picornaviruses .............................................................................................................. 11 
1.4.1. General aspects ........................................................................................................ 11 
1.4.2. Classification ........................................................................................................... 13 
1.4.3. Genome organisation and proteolytic processing ................................................... 14 
1.4.4. Virion structure ....................................................................................................... 16 
1.4.5. Life cycles of picornaviruses ................................................................................... 17 
1.4.6. Recombination in the evolution of picornaviruses .................................................. 21 
1.5. Picornavirus genera in this study ............................................................................... 22 
1.5.1. Enterovirus .............................................................................................................. 22 
1.5.2. Parechovirus ........................................................................................................... 24 
1.5.3. Cosavirus ................................................................................................................. 26 
1.5.4. Cardiovirus ............................................................................................................. 27 
1.5.5. Kobuvirus ................................................................................................................ 29 
1.5.6. Hunnivirus ............................................................................................................... 30 
1.6. VIZIONS (Vietnam Initiative on Zoonotic Infections) ............................................. 31 




Chapter 2. Materials and methods ..................................................................................... 35 
2.1. Biological samples ........................................................................................................ 35 
2.1.1. Pigs and wild boars ................................................................................................. 36 
2.1.2. Chickens and ducks ................................................................................................. 37 
2.1.3. Rats and shrews ....................................................................................................... 38 
2.1.4. Bats .......................................................................................................................... 38 
2.1.5. Civets and porcupines ............................................................................................. 39 
2.1.6. Monkeys .................................................................................................................. 40 
2.1.7. Humans ................................................................................................................... 40 
2.2. Laboratory techniques ................................................................................................ 40 
2.2.1. Nucleic acid extraction ............................................................................................ 42 
2.2.2. Reverse transcription of RNA ................................................................................. 43 
2.2.3. Polymerase chain reaction (PCR) and related techniques ....................................... 44 
2.2.3.1. Design of oligonucleotide primers ..................................................................... 44 
2.2.3.2. PCR protocols .................................................................................................... 45 
2.2.3.3. Real-time PCR ................................................................................................... 46 
2.2.3.4. SuperScript One-Step reverse transcription polymerase chain reaction ............ 56 
2.2.3.5. SequalPrep™ long PCR ..................................................................................... 57 
2.2.3.6. Agarose gel electrophoresis ............................................................................... 58 
2.2.3.7. Gel extraction and purification of amplified products ....................................... 58 
2.2.3.8. DNA sequencing ................................................................................................ 59 
2.2.3.9. Complete genome sequencing ........................................................................... 59 
2.2.3.10. Identification of animal species ....................................................................... 59 
2.3. Computational methods .............................................................................................. 60 
2.3.1. Statistical methods................................................................................................... 60 
2.3.2. Sequence alignment................................................................................................. 60 
2.3.3. Construction of phylogenetic trees .......................................................................... 61 
2.3.4. Bootstrapping .......................................................................................................... 63 
2.3.5. Recombination detection methods .......................................................................... 63 
 
Chapter 3. Prevalence of picornaviruses in screened samples ......................................... 65 
3.1. Introduction .................................................................................................................. 65 




3.3. Methods ........................................................................................................................ 66 
3.4. Results ........................................................................................................................... 67 
3.5. Discussion ..................................................................................................................... 69 
3.5.1. Enterovirus ............................................................................................................... 69 
3.5.2. Kobuvirus ................................................................................................................. 70 
3.5.3. Cardiovirus ............................................................................................................... 70 
3.5.4. Parechovirus ............................................................................................................. 71 
3.5.5. Cosavirus .................................................................................................................. 72 
3.5.6. Hunnivirus ................................................................................................................ 72 
3.5.7. Absence of the screened picornaviruses in bats, chickens and ducks ...................... 72 
 
Chapter 4. Enterovirus and kobuvirus infection in domestic pigs and boars ................ 74 
Introduction .......................................................................................................................... 74 
Pathogenicity of EVs and kobuviruses infecting pigs and boars ..................................... 74 
Definition of new EV types based on sequence divergence in the VP1 region ............... 75 
Prevalence, genetic diversity and recombination of species G enteroviruses infecting 
pigs in Vietnam ..................................................................................................................... 77 
INTRODUCTION ............................................................................................................ 78 
RESULTS .......................................................................................................................... 80 
Infection frequency of EV .............................................................................................. 80 
Genetic diversity of EV variants ..................................................................................... 80 
Recombination in the EV-G genome .............................................................................. 82 
DISCUSSION ................................................................................................................... 85 
METHODS ....................................................................................................................... 89 
Porcine EV screening ..................................................................................................... 89 
Amplification of VP4/VP2, VP1, 3Dpol and 5’UTR sequences .................................... 89 
ACKNOWLEDGEMENTS ............................................................................................. 91 
REFERENCES ................................................................................................................. 91 
Large-scale screening and characterization of enteroviruses and kobuviruses infecting 
pigs in Vietnam ..................................................................................................................... 95 
ABSTRACT ...................................................................................................................... 96 
INTRODUCTION ............................................................................................................ 96 
RESULTS .......................................................................................................................... 98 




Detection of kobuviruses ................................................................................................ 99 
Genetic characterization of porcine EV ........................................................................ 100 
Sequence and phylogenetic analysis of PKV ............................................................... 102 
Recombination of new types EV-G8, 9 ........................................................................ 104 
DISCUSSION ................................................................................................................. 106 
Genetic diversity and recombination in EV-G .............................................................. 107 
Infection frequencies, diversity and disease associations of PKV ................................ 108 
Conclusions .................................................................................................................. 110 
MATERIALS AND METHODS ................................................................................... 110 
Screening and typing of enteroviruses .......................................................................... 110 
Screening and characterization of kobuviruses ............................................................ 111 
PKV viral load measurement ........................................................................................ 111 
Complete genome sequencing of enteroviruses ............................................................ 112 
Sequence analysis ......................................................................................................... 112 
Statistical analyses ........................................................................................................ 112 
Nucleotide sequence accession numbers ...................................................................... 113 
ACKNOWLEDGEMENTS ........................................................................................... 113 
REFERENCES ............................................................................................................... 113 
Chapter conclusion ............................................................................................................ 117 
 
Chapter 5. Genetic characterization of enteroviruses in monkeys ................................ 118 
Introduction ........................................................................................................................ 118 
Picornavirus taxonomy and species definition ..................................................................... 118 
Species demarcation criteria in the Enterovirus genus ........................................................ 119 
Role of recombination in maintenance of picornavirus species ........................................... 120 
Impact of recombination on classification of EVs ............................................................... 120 
High Rates of Infection with Novel Enterovirus Variants in Wild Populations of 
Mandrills and Other Old World Monkey Species .......................................................... 122 
ABSTRACT .................................................................................................................... 123 
IMPORTANCE .............................................................................................................. 123 
MATERIALS AND METHODS ................................................................................... 125 
Samples. ........................................................................................................................ 125 




Whole-genome sequencing ........................................................................................... 126 
Direct sequencing of PCR products .............................................................................. 127 
Genetic analysis of EV sequences ................................................................................ 127 
Nucleotide sequence accession numbers ...................................................................... 127 
RESULTS ........................................................................................................................ 127 
EV RNA detection frequencies and viral loads ............................................................ 127 
EV type assignments..................................................................................................... 128 
Species assignment ....................................................................................................... 131 
Chimerism in EV genomes ........................................................................................... 132 
Genetic exchange of 5’- and 3’UTR sequences ............................................................ 135 
DISCUSSION ................................................................................................................. 136 
ACKNOWLEDGMENTS.............................................................................................. 142 
REFERENCES ............................................................................................................... 142 
Chapter conclusion ............................................................................................................ 146 
 
Chapter 6. Genetic characterization of picornaviruses in rodents and civets .............. 147 
6.1. Introduction ................................................................................................................. 147 
6.1.1. Rodents and civets as hosts of zoonotic pathogens ................................................ 147 
6.1.2. Kobuvirus, cardiovirus and hunnivirus infection in rodents .................................. 148 
6.1.3. Rodent and civet consumption in Vietnam ............................................................ 149 
6.2. Materials and methods ............................................................................................... 150 
6.2.1. Materials ................................................................................................................. 150 
6.2.2. Identification of rodent species .............................................................................. 150 
6.2.3. VP4/VP2, VP1 amplification ................................................................................. 150 
6.2.4. Complete genome sequencing of novel HuVs ....................................................... 151 
6.2.5. Sequence analysis ................................................................................................... 151 
6.3. Results .......................................................................................................................... 152 
6.3.1. Species identification ............................................................................................. 152 
6.3.2. Prevalence of picornaviruses .................................................................................. 152 
6.3.3. Genetic characterization of picornaviruses in rodents and civets ........................... 153 
6.3.4. Analysis of HuV coding region complete sequences ............................................. 156 
6.4. Discussion..................................................................................................................... 158 




6.4.2. Classification and zoonotic potential of the detected picornaviruses ..................... 158 
 
Chapter 7. Genetic characterization of picornaviruses in human samples .................. 162 
7.1. Introduction ................................................................................................................. 162 
7.1.1. Detection of EVs, kobuviruses and cardioviruses in humans ................................ 162 
7.1.2. People at high risk of zoonotic infections .............................................................. 162 
7.1.3. High risk cohort in this study ................................................................................. 163 
7.2. Materials and methods ............................................................................................... 164 
7.2.1. Materials ................................................................................................................. 164 
7.2.2. Methods .................................................................................................................. 164 
7.3. Results .......................................................................................................................... 164 
7.4. Discussion..................................................................................................................... 168 
7.4.1. Direct identification of viruses from clinical samples ............................................ 168 
7.4.2. Genetic diversity and disease association of the identified picornaviruses ............ 169 
7.4.3. Zoonotic origin of picornaviruses .......................................................................... 170 
7.4.4. Limitations of this study ......................................................................................... 170 
 
Chapter 8. Concluding remarks ....................................................................................... 172 
8.1. Prevalence of picornaviruses in screened samples ................................................... 172 
8.2. Association of the identified viruses with disease and age of infected humans and 
animals ................................................................................................................................ 173 
8.3. Diversity of the identified viruses .............................................................................. 173 
8.4. Absence of overlaps between viruses circulating among humans and other 
animals….. .......................................................................................................................... 174 
8.5. Future directions ......................................................................................................... 176 
8.6. Conclusion ................................................................................................................... 177 
 
Appendix 1. Permissions for reproduction of figures .......................................................... 178 
Appendix 2. Sequences obtained in Chapter 7 .................................................................... 181 




Chapter 1. Introduction 
 
1.1. Introduction 
Picornaviruses, members of the large and highly genetically diverse virus family 
(Picornaviridae), are of major economic and medical importance. Picornaviruses can 
infect a wide range of human and animal hosts (Table 1.1). Although most infections 
are asymptomatic, some picornaviruses cause mild illnesses, whereas infection with 
other picornaviruses results in serious conditions of the central nervous system, heart, 
skeletal muscles, and liver (Yin-Murphy & Almond, 1996). Pathogens of clinical 
importance in humans and other animals include the emerging hand, foot, and mouth 
disease viruses, poliovirus, hepatitis A virus and foot and mouth disease virus.   
A number of novel picornaviruses belonging to genera Enterovirus, Parechovirus, 
Cosavirus, Cardiovirus, Kobuvirus, Hunnivirus, etc. have recently been discovered 
and described (Knowles et al., 2012) with unknown zoonotic potential and disease 
association. Our understanding of the global epidemiology, transmission dynamics and 
genetic diversity of both the emerging and newly discovered picornaviruses is also 
limited. This thesis carried out as part of the VIZIONS project (Vietnam Initiative on 
Zoonotic Infections) (Rabaa et al., 2015) aims to address some of these gaps in our 
knowledge by examining viral diversity, distribution of types, molecular epidemiology 
(incidence, age and seasonal distribution), recent evolution and potential disease 
associations of viruses in the picornavirus genera mentioned above in the VIZIONS 
samples and monkey samples from Cameroon. 
These investigations apply recent advances in molecular technologies for the effective 
surveillance and diagnostic screening of viruses. Deep sequencing which requires no 
prior known knowledge of sequences to be detected is considered as the most effective 
tool for novel virus discovery (Knox et al., 2012). Its application has also helped 
elucidate microbiological aetiology of diseases of unknown origins (Kriesel et al., 
2012; Yozwiak et al., 2012). The method, on the other hand, has disadvantages of high 
costs of instruments and supplies, as well as methodological and bioinformatic 
complexity (Isakov & Shomron, 2011; McElroy et al., 2014). Furthermore, it is most 
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effective on samples collected from sterile sites such as cerebrospinal fluid, and 
samples which other potential causative agents have been excluded. Pre-identification 
of potential agents in clinical samples beyond current diagnostic screening is, 
therefore, useful for subsequent selection of samples for deep sequencing. Meanwhile, 
the much simpler molecular method of polymerase chain reaction (PCR), when using 
well-designed primer sets, can enable rapid "generic" protocols for detection of wide 
ranges of viruses. 
1.2. Zoonoses 
1.2.1.  Introduction 
The World Health Organization (WHO, 1959) defines zoonoses as diseases or 
infections that are naturally transmissible between vertebrate animals and humans. 
Among 1,407 human pathogen species, 816 (58%) were classified as zoonotic in a 
review by Woolhouse and Gowtage-Sequeria (2005). The review also showed 
zoonotic pathogens accounted for 73% (130/177) of emerging or reemerging species. 
The occurrence of zoonoses relies on the human-animal interface, which is the 
continuum of contacts between humans and animals, either directly or indirectly 
through their environments, or their products (Gortazar et al., 2014; Reperant et al., 
2012). People who have frequent and close exposure to animals are therefore at high 
risk, as indicated by modes of transmission of zoonotic pathogens: 35% by direct 
contact, 61% by indirect contact, 22% by vectors (Woolhouse & Gowtage-Sequeria, 
2005).  
Throughout history, human beings have suffered severe losses from the emergence of 
many infectious diseases, particularly those caused by viruses. Until now, Spanish 
Influenza was probably the worst pandemic, which killed more than 20 million people 
during 1918 – 1919. More recently, HIV remains incurable since its initial emergence 
in the early 1980s, with approximately 2 million deaths worldwide each year (Kuiken 
et al., 2003). Meanwhile, H5N1 has attracted considerable attention due to its ability 
to cause fatal human disease (Kerkhove, 2009) and raised public anxiety that the virus 
could acquire the ability to transmit efficiently between humans while retaining its 
high pathogenicity (Parrish et al. 2008). Understanding the underlying causes that 
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drive the emergence of viruses may help to develop strategies for infection control and 
prevention. 
1.2.2.  Factors underlying the emergence of zoonotic pathogens 
The emergence of a disease combines two elements: the introduction of the pathogen 
into the human population and its subsequent spread and maintenance within the 
population. There are a number of factors involved in the emergence of new viral 
diseases. In addition to virus evolution, environmental factors may also have important 
contributions. These together with host population determinants such as rapid growth 
of the world population and global transportation favour the establishment and rapid 
spread of viral diseases (Daszak et al., 2000; Jones et al., 2013; Morse, 2004; Özbal, 
2010; Parrish et al., 2008; Wang & Crameri, 2014). 
a) ENVIRONMENTAL FACTORS 
Environmental factors, especially changes in climate and land use, are often 
considered as the specific cause of emergence. These factors facilitate contact between 
humans and new natural reservoirs either by placing humans in close proximity to 
reservoir or by changing conditions that favour an increased population of the microbe 
or its natural host (Morse, 2004).  
Land use is changed due to most of the economic development activities like 
agricultural development or water projects, urbanization and deforestation. 
Disturbance of habitats as a result of change in land use, in turn, may influence the 
breeding sites or the biodiversity of vectors or hosts (Patz et al., 2008). There are strong 
evidences that emergence of new viral infections is associated with increased human-
reservoir contact as a result of change in land use. A recent example is Venezuelan 
hemorrhagic fever (Salas et al., 1991), a new disease caused by an arenavirus. The 
disease emerged primarily in settlers moving into areas of forest cleared for agriculture 
which was a favourable environment for the probable reservoir host, the cane mouse 
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Climate change  
Climate change is of a growing concern as a factor in the viral emergence. There are 
three major ways whereby warming climate has damaging impacts on human health:  
(a) creating conditions advantageous for outbreaks of infectious diseases to occur, 
(b) increasing the potential for transmissions of vector-borne diseases which are 
facilitated by wide distribution of vectors and the exposure of millions of people to 
new diseases and health risks, and 
(c) hindering the future control of disease (Mahmood, 2012).  
It results in the fact that viruses which used to be restricted to tropical areas may now 
spread to Europe and North America, for instance. In other words, emerging diseases 
can extend or reach new geographic areas due to climate change. In fact, this has 
happened and has been recorded. In 2007, chikungunya virus caused the first outbreak 
in Europe of a disease that had previously been found only in the tropical regions 
around Indian Ocean. Global warming has created conditions that make it easier for 
the tiger mosquito (Aedes albopictus), the vector of chikungunya, to be able to move 
north and occupy areas in Italy and spread the disease. Although this virus has not been 
reported to cause death in humans, the outbreak warns that other tropical diseases with 
more serious consequences can occur in the same way (Grazzini, 2008). Another 
example is the emergence of West Nile virus in the United States during the summers 
of 2002 and 2004, when the temperatures were above average, a condition required for 
efficient transmission of the virus (Reisen, 2006). 
Similarly, deforestation and climate change are blamed for the emergence of Nipah 
virus in Malaysia, resulting in hundreds of reported cases of acute viral encephalitis in 
1998 (Pike et al., 2010). Fruit bats (Pteropus vampyrus, Pteropus hypomelanus) are 
thought to be the natural reservoir hosts of the virus (Chua et al., 2002). The habitat 
loss due to forest fires and deforestation forced the fruit bats to search for fruits in 
orchards near the pig farms. The pigs in turn ate fruits contaminated with bat urine and 
saliva, and spread the virus to pig farmers (Jones et al., 2013; Reperant et al., 2012). 
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b)  VIRAL EVOLUTION 
In addition to the importance of ecological factors, it is also possible that genetic 
factors play an important role in the process of disease emergence (Holmes & 
Rambaut, 2004). Not all viruses require evolutionary changes to emerge in new hosts 
(Cutler et al., 2010). In some cases of viral emergence, the evolution of the virus is 
necessary to allow efficient infection and transmission within the new host (Parrish et 
al., 2008). Viruses can evolve quickly to adapt to the changing environmental 
conditions because they can acquire genetic variation by many mechanisms.  
Mutation 
The most common mechanism that affects all viruses is mutation which involves small 
changes in their genomic sequences. On average, a mutation happens during almost 
each replication cycle of virus genome (Holmes, 2009). Mutants can be point mutants 
(one base replaced by another) or insertion/deletion mutants. This can occur either in 
response to selective pressure and environmental conditions (such as radiation) or 
randomly as errors during genome replication for which RNA viruses generally have 
much higher mutation rates than DNA viruses do (Domingo, 2010). That is due to the 
inherent absence of RNA polymerase proofreading activity in RNA viruses, which 
leads to estimated mutation rates of 10-3 to 10-5 misincorporations per nucleotide 
copied (Domingo, 2010; Duffy et al., 2008), while that corresponding figure for 
eukaryotes is just 10-9 (Holmes, 2009). Although mutation has not been the mechanism 
leading to pandemic zoonotic influenza, it was of great concern when a controversial 
paper on avian influenza A/H5N1 mutant strain was published on Science (Herfst et 
al., 2012) after debate. The authors showed just as few as five amino acid substitutions, 
introduced in the laboratory by site-directed mutagenesis and subsequent serial 
passage in ferrets, were sufficient for the avian influenza A/H5N1 strain to become 
airborne transmissible between these mammals. This finding highlighted the threat that 
highly pathogenic avian influenza A/H5N1 virus, which can cause morbidity and 
mortality in humans, may naturally acquire similar mutations to be transmitted by 
aerosol or respiratory droplet. 
 
 




Figure 1.1. Comparison of mutation rates in viruses. Adapted from Duffy et al., 2008. 
Recombination 
Viruses can also achieve new genetic information by exchange of a short part between 
two strands of viral DNA/RNA during the process of viral nucleic acid replication 
inside the host cell, termed recombination, which can be of major evolutionary 
importance. In order for recombination to take place, a cell needs to be infected with 
at least two viruses. It occurs at dramatically different rates among viruses and is 
reported mainly from RNA viruses (Holmes, 2009). This mechanism is considered as 
a force to remove deleterious mutations or a means to create genomic diversity, 
whereby increasing the chance of finding a genetic combination that can adapt the new 
environment, such as a new host (Domingo, 2010; Holmes, 2011). For example, a 
number of poliomyelitis outbreaks were related to recombinant viruses between 
attenuated vaccine polioviruses and other circulating EVs (Adu et al., 2007; Estívariz 
et al., 2008; Kew et al., 2002; Rakoto-Andrianarivelo et al., 2008; Rousset et al., 2003; 
Shimizu et al., 2004; Yang et al., 2003). 
Reassortment 
The third most common mechanism of virus evolution is reassortment in which 
segments of genomes from different viruses infecting the same cell (mixed infections) 
are exchanged. Therefore, segment reassortment is a major evolutionary force which 
occurs only in some viruses with segmented genome and is a key mechanism for rapid 
novel virus creation (Holmes, 2011). Strains with novel reassortment can escape from 
the attack of adaptive immunity by introducing antigens to a naïve host population. 
New antigenic combinations acquired from recombination or reassortment may 
support emerging viruses in the process of cross-species jump to infect humans 
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(Domingo, 2010) or can create a novel virus that is both highly pathogenic and easily 
transmissible between humans (Özbal, 2010).  
It is worth noting that many recent emerging viruses that cause human infections show 
active recombination or reassortment (Domingo, 2010). The continual change of genes 
that encode 2 envelope proteins of influenza A virus (haemagglutinin and 
neuraminidase) is a convincing example of how the virus has benefited from 
recombination and reassortment (Holmes, 2011). Reassortment which involved a 
genome of nonhuman origin is responsible for at least two human influenza pandemics 
in the 20th century. It was reinforced by the emergence of the H1N1 influenza (swine 
flu) in humans (Greenbaum et al., 2012). First described in April 2009, the virus arose 
from a triple reassortment of genes from human, swine and avian influenza A viruses. 
Emerging in Mexico, this virus quickly spread the globe and was then declared the 
cause of a new pandemic by the World Health Organization (WHO). According to the 
recent WHO statistics (July 2010), the virus had killed more than 18,000 people since 
it appeared, however the real number from the H1N1 strain is "unquestionably higher" 
due to unconfirmed or unreported deaths (WHO, 2010). 
c) TRAVEL 
Global travel has been considered as one of the major factors that enhance the risk of 
global spread of infectious diseases. Modern means of transportation like air transport 
facilitate the spread of infectious agents (Wilson, 1995). In 2005 Steve Fossett 
completed non-stop circumnavigation in a record time of just sixty seven hours by air 
while a century ago, the same journey took more than a year (Smith, 2009). Human 
migration facilitates the emergence of infectious diseases by unintentionally carrying 
pathogens or disease vectors in or on their bodies and luggage. Furthermore, their 
cultural traditions, habits and behavioral patterns may be not suitable for a new 
environment, increasing their risk for infection. A compelling example is the first 
severe infectious disease to emerge in the 21st century, severe acute respiratory 
syndrome or SARS, whose international spread was enabled by long distance travel 
(Ruan et al., 2006). The rapid transmission of the virus, forced the WHO to issue 
emergency travel guidance and advice to airlines and travelers, providing case 
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definitions for probable and suspect cases of SARS (WHO, March 15, 2003). SARS 
was rapidly brought under control but had caused more than 8,000 confirmed cases 
and 774 deaths in 30 countries and regions (WHO, 8/15/2003) (Ruan et al., 2006).  
d) DEMOGRAPHICS  
Animals have long been identified as reservoirs of zoonotic viruses and are responsible 
for most newly emerging viral infections in humans (Murphy, 1998; Taylor, 2001; 
Woolhouse & Gaunt, 2007). Meanwhile, the global human and livestock animal 
populations have undergone explosive growth. The world population reached more 
than seven billion people by the end of 2011, and it is projected to soar to over nine 
billion by 2050. Population growth has resulted in global overpopulation which 
favours infectious diseases by many ways, including increased travel, increases in wars 
and refugees, more overcrowded slums, environmental pollution and increasing 
interactions between humans and animals through hunting, trading of animal products, 
animal husbandry, and the domestication of animals or exotic pets. The probability of 
cross-species transmission, as a consequence, appears to be dramatically accelerating. 
For example, studies on the emergence of the H5N1 influenza viruses, which have 
caused sporadic outbreaks in Asia and Europe since 1997, have showed that direct 
contact with sick or dead poultry or wild birds is the most important risk factors for 
human H5N1 infection (Zhou et al., 2009). HIV is another example. Human contact 
with wild primates through hunting and butchering in the early 20th century led to the 
introduction of simian immunodeficiency virus into the humans, resulting in current 
HIV pandemic (Worobey et al., 2008). 
In summary, many factors underlie the emergence of new human infections caused by 
viruses, including changes in human demographics and behavior, microbial adaptation 
and evolution, ecological and environmental changes. Clearly understanding of these 
determinants is needed for prevention and control of emerging viral diseases. New 
viral diseases will continue to emerge in humans in the future but when and where they 
occur is unknown. Survey of the circulating zoonotic viruses, assessment of the risk to 
the human and animal populations, with effective communications networks, 
developing new vaccines and antiviral agents, along with an increasing understanding 
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of viral population dynamics will contribute to either delaying viral emergences or 
minimizing their impact once they occur (Domingo 2010). 
1.3. Pathogen pyramid 
The concept of the pathogen pyramid (Figure 1.2) was suggested (Wolfe et al., 2004) 
and developed (Wolfe et al., 2007) to summarize disease emergence. The pyramid has 
four levels (Woolhouse & Gaunt, 2007) representing different degrees of human-
pathogen interaction.  
Level 1: Exposure 
This stage represents the exposure of humans to a microbe but this does not result in a 
particular infection in humans. The source of emerging viruses is most likely to be 
other mammals or birds. The exposure can be via contact with materials containing the 
microbe (blood, saliva, faeces) or contaminated food and water or via a vector. The 
exposure rate depends on both the distribution and ecology of the animal host and 
human activities as reviewed above. 
 
Figure 1.2. The pathogen pyramid, adapted from (Woolhouse & Gaunt, 2007). Each level represents a 
different degree of interaction between pathogens and humans. Some pathogens are able to progress 
from one level to the next (arrows); others are prevented from doing so by biological or ecological 
barriers (bars). 
Level 2: Infection 
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At this stage, a microbe is capable of infecting humans and may cause disease. Only a 
subset of the animal microbes that humans expose to can cross the ‘species barrier’ - 
the natural mechanisms that involve both the molecular biology of the microbe (e.g. is 
it capable of replicating in human cells) and the physiology of the exposed human 
(especially immunocompetence) - to infect humans. As mentioned above, 1,407 
pathogen species, more than half of which are from other species of mammal, have 
been known to reach this stage. Moreover, it is notable that almost 70% of 374 
pathogen species in dogs and cats are zoonotic (Cleaveland et al., 2001). This indicates 
the species barrier (at least between humans and other mammals) may not always be 
profound. 
Level 3: Transmission 
A subset of microbes from level 2 that can infect humans are also capable of 
transmission between humans. Transmission can be direct (e.g. via sexual contact) or 
indirect (e.g. via contaminated food) or via an arthropod vector. Despite the lack of 
information for many pathogen species, a literature search (Taylor et al., 2001) 
suggested that at least 500 species can transmit between humans. The barriers to 
human-to-human transmission mainly reflect the human host-pathogen interaction, 
with focus of the possibility of the virus to access tissues from which it can exit the 
host, such as the upper respiratory tract, lower gut, urogenital tract, skin or blood.  
Level 4: Epidemic Spread 
Pathogens that can progress to this stage are characterised by their ability of sufficient 
transmission between humans to cause major epidemics and/or become endemic in 
human populations without the requirement of animal host. Only a few pathogens that 
spill over from animals have epidemic or pandemic potential but the global impact 
could be devastating. It was estimated that 100 to 150 pathogen species are capable of 
causing major outbreaks within human populations (Woolhouse & Gowtage-Sequeria, 
2005). 
Level 3 and 4 can be differentiated using the concept of the basic reproduction number, 
R0, defined as the average number of secondary cases of infection produced when a 
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primary case is introduced into a large population of previously unexposed hosts 
(Anderson & May, 1992). On average, for level 3, a single primary case will produce 
less than one (R0 < 1) secondary case. In contrast, at level 4, on average, more than 
one secondary case are produced from a single primary case (R0 > 1), leading to at 
least initially an exponential increase in the number of cases and possibly ultimately a 
major epidemic. 
The barriers between level 3 and level 4 are both biological (pathogen infectivity, host 
susceptibility, the infectiousness of the infected host, the length of the infection) and 
epidemiological (the rate and pattern of contacts between infectious and susceptible 
hosts).  
While relatively little is known about the factors driving the transition from one level 
to the next, clearly the human-animal interface is of paramount importance in the 
process. The possibility of cross-species transmission dramatically increases with the 
interaction between humans and animals through bushmeat practice, the trading of 
animal foods, animal husbandry practices, wet markets, the domestication of animals 
(Pike et al., 2010). 
1.4. Picornaviruses  
1.4.1. General aspects 
Picornaviruses belong to the family Picornaviridae, one of five virus families of the 
order Picornavirales (which also includes Dicistroviridae, Marnaviridae, Iflaviridae 
and Secoviridae) (Sanfaçon et al., 2011). Members of the order have a single stranded 
positive sense ribonucleic acid (RNA) genome and are grouped together on the basis 
of similar capsid structure and viral life cycles. The family is named for the fact that 
all members are extremely small (pico) RNA viruses. 
Picornaviruses have a wide range of human and animal hosts (Table 1.1) with 
infections ranging from asymptomatic to severe illnesses such as gastroenteritis, 
aseptic meningitis, encephalitis, the common cold, hand-foot-and-mouth disease, 
conjunctivitis, herpangina, myositis, myocarditis, hepatitis, foot-and-mouth disease 
(Knowles et al., 2010; Yin-Murphy & Almond, 1996). 
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a Information included on number of types and known host species is adapted from information available 
Table 1.1. Members of the family Picornaviridae and their natural hosts 
Genera Species Number of typesa Host 
Apthovirus 
Foot and mouth disease virus 
(FMDV) 
7 Cloven-footed animals 
(cattle and pigs) 
Bovine rhinitis A virus (BRAV) 2 Cows 
Bovine rhinitis B virus (BRBV) 3 Cows 
Equine rhinitis A virus (ERAV) 1 Horses 
Aquamavirus Aquamavirus A 1 Seals 
Avihepatovirus Avihepatovirus A  3 Ducks 
Avisivirus Avisivirus A 1 Turkeys 
Cardiovirus 
Cardiovirus A 
2 Pigs, aardvarks, domesticated 
wild boars, mice, tigers, 
primates, humans, elephant 
Cardiovirus B 15 Rodents, humans 
Cardiovirus C 2 Rats 
Cosavirus Cosavirus A 24 Humans 
Dicipivirus Dicipivirus A 1 Dogs 
Enterovirus 
Enterovirus A (EV-A) 25 Humans, primates 
Enterovirus B (EV-B) 63 Humans, primates, pigs 
Enterovirus C (EV-C) 23 Humans, primates 
Enterovirus D (EV-D) 5 Humans, primates 
Enterovirus E (EV-E) 4 Cows 
Enterovirus F (EV-F) 6 Cows, possums 
Enterovirus G (EV-G) 16 Pigs, sheep 
Enterovirus H (EV-H) 1 Primates 
Enterovirus J (EV-J) 6 Primates 
Rhinovirus A  80 Humans 
Rhinovirus B 32 Humans 
Rhinovirus C 55 Humans 
Erbovirus Erbovirus A 3 Horses  
Gallivirus  Gallivirus A 1 Chickens, turkeys 
Hepatovirus  Hepatovirus A 1 Humans, primates 
Hunnivirus  Hunnivirus A 4 Cattle, sheep, rats  
Kobuvirus  
Aichivirus A 1 Humans 
Aichivirus B 2 Cows, sheep 
Aichivirus C 1 Pigs, wild boars 
Kunsagivirus  Kunsagivirus A 1 Rollers 
Megrivirus  Melegrivirus A 1 Turkeys 
Mischivirus  Mischivirus A 1 Bats 
Mosavirus  Mosavirus A 2 Mice, rollers 
Oscivirus  Oscivirus A 2 Birds 
Parechovirus  
Parechovirus A 16 Humans, primates 
Parechovirus B 4 Voles  
Pasivirus  Pasivirus A 3 Pigs  
Passerivirus  Passerivirus A 1 Birds 
Rosavirus  Rosavirus A 2 Humans, mice 
Sakobuvirus  Sakobuvirus A 1 Cats  
Salivirus  Salivirus A 2 Humans, primates 
Sapelovirus  
Sapelovirus A 1 Pigs 
Sapelovirus B 3 Primates 
Senecavirus  Senecavirus A 1 Pigs 
Sicinivirus  Sicinivirus A 1 Chickens 
Teschovirus  Teschovirus A 13 Pigs, wild boars 






Chapter 1. Introduction 
13 
 
on the Picornavirus Study Group website (www.picornaviridae.com, accessed November 10, 2015). 
Transmission is horizontal through either faeco-oral or respiratory routes or both. 
Some picornaviruses can remain infectious for variable periods in the environment 
outside their host cells and, therefore, may be transmitted via contaminated surfaces 
(Knowles et al., 2010). 
1.4.2.  Classification 
Picornaviridae is one of the most diverse virus families, with 50 species grouped into 
29 genera (Table 1.1) (http://www.picornaviridae.com, accessed November 10, 2015). 
The classification of RNA viruses has particular difficulties due to their frequent 
recombination and high mutation rates during replication of the genome. Picornavirus 
classification is still in flux because a number of candidates for novel viruses belonging 
to this family have recently been discovered and described (Knowles et al., 2012). The 
discovery of novel picornaviruses that are unassigned and appear to be intermediate 
between known genera may result in the joining of some genera (as the case of entero- 
and rhinoviruses). Picornaviruses were formerly classified using properties, some of 
which such as pH stability, host specificity and receptor usage have been found 
unreliable for measuring relationships. The classification of picornaviruses is now 
based on phylogenetics, minor differences in genome organization and gene content 
(Knowles et al., 2010).  
The length of sequences (whole genomes or smaller regions) used for classification 
will depend on (i) the taxonomic level being studied and (ii) whether recombination 
with other picornaviruses has been reported. For genera and species levels, P1 (the 
precursor of proteins 1A – 1D) and the combined 2C and 3CD regions are used as one 
of the main criteria for classification as P1 has the antigenic properties, the traditional 
way of defining virus identity, while 2C + 3CD is usually the most conserved and 
readily aligned region of the genome (Knowles et al., 2010). According to the Ninth 
Report of the International Committee on Taxonomy of Viruses (Knowles et al., 
2012), members of a picornavirus species must share i) a natural host range, ii) a 
common genome organization, iii) greater than 70% identity in the amino acid 
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sequences of both the polyprotein and the combined 2C + 3CD polypeptides. The P1 
thresholds of species vary between genera. 
Because distinct viral genotypes or even minor genetic variations can lead to large 
changes in viral pathogenicity (Blinkova et al., 2009; Zoll et al., 2009a), it is necessary 
to identify picornaviruses to type level which for many years, serological methods 
were the standard technique. Serotyping, which includes virus isolation and 
subsequent neutralization of cultured viruses, is time-consuming (isolation and 
serotype determination serotyping of EV takes 1 – 2 weeks). Moreover, virus isolation 
requiring multiple cell lines and highly optimised cell culture methods is labour 
intensive (Muir et al., 1998). Some viruses (such as members of Rhinovirus C) are 
difficult or even impossible to isolate (Bochkov & Gern, 2012). The neutralization step 
requires standardised sera which are in limited supply. 
The ability of PCR-based methods to directly identify serotypes in clinical specimens 
overcomes these disadvantages of cell culture-based methods for serotying (Leitch et 
al., 2009). The EV VP1 gene encoding for a protein that contains a number of 
neutralization domains has been proved to correspond with results obtained by 
neutralization (serotype) test, and hence, with phylogenetic lineage (Kiang et al., 2009; 
Kilpatrick et al., 1998; Oberste et al., 1999). In such manner, both genotypic 
identification and assignment of types are based on the sequences of VP1 (Stanway et 
al., 2005). Practical thresholds for EV type identification include VP1 identity of at 
least 75% in the nucleotide sequence or 88% in amino acid sequence (Oberste et al., 
1999). 
1.4.3.  Genome organisation and proteolytic processing 
The genomes of all picornaviruses consist of single-stranded, positive sense, 
nonsegmented RNA. The known genomes range in length from 7,032 bases (Avian 
encephalomyelitis virus) to 8,828 bases (Erbovirus) and share a highly conserved 
organization which is also a defining characteristic of the family. The genomes 
comprise of 5’ and 3’ untranslated terminal regions flanking a single open reading 
frame (Palmenberg et al., 2010). The 3ˈ poly(A) tail is genetically encoded and 
essential for genome replication (Herold & Andino, 2001). The 5’ end of the RNA 
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genome covalently links to a small viral genome-linked protein (VPg), which acts as 
a primer for genome replication. The VPg is encoded by the short and well conserved 
3B gene. Unlike other picornaviruses, FMDV and aquamavirus A genomes consist of 
more than one sequential paralogous VPg genes (Forss & Schaller, 1982; Knowles & 
Wadsworth, 2010). In contrast to eukaryotic messenger RNA, picornavirus RNA lacks 
a methylated 5ˈcap structure. The cap-independent translation occurs via ribosome 
binding to an internal ribosome entry site (IRES) located in the 5’UTR of the viral 
RNA (Palmenberg et al., 2010).  
The single open reading frame encodes for a co-translationally cleaved polyprotein. 
Therefore, full-length translation products are not present in the infected cells 
(Martinez-Salas & Ryan, 2010). The translated polyprotein is cleaved into three 
regions known as P1, P2 and P3 (Rueckert & Wimmer, 1984). These regions are then 
processed by viral proteases and autocatalytic cleavages (Figure 1.3) to produce capsid 
components and non-structural proteins.  
 
Figure 1.3. Genome organisation, polyprotein processing cascade and capsid architecture of EV. 
Several notable differences between proteolytic processing events in other picornavirus genera exist. 
Adapted from (Hober et al., 2013). Organisation of picornavirus genome is shown on the top line. The 
translation of the genome results in a polyprotein which is cleaved into four capsid proteins (dark gray) 
and seven non-structural proteins (light gray and yellow). 
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As ribosomes traverse the middle region of the genome, the junction between the P1 
and P2 coding regions is cleaved by the 2A proteinase in Enterovirus and by the 3C 
proteinase in Cardiovirus, Parechovirus, Hepatovirus and Apthovirus, whose 2A 
protein does not have proteolytic activity. In some picornavirus genera (Apthovirus, 
Cardiovirus, Erbovirus, Kobuvirus and Sapelovirus), the P1 region is preceded by a 
leader protein (L). However, only the leader protein of Apthovirus and Erbovirus 
functions as a proteinase (Martinez-Salas & Ryan, 2010). Next, 3C proteinase 
catalyzes the cleavage between the P2 from P3 regions in all picornaviruses. 
Subsequent cleavage events are processed either by the 3C proteinase or its precursor 
(3CDpro), that also possesses proteolytic activity. The final event is the maturation of 
VP0 to form VP4 and VP2 during the last stages of virion morphogenesis. VP0 
cleavage is thought to be autocatalytic (Fry & Stuart, 2010), as the VP0 scissile bond 
is located deep within a maturing particle and is inaccessible to exogenous proteases 
(Arnold et al., 1987). 
1.4.4.  Virion structure 
As the name indicates, picornaviruses are small viruses (28 – 30nm in diameter) with 
positive-stranded RNA genome surrounded by a protein shell (capsid). Their infectivity is 
not affected by inorganic solvents as they lack a lipid envelope. Despite the genetic 
diversity of the capsid coding sequences, picornaviruses share the conserved capsid 
structure across the family (Racaniello, 2007). The three dimensional structure of the 
capsid has been determined for some picornaviruses of different genera such as EVs 
(Filman et al., 1998; Garriga et al., 2012; Hadfield et al., 1997; Medappa et al., 1971; 
Oliveira et al., 1993), senecavirus (Venkataraman et al., 2008), FMDV (Acharya et al., 
1989; Lea et al., 1995; Lea et al., 1994) and cardioviruses (Grant et al., 1992; Luo et al., 
1992). 
Figure 1.4. The structure of human rhinovirus virions. Adapted from (Dreschers et al., 2007). (a): Electron 
microscopy analysis of purified rhinoviruses. (b): Structural model of rhinovirus obtained from cryoelectron 
microscopic data. (c): Positions of capsid proteins VP1, VP2 and VP3 on the rhinovirus capsid. 
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The capsid of most picornaviruses is composed of 60 copies of the four proteins VP1 
to VP4. For parechoviruses and kobuviruses, VP0 remains uncleaved and their virions 
contain 60 copies of only three proteins, VP0, VP1 and VP3 (Stanway et al., 1994). 
The external capsid proteins, VP1 to VP3 make up an 8 stranded antiparallel beta 
barrel (jelly roll) widely found in RNA viruses. The VP4 protein is attached to the 
inner surface of the capsid (Fry & Stuart, 2010). 
The capsid proteins are assembled in a stepwise process. First, VP0, VP1 and VP3 
form a protomer. After that, a pentamer is produced from five protomers. Twelve 
pentamers then assemble to form a rigid pseudo-spherical structure with icosahedral 
symmetry surrounding a newly synthesized RNA (Hellen & Wimmer, 1995). The 
maturation cleavage of VP0 into VP4 and VP2 confers stability on the particle. The 
capsid is stable to protect the fragile RNA genome but, at the appropriate signal, is 
also flexible (Smyth & Martin, 2002) to dissociate or undergo conformational changes 
described as “breathing” during which VP4 and the N-terminus of VP1 become 
exposed (Lewis et al., 1998; Li et al., 1994). These changes are necessary for viral 
RNA genome release.  
The virion has five fold, three fold and two fold axes of symmetry. In most 
picornaviruses, a circular depression or “canyon” formed by the beta barrels of the 
VP1 protein around each icosahedral fivefold axis of symmetry is a receptor-binding 
site (Colonno et al., 1988; Hewat et al., 2000). Apthoviruses lack the canyon and bind 
to receptors via flexible surface loops (Acharya et al., 1989). The VP1 β-barrel of 
many picornaviruses also contains a hydrophobic pocket which is occupied by “pocket 
factors” (Oliveira et al., 1993; Verdaguer et al., 2000). Antiviral drugs such as 
hydrophobic antiviral WIN compounds, which bind tightly to this pocket, inhibit the 
uncoating and subsequent delivery of the RNA genome into the host cell (Smith et al., 
1986). 
1.4.5.  Life cycles of picornaviruses  
The replication of picornaviruses takes place in the cytoplasm of the host cell. Binding 
of the virus to specific host cell receptors triggers irreversible conformational 
alterations in the capsid which results in the cell entry and release of the viral RNA 
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genome into the cytoplasm. The genome is first translated to produce the viral proteins 
needed for genome replication. After negative strands are synthesized from the RNA 
genome, they are used as templates for positive strand RNA synthesis. Capsid proteins 
and newly synthesized viral RNA genomes assemble into mature virions which are 
then released from the cell. The entire cycle (Figure 1.5) completes in around 5 – 10 
hours (Racaniello, 2007).  
 
Figure 1.5. Summary of the picornavirus life cycle. Adapted from (Whitton et al., 2005). The figure 
summarises key events in the replication of picornaviruses and the main events are described in the text 
below. © represents the cap present on most cellular mRNA.  
Picornaviruses can use a wide variety of cell surface receptors for binding and cell 
entry. The receptor usage profile of picornaviruses is complex and receptor 
specificities of some major picornavirus species are summarised in Table 1.2. Cell 
surface receptor specificity is an essential factor determining cell/tissue tropism and, 
thereby, defining host species and pathogenesis. However, receptor expression seems 
not to be the sole determinant of tissue tropism because cellular receptors used by 
picornaviruses are expressed in many tissues but viral tropism may be limited to just 
some of those tissues. For example, both ICAM-1 (exploited by HRV) and CD155 
(PV receptor) are expressed in many tissue types throughout the body but HRV and 
PV primarily replicate in the respiratory and gastrointestinal tracts, respectively. 
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A picornavirus may use multiple routes of entry, depending on the target cell and the 
receptors available on that cell (Bergelson & Coyne, 2013). Picornaviruses have no 
lipid membrane that can directly fuse with the host cell plasma membrane for cell 
entry. Instead, picornaviruses utilize a variety of mechanisms for effective deliver of 
their genome into the cytoplasm. Picornaviruses enter the cell by different mechanisms 
of endocytosis and subsequent release from vesicles (Brandenburg et al., 2007; Tuthill 
et al., 2010). For apthoviruses and some HRV, the endocytosis is clathrin-mediated 
(Tuthill et al., 2010). Some EVs undergo endocytotic uptake via a caveolin mediated 
pathway, while PVs rely on a caveolin, clathrin-independent process (Brandenburg et 
al., 2007; DeTulleo & Kirchhausen, 1998). 
Table 1.2. Receptors used by selected picornaviruses 
Receptor Virus Natural host 
CD155 Poliovirus Humans 
ICAM-1 Rhinovirus (major group) Humans 
LDLR Rhinovirus (minor group) Humans 
Coxsackie and adenovirus 
receptor (CAR) 
Coxsackie viruses Humans 
DAF/CD55 Coxsackie viruses, EV70 Humans 
Murine vascular cell adhesion 
molecular 1 (VCAM-1) 
Encephalomyocarditis virus Rodents 
Integrins FMDV 
Parechovirus 
Cloven footed animals 
Humans 






Human P-selectin glycoprotein 
ligand 1 
EV71 Humans 
HAV-cr1 Hepatitis A virus Humans 
 
Information adapted from (Bergelson, 2010; Pallansch & Roos, 2007; Racaniello, 2007; Tuthill et al., 
2010). 
The uncoating of the RNA genome is regulated by cues from receptors (as for PVs and 
major group HRVs) and/or chemical cues such as low pH as in the case of minor group 
HRVs (Suomalainen & Greber, 2013). Binding of PVs and the major group HRVs to 
their receptors (CD155 and ICAM-1, respectively) induces externalization of the N-
terminus of VP1 and release of the N-myristoylated VP4 from the virion (or capsid 
breathing) before or during virus uptake by endocytosis (Brandenburg et al., 2007; 
DeTulleo & Kirchhausen, 1998). In contrast, minor HRV such as HRV-2 do not 
receive sufficient uncoating cues from binding to their receptor (LDLR) and must also 
depend on acidification (pH 5.4) of the late endosomes to undergo antigenic 
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conversion (Brabec et al., 2003; Garriga et al., 2012; Schober et al., 1998). The 
exposed VP1 tethers the virus to the endosomal membrane, and VP4 forms an aqueous 
pore in the membrane which is thought to be the entry of viral RNA into the cytoplasm 
(Danthi et al., 2003; Davis et al., 2008b; Fricks & Hogle, 1990). Capsid breathing can 
be blocked by uncoating inhibitors, such as pleconaril or WIN compounds. These bind 
to the receptor-docking cavity in the capsid, stabilize the capsid conformation, thereby 
block the release of VP4 and RNA from the virus (Lewis et al., 1998). 
Once in the cytoplasm, the viral RNA must be first translated in order to produce the 
viral proteins necessary for genome replication. These proteins are not naturally 
available in the host cell. When sufficient amounts of viral proteins have been 
produced, the switch from translation to replication occurs as viral genomes that are 
being actively translated cannot serve as templates for RNA synthesis (Barton et al., 
1999; Gamarnik & Andino, 1998). The host protein poly(rC) binding protein and the 
uncleaved viral protease polymerase precursor 3CD bind to the 5ˈ cloverleaf structure 
of the RNA genome to form a ribonucleoprotein (RNP) complex (Andino et al., 1990; 
Rohll et al., 1994). This complex interacts with the poly(A) binding protein that is 
bound to the 3ˈ end of the viral genome. As a result of this interaction, the ends of the 
viral RNA link together to form a circular RNP complex, which in turn initiates 
negative strand RNA synthesis from the 3ˈpolyA region (Herold & Andino, 2001). 
The viral RNA dependent RNA polymerase, encoded by the 3D gene, is responsible 
for RNA synthesis. The negative strand then functions as a template for synthesis of 
positive strand, possibly after being anchored in the membranous replication complex 
by viral protein 2C (Banerjee et al., 1997). The viral polymerase uses the uridylated 
protein VPg (VPg-pU-pU) as a primer for RNA synthesis which takes place within 
replication complexes bound to smooth membrane vesicles (Bienz et al., 1994). The 
compartmentalization of RNA replication may enhance replication efficiency by 
localisation of all required components and protection from host defences (e.g. a 
dsRNA activated immune response) during the replication cycle (Racaniello, 2007).  
Some of the newly synthesized positive stranded RNA viral genomes are translated to 
produce viral capsid components. Each positive-sense RNA genome is linked to a VPg 
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protein and enclosed in a capsid. The final event prior to cell lysis is the cleavage of 
VP0 to yield the mature capsid proteins VP4 and VP2 (Lee et al., 1993). 
1.4.6. Recombination in the evolution of picornaviruses 
As mentioned, recombination is the process of genetic exchange between different 
organisms to create a chimeric genome. Recombination can be inferred indirectly from 
the identification of separate evolutionary origins of different genome regions created 
by a recombination event. A limitation of these observational methods is that they are 
unable to detect recombination between identical or very closely related parents, or in 
case the recombination parents no longer exist (Simmonds, 2010). Non-viable 
recombinants that are generated randomly within a single replication cycle cannot 
usually be detected either. Recombination in picornaviruses can be classified as 
homologous (between homologous parental RNAs, crossovers at homologous sites), 
aberrant homologous (between similar viruses without maintaining strict alignment) 
or nonhomologous (between unrelated RNA sequences) (Lai, 1992). Due to the 
likelihood of generating viable recombinants, homologous recombination is most 
frequently observed (Holmblat et al., 2014). 
The most widely accepted recombination model in RNA viruses is the copy-choice 
model. In this process, the RNA dependent RNA polymerase switches from one RNA 
molecule to another during synthesis while still binding to the nascent RNA. 
Consequently, an RNA molecule with mixed ancestry is generated (Simon-Loriere & 
Holmes, 2011). This mechanism requires coinfection of the same host cell by two 
different viruses whose replication takes place simultaneously within the same cellular 
compartment. The nascent strand dissociation may be promoted by RNA secondary 
structure or nucleotide misincorporations which causes the elongation pausing (Agol, 
1997). Another proposed mechanism of recombination which is replication 
independent is the breakage and rejoining of RNA strands (Gmyl et al., 2003).  
Natural recombination is very frequent in picornaviruses and has been well 
documented in different picornavirus genera such as Aphthovirus (Heath et al., 2006; 
Simmonds, 2006), Parechovirus (Benschop et al., 2008c; Calvert et al., 2010; Chen et 
al., 2015; Zoll et al., 2009b), Teschovirus (Simmonds, 2006; Wang et al., 2010), 
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Cardiovirus (Naeem et al., 2014; Ren et al., 2013), Kobuvirus (Fan et al., 2013) and 
Enterovirus (Gaunt et al., 2015; Liu et al., 2014; Lukashev et al., 2003; McIntyre et 
al., 2013a; Oberste et al., 2004a; Oprisan et al., 2002; Santti et al., 1999; Simmonds 
& Welch, 2006; Smura et al., 2014; Tang et al., 2014; van der Sanden et al., 2011). 
Documented recombination events in these genera tended to occur in the 5ˈUTR and 
the non-structural coding regions.  
There is evidence that picornaviruses benefit from recombination. A recent study 
suggested recombination may play a role in the emergence and pathogenicity of CVA6 
associated with several outbreaks worldwide of atypical HFMD or eczema herpeticum 
in the UK (Gaunt et al., 2015). More convincingly, natural recombination between oral 
live-attenuated poliovirus vaccine strains and circulating EV generated pathogenic 
vaccine-derived PVs that subsequently caused outbreaks of vaccine associated 
poliomyelitis, implicating difficulties for the PV eradication campaign (Cuervo et al., 
2001; Guillot et al., 2000; Jegouic et al., 2009; Simmonds & Welch, 2006). 
Understanding the frequency and nature of naturally occurring recombination events 
in the circulation of a virus is, therefore, important for development and 
implementation of therapeutic strategies and potential vaccines. 
1.5. Picornavirus genera in this study 
1.5.1.  Enterovirus 
EVs are among the most common viruses infecting humans and are associated with a 
broad spectrum of clinical syndromes, ranging from minor febrile illness to severe and 
potentially fatal diseases (Bessaud et al., 2008). The EVs originally included only 
human viruses and were classified into four groups on the basis of their pathogenesis 
in humans and experimental animals: polioviruses (PV), coxsackieviruses A (CVA), 
coxsackieviruses B (CVB), and echoviruses. PV can infect primates although they are 
unlikely reservoirs in nature (Dowdle & Birmingham, 1997). CVA were discovered 
from stool samples of children with paralysis in the town of Coxsackie, New York 
(Dalldorf & Sickles, 1948). CVB were isolated from cases of aseptic meningitis 
(Melnick et al., 1949). CVA caused a flaccid paralysis while infection with CVB 
resulted in a spastic paralysis and severe systemic infection in suckling mice. The last 
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classical group of human EV are named echoviruses (enteric cytopathogenic human 
orphan viruses) due to their initial lack of association with clinical disease in either 
humans or laboratory animals. Echoviruses were first isolated from tissue culture 
samples (Robbins et al., 1951).  
As more sequence data were available, it was realized that these subgroups did not 
correlate with observed phylogenetic relationships (Hyypiä et al., 1997). In addition, 
each type may cause a wide spectrum of symptoms, making classification using 
clinical terms impossible. Therefore, human EVs were reclassified into four species 
(HEV-A – D) on the basis of sequence identity and phylogenetic relationships. Within 
each species, individual types were identified either by neutralization test or sequence 
comparison of the VP1 region. This new classification method has led to the 
recognition that many animal viruses also belong to the Enterovirus genus (Table 1.1). 
Indeed, many EVs infecting non-human primates are members of human EV species 
HEV-A – D (Harvala et al., 2012; Harvala et al., 2011b; Sadeuh-Mba et al., 2014). 
This has resulted in the removal of the host species from the enterovirus names.  
The Enterovirus genus consists of 12 species, including 3 rhinovirus species (A to C) 
and 9 enterovirus species (A to J) that infect humans, pigs, cows and nonhuman 
primates (www.picornaviridae.com, accessed November 10, 2015 (Knowles et al., 
2010)). The genus is notable for its high genetic and antigenic diversity with more than 
300 serotypes (Table 1.1). Among these, some human coxsackieviruses have been 
isolated from the blood of a rabbit (CVA4) (O'Connor & Morris, 1955), the brain of a 
fox (CVA5) (Makower & Skurska, 1957), the intestine of a bat (CVB3) and rats 
(CVB3 & CVB6) (Gregorio et al., 1972), pigs (CVB4, CVA20) (Grew et al., 1970; 
Lomakina et al., 2015), dogs (CVB3, CVB5, CVB6) and chickens (CVB4) (Graves & 
Oppenheimer, 1975). Since the discovery of simian enteroviruses in the 1950s from 
primate cell cultures, many more enterovirus serotypes have been identified, mostly 
from chimpanzees, gorillas and the Old World monkeys in Bangladesh and Cameroon 
(Harvala et al., 2011b; Harvala et al., 2014; Oberste et al., 2013a; Oberste et al., 2013b; 
Sadeuh-Mba et al., 2014). They are normally genetically separate from those infecting 
humans but a number of serotypes in enterovirus species A (CVA2, CVA5, EV71, 
EV76, EV89, EV90, EV119), B (CVB1, CVB3, CVB5, CVB6, E11, E15, E19, E20, 
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E21, E24, E29, E33, EV74, EV75, EV97, B82), C (CVA13, CVA19, CVA20, CVA22, 
CVA24, Sabin-3, EV99) and D (D111) have been detected in both human and non-
human primate samples. In addition, Harvala et al. (2012) showed high seroprevalence 
of human serotypes E11, EV76, EV94 in apes and Old World monkeys. These 
evidences of cross-species transmission of EVs between primates have raised concerns 
about the primate reservoirs as a potential source of emerging EV infections. However, 
the transfer direction and the potential primate sources of zoonotic EV infections in 
humans require further investigation (Harvala et al., 2011b).  
1.5.2.  Parechovirus 
The genus Parechovirus is comprised of two species, Parechovirus A (formerly named 
Human parechovirus - HPeV) and Parechovirus B (formerly named Ljungan virus) 
and a candidate species, Sebokele virus 1 from rodents (www.picornaviridae.com, 
accessed November 10, 2015). A fourth parechovirus from ferrets has recently been 
described (Smits et al., 2013).  
Ljungan virus (LV) was first isolated from bank voles at the Ljungan River in central 
Sweden in efforts to find the causative agent of lethal myocarditis in six Swedish 
orienteers. Antibodies against one of the three LV isolates were detected in four of five 
sera from the orienteer patients (Niklasson et al., 1999). Another seroprevalence study 
showed evidence of LV specific antibodies in 14/37 (38%) patient serum samples 
(Jääskeläinen et al., 2013b). However, no LV RNA has been detected in human 
samples. LV is common (24.4% positive by PCR) in rodents in the UK (Salisbury et 
al., 2014) and was also detected in wild voles or mice in the USA (Johansson et al., 
2003) and Italy (Hauffe et al., 2010). LV is associated with diseases such as 
myocarditis, encephalitis, pregnancy related diseases, and diabetes in several species 
of wild rodents (Niklasson et al., 2006). 
The respiratory and gastrointestinal tract is thought to be the primary site of HPeV 
replication. Replication in the intestine leads to prolonged shedding of the virus in 
faeces which can be detected by virus isolation and polymerase chain reaction (PCR) 
methods (Harvala & Simmonds, 2009). Sixteen types (HPeV-1 – 16) of Parechovirus 
A have been described on the basis of the phylogenetic analyses of the VP1 encoding 
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region (Esposito et al., 2014). HPeV-1 and HPeV-2 were formerly classified in the 
Enterovirus genus as echovirus 22 and 23, respectively. They were then reclassified 
as members of a new genus due to differences from the Enterovirus genus (King et al., 
1999).  
HPeVs have recently been recognized as important viral pathogens causing various 
illnesses (Walters, 2011). The majority of published reports relate to types HPeV-1 to 
-8 from children (Benschop et al., 2008b; Ghazi et al., 2012; Harvala et al., 2011a). In 
pediatrics, HPeVs are associated with a variety of symptoms from mild gastrointestinal 
or respiratory illness (by HPeV-1 – 3) to more serious diseases such as myocarditis, 
encephalitis, pneumonia, meningitis, flaccid paralysis, Reye syndrome and fatal 
neonatal infection (HPeV-1 – 2) (Khetsuriani et al., 2006; Stanway et al., 2000). In 
infants, HPeV-3 is a significant cause of sepsis-like illness (as is HPeV-4) (Benschop 
et al., 2006; Harvala et al., 2011a; Jääskeläinen et al., 2013a; Sharp et al., 2013) and 
encephalitis (Verboon-Maciolek et al., 2008). HPeV-5 – 8 seem to cause diseases 
similar to those by HPeV1 and HPeV2 (Levorson & Jantausch, 2009).  
Seroprevalence studies show HPeV infections are prevalent in the general population. 
Specific antibodies against HPeV serotypes 1, 2, 4 – 6 have been detected at high 
prevalence (35 – 99%) in children of 10 years old or younger (Korpela & Hyypiä, 
1998; Westerhuis et al., 2013). HPeV1-specific antibodies were also reported in 97 – 
99% of the adult population (Korpela & Hyypiä, 1998; Tauriainen et al., 2007). The 
extremely high seroprevalence of HPeV-1 and -2 in young children indicates that 
severe disease associations with infection are rare (Harvala & Simmonds, 2009), as 
confirmed by a recent longitudinal study of a group of 102 infants in Norway. HPeVs 
(mainly type 1) were detected in 11% of 1941 stool samples without significant 
association with coughing, sneezing, fever, diarrhoea or vomiting (Tapia et al., 2008). 
HPeV-1 and -6 were recently detected in faeces of 6/116 diarrhoeic monkeys on a 
monkey farm in China (Shan et al., 2010). Another study (Oberste et al., 2013b) 
detected HPeV in 21/618 faecal samples from rhesus macaques with types identified 
as HPeV1, HPeV4, HPeV5, HPeV12, HPeV14 and HPeV15. These findings indicate 
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monkeys may serve as reservoirs for zoonotic transmissions of HPeVs and as models 
for studies of HPeV pathogenesis. 
Although HPeVs are frequently isolated from respiratory samples and are thought to 
be associated with disease, HPeVs are not yet commonly a part of respiratory screening 
(Esposito et al., 2014; Harvala et al., 2008). This may have resulted in very limited 
information on the infection and molecular characteristics of HPeVs in Vietnam. 
1.5.3.  Cosavirus 
Cosavirus (common stool-associated virus) is a new genus, which is currently 
composed of the species Cosavirus A (with 25 types) and four candidate species 
(Cosavirus B to E) (www.picornaviridae.com). This genus has not only apparently 
wide geographic distribution with prevalence varying according to age and condition 
of the studied populations, and geographic area, but also a wide genetic diversity. 
Cosaviruses were originally identified in 2008 in the faeces of children with non-polio 
acute flaccid paralysis (AFP) and healthy children in South Asia (Kapoor et al., 2008). 
Based on the genetic comparisons, the authors proposed that the detected cosavirus 
variants comprise 4 different species (Cosavirus A – D). Similarly, a novel cosavirus 
detected in Australia was proposed to represent a new species (Cosavirus E) (Holtz et 
al., 2008).  
The wide genetic diversity of human cosaviruses (HCoSVs) complicates studies on 
their disease association since different serotypes or even minor genetic variations can 
result in large changes in viral pathogenicity (as shown by the extensively studied EVs) 
(Kapusinszky et al., 2012). Although studies show that cosaviruses are widely 
distributed across different regions of the world, their clinical significance is uncertain. 
In support for potential disease associations of the virus, a study in Tunisia showed 
significantly higher prevalence of HCoSVs in AFP patients (42.8%) than that in 
healthy controls (25.4%) (Rezig et al., 2015). HCoSV induced rapid cytopathic effects 
(CPE) in human embryonic lung MRC5 cell line with a remarkable decrease in live 
cells observed on the third day of CPE (Rezig et al., 2014). A cosavirus infection was 
also reported in an Australian child (Holtz et al., 2008), a Thai adult, both with 
diarrhoea (Khamrin et al., 2012), and an Italian patient with chronic diarrhoea 
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associated with cosavirus persistent infection (Campanini et al., 2013). However, 
HCoSVs were detected with no statistically significant difference in prevalence 
between healthy controls and paralyzed children in Pakistan (Kapoor et al., 2008) or 
children with diarrhoea in China (Dai et al., 2010). In addition, a study in Brazil even 
showed higher prevalence of cosavirus in controls than in patients, frequent co-
infections with established pathogens in diarrheal children, and low viral loads. These 
findings provide evidence against pathogenicity of HCoSVs (Stöcker et al., 2012).  
1.5.4.  Cardiovirus 
The Cardiovirus genus is made up of three species, Cardiovirus A – C (formerly 
named Encephalomyocarditis virus, Theilovirus and Boone cardiovirus, respectively). 
Cardiovirus A consists of two serotypes, named encephalomyocarditis virus 1 
(EMCV-1) and the newly discovered EMCV-2. Cardiovirus B is comprised of 14 
genotypes, which may also be different serotypes, including Theiler's murine 
encephalomyelitis virus (TMEV), Vilyuisk human encephalomyelitis virus (VHEV), 
Thera virus (TRV) and Saffold virus (SAFV) 1 to 11 (http://www.picornaviridae.com, 
accessed November 10, 2015).  
EMCV-1 has been reported from a wide range of hosts including pigs (Joo, 1999), 
rodents (Wells & Gutter, 1989), cattle (Spradbrow & Chung, 1970), elephants (Grobler 
et al., 1995), squirrels (Blanchard, 1987), baboons (Hubbard et al., 1992), rhesus 
macques (Masek-Hammerman, 2012), chimpanzees (Jones et al., 2011; Reddacliff et 
al., 1997), lemurs (Canelli et al., 2010) and humans (Kirkland et al., 1989; Oberste et 
al., 2009; Verlinde & Van Tangeren, 1953). Among these, rodents are thought to be 
the natural host of EMCV-1 (Tesh & Wallace, 1978) but pigs are the most commonly 
and severely infected domestic animals (Petruccelli et al., 1991). EMCV can cause 
acute myocarditis in young piglets (Gainer, 1967) and reproductive failure in sows 
(Koenen et al., 1991; Love & Grewal, 1986).  
In contrast to the ability of EMCV-1 to infect a variety of hosts, Cardiovirus B shows 
a narrow host range (Philipps et al., 2012). TMEVs were originally isolated from mice 
(Theiler, 1934) and rats (Hemelt et al., 1974). TMEVs mostly cause asymptomatic 
infections of the digestive tract in mice, and rarely spread to the mouse central nervous 
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system (CNS). TMEV isolates are divided into two subgroups on the basis of their 
pathogenesis (Liang et al., 2008). TMEVs with high neurovirulence (such as GDVII) 
cause a rapidly fatal encephalitis in mice, while the low-neurovirulence strains (e.g. 
BeAn, DA) cause persistent infection in the central nervous system of mice (Lehrich 
et al., 1976; Lipton, 1975).  
Whether cardioviruses can actually infect humans was unclear for a long time (Zoll et 
al., 2009a). The first identified human cardiovirus, VHEV, was previously thought to 
cause degenerative neurological disease in inhabitants in Vilyuisk, Siberia, in the 
1950s. The virus was isolated from mice inoculated with human clinical samples but 
has not been identified in any other patient with this disease since then. Using 
complement fixation test, Casals showed that mouse serum against VHEV cross-
reacted with TMEV and weakly with EMCV (Casals, 1963). Its sequence showed 
closest relationship to TMEV, which causes a persistent infection of the central 
nervous system in mice. VHEV therefore may be a contaminating cardiovirus that 
originated from the mice used for isolation of the virus (Lipton, 2008). Similarly, 
detection of human EMCV is questionable (Oberste et al., 2009). 
Recently, however, there has been some strong evidence for the existence of human 
cardioviruses (Zoll et al., 2009a). In 2007, a novel cardiovirus namely Saffold virus 
(SAFV) was discovered in a stool sample from a patient with fever of unknown origin 
(Jones et al., 2007). The virus was subsequently detected by molecular methods in 
children with respiratory symptoms (Abed & Boivin, 2008; Tsukagoshi et al., 2011) 
or gastroenteritis (Chiu et al., 2010; Drexler et al., 2008a; Ren et al., 2009) and in both 
patients with nonpolio AFP and healthy children in Pakistan at high frequencies of 9 
and 12%, respectively (Blinkova et al., 2009). SAFVs identified so far are significantly 
divergent from all known animal cardioviruses, especially in the capsid coding region 
(Zoll et al., 2009a).  
Cell culture researches showed efficient growth of SAFV-3 in several cell lines with a 
clear cytopathic effect. This feature enabled a large-scale serological survey which 
revealed a high seroprevalence of 75% of SAFV-3 in children at 24 months and even 
higher (> 90%) in older children and adults (Zoll et al., 2009a). More notably, SAFV-
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3 was recently isolated from the cerebrospinal fluid (CSF) of a 9-year old boy with 
aseptic meningitis (Himeda et al., 2011), while SAFV-2 was detected in the CSF, 
blood and myocardium of a child who died suddenly with no history of illness (Nielsen 
et al., 2012). These findings indicate that SAFVs may have CNS tropism and disease 
association. SAFVs probably behave similarly to EVs, which cause mainly 
asymptomatic infections or nonspecific symptoms in other patients and rarely result in 
severe disease (Nielsen et al., 2012). However, specific disease associations of the new 
human cardioviruses remain to be determined. 
1.5.5.  Kobuvirus 
Aichivirus A (formerly Aichi virus), Aichivirus B (formerly Bovine kobuvirus) and 
Aichivirus C (porcine kobuvirus) are the three species of the genus Kobuvirus. Other 
kobuviruses from goat (Oem et al., 2014) and European roller (Pankovics et al., 2015) 
may represent two further candidate species. Kobu-like viruses have also been 
identified in bats (Li et al., 2010). 
Aichivirus A currently consists of one type, Aichivirus 1 (AiV-1). Canine kobuvirus 1 
(Carmona-Vicente et al., 2013; Li et al., 2011), feline kobuvirus 1 (Cho et al., 2014; 
Cho et al., 2015; Chung et al., 2013) and murine kobuvirus 1 (Phan et al., 2011) are 
most closely related to AiV-1 and probably represent novel types of this species 
(http://www.picornaviridae.com, accessed November 10, 2015).  
Only AiV-1 is known to be able to infect humans. AiV-1 was first isolated from a stool 
specimen of a patient with oyster-associated nonbacterial gastroenteritis in 1989 in the 
Aichi District of Japan (Yamashita et al., 1991). Surveys in Japan showed 
seroprevalence for AiV-1 increased with age, from 7.2% for persons aged 7 months to 
4 years to about 80% in persons 35 years old (Yamashita et al., 1993). By reverse 
transcription-PCR, a high detection frequency (20.1%) of aichivirus was reported from 
a study of 268 faecal specimens from patients in 12 of 37 gastroenteritis outbreaks in 
Japan, nearly all were associated with oysters (Yamashita et al., 2000). AiV-1 RNA 
was detected at low frequency (0.5 – 3.5%) in samples mostly from patients with 
gastroenteritis in Pakistan (Yamashita et al., 1995) and France (Ambert-Balay et al., 
2008), Japan, Bangladesh, Thailand and Vietnam (Pham et al., 2007), Tunisia (Sdiri-
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Loulizi et al., 2008), Hungary (Reuter et al., 2009), China (Yang et al., 2009), Finland 
(Kaikkonena et al., 2010) and Korea (Han et al., 2014). Although no direct evidence 
for the pathogenesis of the virus has been obtained, these findings strongly suggested 
AiV-1 could be one of the agents causing human gastroenteritis. 
Aichivirus B consists of two types, bovine kobuvirus 1 (Yamashita et al., 2003) and 
sheep kobuvirus 1 (Reuter et al., 2010a). The prototype strain of bovine kobuvirus 1 
(BKV-1) type of the species Aichivirus B, named U-1, was isolated as a cytopathic 
contaminant in the culture medium of HeLa cells. Aichivirus B causes common 
infection with no confirmed disease and the virus is endemic among cattle worldwide 
(Reuter et al., 2011). 
Aichivirus C was accidentally discovered in 2008 in Hungary while screening faecal 
samples from pigs for calicivirus (norovirus and sapovirus) (Reuter et al., 2008). 
Aichivirus C consists of a single type, porcine kobuvirus 1 (PKV-1). PKV-1 has often 
been detected at high frequency in faeces from healthy pigs, wild boars and diarrhoeic 
pigs and prevalence generally decreases with age of pigs (Chen et al., 2013; Di Bartolo 
et al., 2015; Khamrin et al., 2010; Khamrin et al., 2009; Park et al., 2010; Reuter et 
al., 2013; Ribeiro et al., 2013). Some studies showed PKV infection was associated 
with diarrhoea in pigs (Barry et al., 2011; Chen et al., 2013; Park et al., 2010). PKV 
RNA was also detected in serum of virus-infected pigs indicating the possibility of 
kobuvirus viraemia (Barry et al., 2011; Fan et al., 2013; Reuter et al., 2010b). In 
summary, porcine kobuvirus is endemic and distributed worldwide. 
1.5.6.  Hunnivirus 
Hunnivirus (previously known as Hungarovirus) was originally isolated in cell 
cultures from sheep in Northern Ireland (McFerran et al., 1969). Subsequent 
characterization by electron microscopy (McFerran et al., 1971), biochemistry (Adair 
et al., 1987) and sequencing of the 450 nucleotides at the 3′ end of the genome 
(Knowles, 2005) confirmed that this was a novel picornavirus. The virus was 
recognised as a new genus in the Picornaviridae family when the complete genome 
sequences of the first three genotypes from cattle and sheep in Hungary (Reuter et al., 
2012) and Northern Ireland (unpublished data) were determined. The virus name, 
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hunnivirus (HuV), is derived from these two countries, where the first three HuVs were 
found. The forth type was recently detected in rats in New York City (Firth et al., 
2014). The Hunnivirus genus is comprised of a species, Hunnivirus A, with four virus 
types (HuV-A1 to -A4). Interestingly, the nucleotide sequence and secondary RNA 
structure of the 5’UTR of HuVs are homologous to those of parechoviruses; the 
nucleotide sequences of the HuV IRES is particularly similar to those of HPeVs, 
especially HPeV-3, consistent with relatively recent modular exchange of this 
sequence between picornavirus genera. Meanwhile the amino acid sequences of the 
coding region are more closely related to those of porcine teschoviruses. The host 
range of HuVs and their pathogenicity remains unknown (Reuter et al., 2012). 
In Vietnam, a hot-spot for infectious diseases, among the newly discovered 
picornaviruses, only kobuviruses have been reported in river water (all 3 species) 
(Inaba et al., 2014) and faecal specimens (members of Aichivirus A) (Pham et al., 
2007). This may be due to the lack of diagnostic tools and surveillance programs. The 
study hopes to learn more about their occurrence and potential disease associations.  
1.6. VIZIONS (Vietnam Initiative on Zoonotic Infections) 
There are still many gaps in the knowledge of emerging pathogens such as 
epidemiology of pathogens at the animal-human interface, drivers underlying 
pathogen emergence, the nature of the species barrier and the factors that enable 
pathogens to cross these barriers and establish transmission between humans 
(Woolhouse & Gaunt, 2007). These together with the recognition that most of new 
emerging infectious diseases in humans are zoonotic and that the human–animal 
interface is the key process of emergence have given rise to an urgent need to perform 
co-ordinated surveillance of humans who are highly exposed to animals (“at-risk” 
human populations) and animals populations to which people are exposed. Application 
of new approaches for pathogen detection and discovery, such as arrays, ultra-deep 
sequencing, complete genome sequencing, with traditional methods would be useful 
for this investigation. Despite agreement on the need for integrated surveillance 
approaches, there has been no such a global system and it is still far from reality 
(Hughes et al., 2010). In response to this need, the Wellcome Trust funded project - 
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VIZIONS - is establishing a platform for cross-disciplinary research on human and 
animal health in Vietnam, a country regarded as a hot spot for emerging infectious 
diseases. Findings from the project will help understand the nature, public health 
importance and aetiology of the large number of undiagnosed infectious disease cases 
in Vietnam. Its hypothesis is that a significant number of these infections are caused 
by zoonotic pathogens which, in some cases, may include currently unrecognized and 
possibly newly emerging agents. The study will provide new insights into the genetic 
diversity of pathogens (with focus on viruses) in humans and animals and into factors 
(biological and behavioural processes) underlying the emergence of novel pathogens.  
1.7. Aims of this thesis 
The rapid accumulation of data from viral metagenomics has resulted in a growing list 
of “orphan” human and animal picornaviruses whose pathogenicity and zoonotic 
potential, if any, remain unknown. Meanwhile, it is well established for picornaviruses 
that a few substitutions in the genome may remarkably change the virulence of a virus 
variant. This is illustrated by PV in which two nucleotide substitutions attenuate the 
Sabin 2 strain, and 10 substitutions are involved in attenuating the Sabin 3 strain (Kew 
et al., 2005). Testing linkage between a new viral species and animal/human disease, 
therefore, includes an appreciation of the full range of genetic diversity of the viral 
species (Blinkova et al., 2009). This thesis, as part of VIZIONS, hopes to address some 
gaps in our knowledge on molecular epidemiology, disease association, genetic 
diversity of picornaviruses and zoonotic source of picornavirus infection in humans. 
The main hypotheses are the studied picornaviruses may play a role in human and 
animal diseases, and the animals may harbour zoonotic picornaviruses. More 
specifically, studies in this thesis were carried out to answer the following questions: 
1) How prevalent and diverse are picornaviruses in studied samples and in 
comparison with other regions of the world? 
2) Are the identified viruses associated with disease and age of infected humans 
and animals? 
3) Which viruses are circulating among different animal species and geographic-
matched human populations?  
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4) Which animals may be the sources of picornavirus infections in humans? 
A large number of faecal samples from different animals (domestic pigs, wild boars, 
chickens, ducks, bats, rats, bamboo rats, civets, porcupines) that were in close and/or 
frequent contact with humans and from humans were used, as picornaviruses are 
mainly transmitted via faecal-oral route (Simonsson et al., 2013).  
One of the primary goals of this thesis was to understand the prevalence of the targeted 
picornaviruses in the studied samples. It may vary significantly between 
picornaviruses and between animal/human samples. The absence and presence of 
screened picornaviruses are presented and discussed in Chapter 3. Findings in this 
chapter are the background for subsequent studies in the next chapters on positive 
samples. 
EVs and kobuviruses known to infect pigs and wild boars include CVB5, members of 
EV-G and Aichivirus C. Before this work, the species EV-G consisted of 7 types 
detected in wild boars, domestic pigs and sheep (http://www.picornaviridae.com, 
accessed October 15, 2013). Its genetic diversity had not been fully characterized and 
its pathogenicity was unknown. Chapter 4 focuses on the genetic characterization of 
EVs and kobuviruses infecting domestic pigs and wild boars by analysis of VP1 region 
and complete genome sequencing. Our findings of novel EV types, their 
recombination, and disease association of kobuvirus in pigs were published (Nguyen 
et al., 2015 [Epub ahead of print]; Nguyen et al., 2014a). 
Some human EV types have been detected in non-human primates (NHPs), suggesting 
our close relatives may be a source of EV infection in humans (Harvala et al., 2012; 
Harvala et al., 2011b; Harvala et al., 2014; Oberste et al., 2013a; Oberste et al., 2013b; 
Sadeuh-Mba et al., 2014). Chapter 5 identified species and type distributions of EVs 
infecting Old World monkey species in Cameroon and their relationship to variants 
infecting local human populations. This is a larger scale continuation of previous 
studies of EV infection in African primates (Harvala et al., 2012; Harvala et al., 2011b; 
Harvala et al., 2014) and fits within the remit of the PhD investigating zoonotic sources 
of human infections. The results showed the existence of novel EVs with chimeric 
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genome and we proposed new criteria for the division of EVs into genetically defined 
species (Nguyen et al., 2014b). 
Except for cardioviruses, which have been well studied in mice and rats, little was 
known about infection of kobuviruses and viruses of the new genus Hunnivirus in rats, 
especially bamboo rats and civets. This is of public health concern as these small 
rodents are a common source of food for the native peoples in Vietnam while a wide 
range of known and novel viruses from groups with important human pathogens such 
as sapoviruses, cardioviruses, kobuviruses, parechoviruses, rotaviruses and 
hepaciviruses were reported from rats (Firth et al., 2014). Genetic characterization of 
these viruses in rats, bamboo rats and civets is the focus of Chapter 6. 
Chapter 7 reveals picornavirus types detected in human samples from at-risk 
populations. The results indicated no overlaps between picornaviruses circulating in 




Chapter 2. Materials and methods  
2.1. Biological samples 
Sampling was performed by colleagues at the Oxford University Clinical Research 
Unit (OUCRU) - the leading partner of VIZIONS. Most of animal samples in this 
thesis were taken in provinces of Dong Thap in the Mekong delta and Dak Lak in the 
central highland (Table 2.1, Figure 2.1). Dong Thap is characterized by a high density 
of domestic pig and chicken farms, as well as duck flocks (Tu et al., 2015). With an 
area of 3,238 km2, the province is home to about 1.6 million people, 274,000 pigs, 1.3 
million chickens, 3.1 million ducks, and 22,000 cattle and buffalo (Carrique-Mas et 
al., 2014). It is also notable for rice-field rats as a source of meat in Vietnam. 
Meanwhile, Dak Lak has a large number of farms raising wildlife animals including 
bamboo rats, civets, porcupines, deer and snakes for meat. These two provinces were 
thus targeted for sampling of human samples from high risk cohorts.  
For all of the sampled animals in Vietnam, no previous prevalence of the targeted 
viruses had been reported before in Vietnam. Therefore, a prevalence of 50% was used 
for sample size calculation as recommended (https://select-statistics.co.uk/-
calculators/sample-size-calculator-population-proportion/, accessed February, 10, 
2012). Calculations showed at least 383 samples were required to estimate the 
prevalence of viruses with a confidence level of 95% and an error margin of 5%. 
However, the limitation of sampling in this thesis was the insufficient sample sizes of 
live bats, shrews, civets and porcupines (Table 2.1). 
Table 2.1. Origin and sampling periods of samples used in this thesis. 
Sample origin Number 
of samples 
Collection provinces Collection dates 
Pig (Sus scrofa) 682 Dong Thap February – May 2012 
Chicken (boot swab) 120 Dong Thap February – May 2012 
Duck (boot swab) 120 Dong Thap February – May 2012 
Rat (purchased) 
150 (about 
30 rats per 
province) 
Dong Thap, Tien 
Giang, An Giang, Vinh 
Long and Can Tho 
October 2012 
32 Dak Lak April 2014 
Rat (trapped) 
125 Dong Thap 26 February – 8 March 2013 
100 Dak Lak April – May 2014 
Shrew (Suncus murinus) 10 Dong Thap 26 February – 8 March 2013 
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Shrew (Suncus murinus) 50 Dak Lak April 2014 
Farm-bred boar (Sus scrofa) 45 Dak Lak April 2014 
Civet (Paradoxurus 
hermaphroditus) 
30 Dak Lak April 2014 
Porcupine (Hystrix 
brachyura) 
61 Dak Lak April 2014 
Bat 158 Quang Ngai, Dong Nai May 2013 
Monkey 




Human (high risk cohort) 
250 Dong Thap, Dak Lak March 2013 – September 
2015 
    
 
Figure 2.1. Sampling sites in Vietnam and sample numbers 
2.1.1.  Pigs and wild boars 
Faecal samples were collected from 104 farms in four out of twelve districts (Cao 
Lanh, Chau Thanh, Hong Ngu and Thanh Binh) of Dong Thap province from February 
to May 2012. In these districts, a census of all registered farms was available. These 
randomly selected farms represented 3 farm size categories defined as: small (< 10 
pigs), medium (10 – 50 pigs) and large (> 50 pigs). Approximately 9 farms per 
category per district were enrolled. At each farm, 10 freshly voided samples (faeces 
found in the pen within 5 minutes after excretion, about 5 g per sample) from randomly 
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selected healthy pigs and up to four samples from pigs with diarrhoea were included. 
Faecal samples were recorded as diarrhoeic or not based on their consistency. From 
that collection, a subsample of 682 samples, including all 89 diarrhoeic samples and 
representing all sampled farms (5 – 7 samples / farm), were used in this study. In 
addition, 45 faecal samples collected in April 2014 from healthy wild boars which 
were kept at natural living conditions in 6 farms in Dak Lak province were also 
included.  
2.1.2.  Chickens and ducks 
The survey was conducted in the same four districts over the same period with 
sampling of pigs in Dong Thap province mentioned above. The farm sizes were 
determined on the basis of animal numbers per farm: for chickens 20 – 50 (small), 51 
– 100 (medium) and > 100 (large); for ducks 50 – 200 (small), 201 – 1000 (medium) 
and > 1000 (large). 120 chicken and 120 duck farms were randomly selected from the 
census of registered farms.  
In addition to individual samples (10 / farm), environmental sampling was performed 
using boot swabs to collect naturally pooled faeces. The number of boot swabs 
collected depended on farm sizes: 3, 4 and 5 boot swabs for small, medium and large 
farms, respectively. Briefly, farms’ areas dedicated to housing chickens or ducks were 
divided into equally sized sections. Then boot swabs were taken from each section by 
walking over 50 steps while wearing a pair of sterile, pre-moistened overshoe 
protectors. Shuffling motions were focused on areas where fresh droppings were 
visible. Where boot swab sampling was not possible on housing areas (i.e. chickens in 
cages or stilt houses), faeces from 10 sampling points were taken using hand-held 
gauze swabs (∼25 g per swab). Each pair of swabs per section were placed into a sterile 
tube containing 15ml of PBS. After that 1ml of mixed sample was preserved in 1ml of 
RNAlater (Qiagen, UK). Since one pair of boot swabs is roughly equivalent to 
sampling 60 individual droppings (Skov et al., 1999), this sampling strategy helped to 
sample a constant proportion of animals from each farm (Tu et al., 2015). In this thesis, 
boot swabs were used for initial screening for picornaviruses. If positive, individual 
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samples from those farms were screened separately. Aliquots of all swabs from each 
farm were pooled prior to nucleic acid extraction.  
2.1.3.  Rats and shrews 
150 rats and 32 bamboo rats were purchased from markets in five of twelve provinces 
in the Mekong Delta (about 30 rats / province) in October, 2012 and from a market in 
Dak Lak in April, 2014, respectively. Rat trapping was carried out in different 
locations (pig and poultry farms, rice fields, fruit groves, tropical forests, markets, 
slaughter-house) in the provinces of Dong Thap during March 2013 and Dak Lak in 
April 2014 (which was the only sampling trip I participated in). A total of 30 lines (one 
per location) of 10 Tomahawk live traps (http://www.livetrap.com) were set up, 
checked for trapped rats, and reset over 10 consecutive mornings. Traps with rat(s) 
trapped inside were brought back to the laboratory and replaced by new traps. In 
addition to 225 trapped rats, 60 shews (Suncus murinus) were accidentally trapped and 
sampled. Rats and shrews were euthanized by an overdose of inhalant isoflurane using 
the American Veterinary Medical Association guidelines (available at https://www.-
avma.org/KB/Policies/Documents/euthanasia.pdf). After that, biological and 
morphometric characteristics (weight, sex, body length, tail length, foot length, ear 
length, skull length, ear length, fur colour, reproductive status) were measured and 
recorded to allow species identification. Faecal samples as well as other samples (e.g. 
liver, spleen, lung) were aseptically collected during post-mortem and stored in sterile 
tubes at -20oC. Special precautions were taken to avoid cross-contamination. 
Table 2.2. Species of rats and shrews 
Species Number of sample 
Rhizomys pruinosus 32 
Rattus norvegicus 40 
Bandicota indica 65 
Rattus argentiventer 104 
Rattus tanezumi 80 
Rattus exulans 76 
Rattus nitidus 10 
Suncus murinus 60 
2.1.4.  Bats 
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A total of 158 bats were trapped at 6 sites in the provinces of Dong Nai (in Cat Tien 
National Park) and Quang Ngai in May 2013. Bats were trapped by using mist nets 
and harp traps set at ground level. Traps were checked for trapped bats, and reset over 
10 consecutive mornings. Species of the trapped bats (Table 2.3) were identified by 
morphology to make sure they were out of the IUCN (International Union for 
Conservation of Nature) Red List of threatened species (available at http://www.-
iucnredlist.org/). Trapped bats were euthanized and samples were collected as 
described above for rats and shrews. 
Table 2.3. Species of the trapped bats 
Species Number of bats 
Cynopterus sphinx 14 
Glischopus bucephalus 2 
Hipposideros cineracea 1 
Hipposideros armiger 6 
Hipposideros cineracea 3 
Hipposideros galeritus 4 
Hipposideros larvatus 7 
Hipposideros pomona 3 
Kerivoula hardwickii 4 
Kerivoula kachinensis 2 
Megaderma spasma 4 
Megaderma lyra 1 
Megaerops niphanae 3 
Murina annamitica 1 
Murina cyclotis 1 
Murina eleryi 1 
Murina walstoni 1 
Myotis muricola 10 
Myotis rosette 6 
Pipistrellus sp. 1 
Rhinolophus acuminatus 25 
Rhinolophus affinis 23 
Rhinolophus chaseli 3 
Rhinolophus lepidus 2 
Rhinolophus luctus 1 
Rhinolophus pusillus 12 
Rhinolophus shameli 1 
Rhinolophus sinicus 9 
Scotomanes ornatus 1 
Scotophilus heathi 6 
2.1.5.  Civets and porcupines 
Civets and porcupines are commonly raised in Dak Lak for civet coffee production 
and meat. 30 civets and 61 porcupines were purchased from 4 and 8 randomly selected 
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farms raising these animals, respectively. They were euthanized and samples were 
taken as described above for rats and shrews. 
2.1.6.  Monkeys 
This was a separate study which continued previous work investigating EVs in wild 
NHPs in Cameroon (Harvala et al., 2011b; 2014). A total of 113 monkey stool samples 
collected from 8 forest sites in the southern part of Cameroon over the period of 2006 
– 2012 were included in this study. Sampling was performed primarily around night 
nests or feeding sites from natural habitat areas of NHPs - remote and sparsely 
populated areas with minimal human contact (Keele et al., 2006). Samples were 
collected by experienced trackers, preserved in RNAlater (Ambion, USA), stored at 
room temperature at base camps for a maximum of 3 weeks and subsequently 
transported to a central laboratory in Yaoundé before shipment to Edinburgh. 
2.1.7.  Humans 
Human samples used in this thesis included 250 faecal samples from cohorts at high 
risk due to occupational exposure to animals in Dong Thap (100 samples) and Dak 
Lak (150 samples). These samples were collected mostly from people with frequent 
contact with animals such as farmers raising pigs and/or chickens, ducks, slaughter-
house workers, animal health workers. 
2.2. Laboratory techniques 
Nucleic acid extraction, PCR and DNA sequencing are the key laboratory techniques 
involved in this thesis (Figure 2.2). Considerable precautions were taken in order to 
prevent PCR contamination due to its high sensitivity. Central to these precautions was 
the implementation of lab standard operating procedures (SOPs) which provided step-
by-step instructions and detailed lab spaces for each step. In brief, nucleic acid 
extraction, master mix preparation, cDNA synthesis, DNA amplification and gel 
electrophoresis were carried out in dedicated and separated lab areas. Each work area 
had lab coats and gloves. In addition, reagents and primers for reverse transcription 
and PCR were kept in small aliquots in dedicated, clean areas where master mixes 
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were prepared. Templates (RNA, DNA) were added to PCR tubes containing the 
reaction mixtures after all other reagents (Kwok & Higuchi, 1989). A negative control 
using the same reagent mix with actual samples was always included in experiments 
to detect potential contamination.  
Reverse transcription of RNA, PCR and sequencing were performed in thermal cyclers 
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Figure 2.2. The flowchart of key steps and methods used in this thesis. 
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2.2.1. Nucleic acid extraction 
Screening of VIZIONS samples for targeted picornaviruses was performed at OUCRU 
in Ho Chi Minh City, Vietnam. About 10% (w/v) faecal suspensions in phosphate 
buffered saline (PBS) were mixed thoroughly and clarified by low-speed 
centrifugation. Nucleic acids were directly extracted from 180 µl of the resulting 
supernatant using MagNA Pure 96 Viral NA small volume kit and an automated 
extractor (Roche, Basel, Switzerland). RNA quality and the presence of PCR inhibitors 
was assessed by spiking samples with 20 µl of an RNA internal extraction control 
(EAV - equine arterivirus) (Scheltinga et al., 2005) prior to extraction. EAV was 
kindly provided by OUCRU staff. The principle steps are: 
- The sample material and internal extraction control are lysed, nucleic acids are 
released and nucleases are denatured. 
- The nucleic acids bind to the silica surface of the added magnetic glass particles 
(MGPs), due to the chaotropic salt conditions and the high ionic strength of the 
Lysis/Binding Buffer. 
- MGPs with bound nucleic acids are magnetically separated from the residual lysed 
sample. 
- Washing steps remove unbound substances (proteins, cell debris, PCR inhibitors, 
etc.). 
- Purified nucleic acids are eluted from the MGPs in 50 µl of elution buffer and 
stored at -80oC until use.   
RNA of positive samples was re-extracted at OUCRU from the original specimens 
using QIAamp viral RNA mini kits (Qiagen, UK) and sent on dry extraction columns 
to Edinburgh for further genetic characterization. Briefly, 140 μl of sample was mixed 
with 560 μl of prepared viral lysis buffer (Buffer AVL) containing 1 μg/μl carrier RNA 
and incubated at room temperature for 10 minutes. The added carrier RNA enhances 
the yield of viral RNA during extraction by reducing degradation of viral nucleic acid 
due to residual RNases and by assisting the binding of RNA to the QIAamp Mini 
column membrane. 560 μl of ethanol (96 – 100%) was added and mixed by pulse 
vortexing. The resulting solution was passed through a QIAamp Mini column at 6,000 
g (8,000 rpm) for 1 minute. Each column was then subjected to washing with wash 
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buffer 1 (Buffer AW1), followed by wash buffer 2 (Buffer AW2). Residual buffer was 
removed by centrifugation at full speed for 1 minute. The dry extraction columns from 
this step were sent to Edinburgh and RNA was then eluted in 60 μl of nuclease free 
water. Extracted RNA was either used in PCR immediately or stored at -20°C. 
For species identification of monkeys by mitochondrial sequencing, faecal DNA was 
extracted using the QIAamp Stool DNA Mini kit (Qiagen, US) according to the 
instructions from the manufacturer. 
2.2.2. Reverse transcription of RNA 
Two-step RT-PCR protocols were used in the majority of studies. Single stranded 
cDNA was synthesized by reverse transcription (RT) to allow amplification of 
extracted viral RNA by PCR. RT was carried out using the SuperScript III Reverse 
Transcriptase (Invitrogen, UK) according to the manufacturer’s instructions. Briefly, 
6 μl of eluate obtained from RNA extraction was incubated with 1 μl (100 ng) of 
random hexamer primers, 1 μl of 10 mM dNTP mix (Life Technologies, UK) and 5 μl 
nuclease free water at 65°C for 5 minutes, then chilled on ice for at least 1 minute. 7 
μl of master mix containing RT (Table 2.4) was added to each sample. The reaction 
mixture was then incubated at 25oC for 5 minutes followed by an elongation step at 
50oC for 60 minutes. Finally, the reaction was heated at 70oC for 15 minutes to 
inactivate the reverse transcriptase enzyme and prevent it binding to the single stranded 
cDNA. cDNA was then either used immediately for PCR reactions or stored at -20°C. 
All positive and negative controls used in downstream PCR were included in the RT 
reaction to ensure consistency of results. The use of random hexamer primers in the 
RT step enabled synthesized cDNA to be used both for screening of different 
picornaviruses and the amplification of multiple genome regions. 
Table 2.4. RT master mix. 
4 μl 5X First-Strand Buffera 
1 μl 0.1 M DTT 
1 μl RNaseOUT™ (40 units/μl)b 
1 μl SuperScript™ III RT (200 units/μl) 
 
a 5X First-Strand Buffer is supplied with the Superscript III RT kit and contains 250 mM Tris-HCl, 
375 mM KCl, 15 mM MgCl2. 
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b Recombinant RNase Inhibitor (Invitrogen, UK) 
2.2.3.  Polymerase chain reaction (PCR) and related techniques 
2.2.3.1. Design of oligonucleotide primers 
Primers previously unavailable in literature were designed for use in the amplification 
of various picornavirus genome regions. All of the designed primers, including 
degenerate ones to overcome high genetic diversity within regions, must be specific 
to avoid amplification of non-target sequences. Each primer set was tested for 
sensitivity using serial 10-fold dilutions of known positive samples. 
All relevant sequences were first downloaded from GenBank. After alignment using 
SSE version 1.1 (Simmonds, 2012), these sequences were examined for highly 
conserved areas around the target regions. Areas of high sequence conservation were 
then analysed for melting temperature (Tm), hairpin formation, self-annealing, 
hetero-dimer by the Oligo Analyzer Tool (available at http://www.idtdna.com/calc/-
analyzer). Short fragments were considered for the PCR primers in fulfillment of the 
following criteria: 
- Length of 18 – 30 nucleotides 
- Predicted Tm close to 60°C 
- High sequence conservation (as few degenerate bases as possible) 
- G+C content between 40 – 60% with a G or C at the 3ˈ end where possible 
- No runs of 4 or more of one base, or dinucleotide repeats 
- No significant self-annealing (ΔG ≥ -10 kcal/mol) (Bustin & Nolan, 2013) or 
hairpin formation where possible 
Primer pairs for use in the same PCR reactions were selected to have no significant 
hetero-dimer formation and Tm differences of no more than 5 degrees, where 
possible. All primers were blasted (www.ncbi.nlm.nih.gov/tools/primer-blast) to 
ensure the specificity of each primer set.  
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Table 2.5. Codes for nucleotides used in primer design. 





K G or T 
M A or C 
R G or A 
S G or C 
W A or T 
Y T or C 
B G, C or T 
D G, A or T 
H A, C or T 
V G, C or A 
N A, C, G or T 
2.2.3.2. PCR protocols 
Nested PCR was used for virus detection (EVs in monkeys, cosaviruses, 
cardioviruses, kobuviruses and HuVs) and characterization of all viruses in positive 
samples. Positive controls for the screened viruses mentioned above were usually 
from clinical specimens or concentrated sewage (cosavirus). The reaction mixture 
(Table 2.6) was subjected to a basic PCR protocol comprised an initial denaturation 
step at 94°C for 5 minutes, followed by 30 cycles of denaturation (94°C for 30 s), 
annealing (50°C for 30 s) and elongation (72°C, 60 s/kb). Final extension was at 72°C 
for 5 minutes. After that, 1 µl of the first-round reaction was used for the second-
round PCR with similar conditions.  
Table 2.6. Reagents used in PCR reactions 
5X colorless or green GoTaq buffera 4 µl 
Sense primer (10 µM) 1 µl 
Antisense primer (10 µM) 1 µl 
3 mM dNTPsb 0.2 µl 
GoTaq DNA polymerase (Promega, UK) (5 u/μl) 0.1 µl 
Either cDNA or first round PCR productc 1 – 2 µl 
Nuclease free water to 20 µl 
a The 5X colourless and green GoTaq buffers were used for the first- and second-round PCR, 
respectively. The green buffer increases the density of the sample, allowing PCR products to be loaded 
directly onto gels without loading dye. Both buffers contain MgCl2 at a concentration of 7.5 mM. 
b dNTPs (Life Technologies, UK) were acquired as a mix of four nucleotides (dATP, dCTP, dGTP, 
dTTP), each at a concentration of 10 mM and were then diluted to make 3 mM stocks for use in PCR. 
c 2 μl of cDNA was used for the first round of PCR. 1 μl of first round product was used for the second 
round of PCR. 
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For screening, the prevalence of viruses in a subset of 50 randomly selected samples 
was initially checked. After that, cDNA of the remaining samples was screened either 
separately for viruses with high prevalence or in pools of 5 samples for viruses with 
low prevalence. Screening of EV in domestic pigs was completed by a technician of 
OUCRU. Results were kindly provided with permission. 
Individual PCR protocols with new primer sets were optimised prior to use with study 
samples. The optimal set of conditions for each PCR reaction was determined after 
varying certain parameters (annealing temperature, primer, MgCl2 and dNTP 
concentrations). The sensitivity of several PCR protocols was remarkably improved 
when one of the same primers was used in both rounds (hemi-nested reactions). 
Specific primers for each PCR reaction with modifications (if any) to the basic protocol 
are detailed in Table 2.7 together with which thesis chapter these reactions relate to. 
2.2.3.3. Real-time PCR 
Real-time PCR was used to either screen for viruses (EV, parechovirus) or measure 
viral loads (EV in monkeys, PKV in domestic pigs) in samples positive by nested PCR. 
Published protocols for EV (Dierssen et al., 2008) and parechovirus (Benschop et al., 
2008a) were used. Positive controls were 10-fold dilution series (106 to 100 copies/µl) 
of CAV-16 and HPeV-1 RNA transcripts available in the lab for use (McLeish et al., 
2012). RNA was diluted in RNA storage solution (Ambion, UK). In order to increase 
the stability of RNA transcripts, the storage solution was added with 0.05 µg/ml 
herring sperm carrier RNA and 0.1 U/ml RNasin (New England BioLabs, UK). 
Detection limits of 100 and 75 copies of EV and HPeV cDNA per reaction respectively 
were obtained as in published papers (Benschop et al., 2008a; Dierssen et al., 2008).
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Table 2.7. List of primers (Invitrogen, UK) and probes (IDT, UK).  
Primers and probes for real-time PCR  






(Beld et al., 








Probe 6-FAM-TCCGGCCCCTGAATGCGGCTAAT-BHQ1  







































Other primers for screening  
Virus Region Primer Sequence (5’ – 3’) 
Modifications to basic 
reagents, cycling conditions 
Chapter Source 
EV 
(in monkeys only) 
5'UTR 
309s TGTAGHTYWGGTCGATGAGTC 
Hemi-nested reaction - same 











Annealing temperature of 55oC 





(Kapoor et al., 2008) 
oa GGTACCTTCAGGACATCTTTGG 
is ACGGTTTTTGAACCCCACAC 






Annealing temperature of 55oC 

















Annealing temperature of 55oC 
in both rounds 
 
3 













Annealing temperature of 57oC 







956oa CAAAGAAAAAKTCTTCTG BCG TCTGACC 
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Primers for typing 
Virus Region Primer Sequence (5’ – 3’) 

























of 45°C in the 1st round, 
48°C in the 2nd round 
7 































 EV_unassigned VP1 
2337os TGTGGTAYCARACAAAYTTTGTRGTYCC 
Annealing temperature of 
57oC in both rounds 
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Primers for typing 
Virus Region Primer Sequence (5’ – 3’) 
Modifications to basic 
reagents, cycling conditions 
Chapter Source 
 EV-G VP1 
2313os GCTGGKTATRTKACYGGDTGGTWY C Annealing temperature of 












Annealing temperature of 











Annealing temperature of 







1996ia CTGGACDCGCCADCCRCARTT  
Aichivirus A VP1 
2794os CCATYCCCTTCATYTCYAACTCCTACTGG 
Annealing temperature of 




4044oa CGAAGTGGGTRCAGTTGTTGGTKG  
2867is CGGCTAYGTYTCCATCTGGGTKC 
3993ia GGAGTTCAGCRAGRGTCCAATGK 
Aichivirus C VP1 
2817os TACTGGAARGTCACYAAYATGGCYAAYCAG  
Annealing temperature of 
58oC in both rounds  






 Annealing temperature of 
58oC in both rounds 
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Self-designed primers for complete genome of new EV types: EV-G8, EV-G9 (used in addition to EVG VP4, VP1 primers above) 
Region Primer Sequence (5’ – 3’) 
Modifications to basic reagents, 
cycling conditions 
Chapter 




94is     TAGTACCTTTGTACGCCTGTTTT 
779ia TTYTTRCTCATTTGCATHCCCAT 
571 – 2965 
482os CCGGCCCCTGAATGYGGCTAA  
SuperScript III one step RT-PCR  
and SequalPrep long PCR were 
used. 
4 
3390oa GGGTKGCAAGRKGYCTRTTCA  
571is ACCRACTACTTTGGGTGTCCGTG 
2965ia GGRTTWGCKGCASTTTGCCA 
3187 – 5419 
2313os GCTGGKTATRTKACYGGDTGGTWYC 
SuperScript III one step RT-PCR  




3187is (EV-G8) TGCAAGCCAAAACAYATTAAAG 
2679is (EV-G9) GTGGAGAGCTTTTATTCTAGATC 
5419ia TTCATCATBCCDACNCCAAARTCCAT 
5187 – 7373 
4835os GAGAATAAYACCTTGAATGTGACAG - SuperScript III one step RT-
PCR and SequalPrep long 
PCR were used. 
- Annealing temperature of 
53oC in both rounds  
4 
7385oa CATCCGGTGGGWGTRTTG  
5189is GAGATYCCAGTAGATGAGAGRA 
7373ia GTATTGHATCCAATTGAAGYTTWGG 
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Self-designed primers for complete genome of novel EVs in Mandrill monkeys (used in addition to EV VP4, VP1 typing primers)  
Virus Region Primer Sequence (5’ – 3’) 
Modifications to basic reagents, 
cycling conditions 
Chapter 
EV_unassigned 1 – 440 
1s TTAAAATAGCCTSWGGGTTGYTCC  
Hemi-nested reaction - same sense 
primer in both rounds 
5 440ia GCTCARTAGGCTCTTCACACCATGTC 
573oa RGAAACACGGACACCCAAAGTAGT 
EV_unassigned 309 – 764 
309s TGTAGHTYWGGTCGATGAGTC 
Hemi-nested reaction - same sense 
primer in both rounds  
5 764ia TGTCKTGAMACYTGTGCTCCCAT 
891oa TGGGTCCTGGCTRAARTCYTGTTT  
CPML8109 1096 – 2486 
1039os ATTGTAGTAGGGTAYGGWGARTGGC 
Annealing temperature of 58oC in 
both rounds 
5 
2583oa TGTGCCAATGTTATGGGAGGATGC  
1096is GTGGATAAACCAACCAARCCHGAYGT 
2486ia GTCCCCTTGCAGTACAGATGCTT 
CPML3961 1096 – 2496 
1041os GGTTGTGGCKTAYGGTGARTGGC 
Annealing temperature of 58oC in 






GR2815 1096 – 2402 
1040os ATTGTTGTAGGGTATGGTGAGTGGC Annealing temperature of 60oC in 







EV_unassigned 3394 – 4826 
3349os AACAACWGGRGYKTTTGGACAACA    
 Annealing temperature of 58oC in 




3394is GGWGCMRTHTATGTGGGTAATTACAGA  
4826ia GTGCTCTGCTATCTGARATGGTKGG 
EV_unassigned 4692 – 6097 
4447os CGTACAGTTCAAGTCCAAATGCCGC 
 Annealing temperature of 60oC in 
both rounds   
5 
6134oa TCCWCCTTGAGTCTGGGGTCTTTC  
4692is GGTGTCYAGTGTTGAYTTYGTGCCA 
6097ia CGGGTTCCTTCACACCTTCAAAGAT 
EV_unassigned 5907 – 7466 
5825os  CACAGGATGYTHATGTAYAAYTTYCCMAC - Hemi-nested reaction - same 
antisense primer in both rounds 
- Annealing temperature of 55oC in 
both rounds  
5 
5907is  TTCATGTTGGWGGYAATGGRCAYC  
7466a CACTCTGGTTGTGCTAAATTTWCCCCTG 
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Self-designed primers for complete genome of novel HuV (used in addition to HuV VP1 primers above) 
Region Primer Sequence (5’ – 3’) Modifications to basic reagents, cycling conditions Chapter 
74 – 840 
52os AAGARCCCTCACCTGTCA  
Annealing temperature of 53oC in both rounds  6 
956oa CAAAGAAAAAKTCTTCTGBCGTCTGACC 
74is GGGACCACCACTTTCAGT  
840ia GCCTCCATATTGMCTSYTGYTGKATTTG 
525 – 1605 
525s TTGGTATCAYGGCATACCGKAGAG  
Hemi-nested reaction - same sense primer in both 
rounds 
6 2673oa ACATTYTCATTBGTRTTYTCWGCT  
1605ia ACAAACTGKGGCACYAWRAAVACACC 
812 – 2658 
525os TTGGTATCAYGGCATACCGKAGAG  - SuperScript III one step RT-PCR was used for 
cDNA synthesis and the 1st round PCR 




2673oa ACATTYTCATTBGTRTTYTCWGCT  
812is CAAATMCARCARSAGKCAATATGGAGGC 
2658ia CATCTGAACTCAAARTCYTCACCAGC 
3455 – 5766 
3391os* GGAACCAGACYTDGATGARATGTT  - SuperScript III one step RT-PCR and SequalPrep long 
PCR were used. 




5886oa GTCCCYAAGCTCTCTGCYAKAAACATA  
3455is ACAGAYTTTGCYACYTGGATTGAT  
5766ia ATGTCTCTGAAYTGYCTBCCTG 
5428 – 7577 
5128os GAAGGAHGTTGARAARTGGTGTGA  
SuperScript III one step RT-PCR and SequalPrep long 




7577ia GGAAAATTAACCCTGATTTACTAA  
 





Most primers were named using a combination of: 
- Position (numbered relatively to K01392 for EV, NC_001918.1 for kobuvirus, DQ401688 for cardiovirus and HM153767 for HuV) 
- Orientation (os, outer sense; oa, outer antisense; is, inner sense; ia, inner antisense) 
Primers for species identification 
Animal Primer Sequence (5’ – 3’) 







(van der Kuyl et 
al., 1995) 12S-H1478  TGACTGCAGAGGGTGACGGGCGGTGTGT 
Rat 
BatL5310 CCTACTCRGCCATTTTACCTATG Annealing temperature of 
48oC 
6 
(Herbreteau et al., 
2006) R6036R ACTTCTGGGTGTCCAAAGAATCA 
Porcupine 
CYTb1 CCATCCAACATCTCAGCATGATGAAA Annealing temperature of 
55oC 
3 
(Brodmann et al., 
2001) CYTb2 GCCCCTCAGAATGATATTTGTCCTCA 
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In addition, a real-time PCR protocol for porcine kobuvirus (PKV) was developed as 
follows. Primers and a TaqMan probe targeting a 200 bp conserved fragment in the 
5’UTR of PKV were designed using guidelines from literature (Bustin & Nolan, 2013). 
The 200 bp fragment was first amplified from a positive sample using primers for real-
time PCR and cloned into pGEM-T Easy Vector (Promega, UK). In brief, 3 µl of PCR 
product was mixed with 5 μl of 2X Rapid Ligation Buffer, 1 μl of pGEM-T Easy 
Vector (50 ng) and 1 μl of T4 DNA Ligase (3 Weiss units/μl). After incubation at 37oC 
for 1 hour, 2 μl of the ligation product was transformed into 50 μl of E. coli competent 
cells. The cells were recovered in SOC medium for 1 hour at 37oC before plated onto 
LB/ampicillin/IPTG/X-Gal plates. The resulting white colonies were screened by PCR 
with M13 primers using the basic protocol above and confirmed by sequencing of PCR 
product. A confirmed colony was grown in 10 ml of LB/ampicillin at 37oC overnight. 
Cells were harvested by centrifugation at 2,500 g for 5 minutes. The constructed 
plasmid was then isolated using QIAprep Spin Miniprep Kit (Qiagen, UK) and 
linearized by treatment with NsiI. The purified linear plasmid was used as template for 
transcription using MEGAscript T7 transcription kit (Ambion, UK). The transcription 
reaction (Table 2.8) was incubated at 37°C for 4 hours. DNA template was removed 
by incubation with 1 µl of TURBO DNase at 37°C for 15 minutes. Transcribed RNA 
was purified using RNeasy purification kit (Qiagen, UK). Concentration of the purified 
RNA was determined by Nanodrop ND1000 (Thermo Fisher Scientific, UK) and 
converted to copy number/µl using the website http://www.sciencelauncher.com-
MWcalc.html. Finally, a 10-fold dilution series of RNA was prepared as mentioned 
above for optimization and assessment of the real-time PCR assay using SensiFAST 
Probe Hi-ROX kit (Bioline, UK). 
Table 2.8. Reagents used in transcription. 
Component Amount 
ATP solution 2 µl 
CTP solution 2 µl 
GTP solution 2 µl 
UTP solution 2 µl 
10X Reaction Buffer 2 µl 
Linear plasmid 0.5 µg 
Enzyme mix 2 µl 
Nuclease free water to 20 µl 
 
Chapter 2. Materials and methods 
56 
 
All primers and probes for real-time PCR are presented in Table 2.7. The optimised 
cycling conditions of the real-time PCR assays were 1 cycle of 95°C for 5 minutes, 
then 45 cycles of 95°C for 15 s, and 60°C for 45 s (PKV) or 60 s (parechovirus and 
EV). Probes were labelled with different dyes: FAM (for EV and PKV), LCRED610 
(for parechovirus) and Cy5 (for EAV control). Amplified nucleic acid was detected 
directly using LightCycler 480 (Roche, UK) or Rotor-Gene Q (Qiagen, UK). 
Table 2.9. Reagents used in real-time PCR for EVs, parechovirus and PKV. 
Reagent  
Volume (µl) 
EV HPeV LV PKV 
2x SensiFAST Probe Hi-ROX mix*  10 10 10 10 
Sense primer (10 µM) 2 1 0.4 0.8 
Antisense primer (10 µM) 2 1 0.4 0.8 
Target picornavirus probe (10 µM)  0.4 0.2 0.2 0.4 
EAV sense + antisense primer mix (10 µM) 0.4 0.4 0.4 - 
EAV probe (10 µM) 0.1 0.1 0.1 - 
cDNA 5 5 5 5 
Nuclease free water 0.1 2.3 3.5 3 
* 2x mastermix contains all the components needed for real-time PCR, including dNTPs, MgCl2, 
Taq DNA polymerase, stabilizers and enhancers. 
2.2.3.4. SuperScript One-Step reverse transcription polymerase chain reaction 
(RT-PCR) 
A more sensitive protocol in which both steps of cDNA synthesis and DNA 
amplification are performed in a single tube was used in case the optimized GoTaq 
protocols listed above failed to amplify the expected regions. This was obtained by 
using specific primers and SuperScript III one-step RT-PCR system with Platinum 
Taq DNA polymerase (Invitrogen, UK). The optimized parameters and cycling 
conditions are as follows. 
Table 2.10. Reagents used in one step RT-PCR  
Component Volume (μl) 
2X reaction mix* 10 
Outer sense primer (10 µM) 1 
Outer antisense primer (10 μM) 1 
SuperScript® III reverse 
transcriptase with platinum Taq 
0.8 
Extracted RNA 6 
Nuclease free water 1.2 
* 2X reaction mix is supplied with the Superscript III One-step RT-PCR kit and contains 4 mM of 
each dNTP and 3.2 mM of MgSO4. 
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Table 2.11. Cycling conditions in one step RT-PCR 
Number of cycles Temperature Time 
1 45°C 1 hour 
20 
53°C 60 s 
55°C 60 s 
1 70°C 15 min 
1 94°C 2 min 
40 
94°C 30 s 
50 – 55°C* 30 s 
68°C 1 min/kb 
1 68°C 5 min 
* Annealing temperatures varied among target viruses and regions to be amplified. 
As primers specific for a particular region were used in the RT step and first round 
PCR, the resulting product could only be used as template in second round PCR 
(previously described) for amplification of that specific fragment. Platinum Taq DNA 
polymerase is complexed with a proprietary antibody that blocks polymerase activity 
at room temperatures. Polymerase activity is restored after the complexed antibody is 
denatured at high temperature of the denaturation step. This automatic “hot start” in 
PCR increases sensitivity, specificity, and yield (Chou et al., 1992; Sharkey et al., 
1994). 
2.2.3.5. SequalPrep™ long PCR 
For efficient amplification of long fragments (> 2 kb), in addition to the use of 
SuperScript III one-step RT-PCR in the first round PCR as described above, 
SequalPrep long PCR kit (Invitrogen, UK) was used in the second round PCR 
following the manufacturer’s instructions. Reagents and cycling conditions are 
detailed below. 
Table 2.12. Reagents used in SequalPrep long PCR 
Component Volume (μl) 
SequalPrep 10X reaction buffer 2 
DMSO 0.4 
SequalPrep 10X enhancer A 2 
SequalPrep long Polymerase, 5 U/μl 0.36 
Inner sense primer (10 µM) 1 
Inner antisense primer (10 µM) 1 
First round PCR product 1 
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Table 2.13. Cycling conditions for SequalPrep™ long PCR 
Number of cycles Temperature Time 
1 94°C 2 min 
10 
94°C 10 s 
50 – 55°C* 30 s 
68°C 1 min/kb 
30 
94°C 10 s 
52 – 56°C* 30 s 
68°C 1 min/kb (+20 s/cycle) 
1 72°C 5 min 
* Annealing temperatures varied between primer sets. 
2.2.3.6. Agarose gel electrophoresis 
Products of the second round PCR were visualised by agarose gel electrophoresis. For 
good separation of DNA, 2% (w/v) agarose gels were used for DNA less than 1 kb in 
length while 1% agarose gels were used for longer DNA product. Agarose powder 
(Invitrogen, UK) was dissolved in 1X TAE buffer and mixed with an appropriate 
volume of SYBR® Safe DNA gel stain (Invitrogen, UK) recommended by the 
manufacturer before casting. 6 μl of product of second round PCR (using 5X green 
GoTaq reaction buffer) was loaded directly onto a well of prepared gel. In case 5X 
green GoTaq reaction buffer was not used (e.g. SequalPrep long PCR), 6 μl of PCR 
product was mixed well with 1.5 μl of 6X loading buffer before loaded. After 
electrophoresis at 150 volts for about 45 minutes, the product size was estimated by 
visualizing and comparing the band with a ladder electrophoresed alongside in a UV 
transilluminator.  
2.2.3.7. Gel extraction and purification of amplified products 
In cases additional bands were visualized on agarose gel although the PCR had been 
thoroughly optimised, bands of expected sizes were excised and purified using 
QIAquick gel extraction kit (Qiagen, UK) and the instructions of the manufacturer. In 
brief, 3 volumes of buffer QG were added to 1 volume of gel in a 1.5 ml tube. As the 
gel slice had completely dissolved after incubation at 50oC, the sample was mixed with 
1 volume of isopropanol. The solution was then transferred to a QIAquick column and 
centrifuged at 17,900 g (13,000 rpm) for 1 minute. The column was washed with 0.75 
ml of buffer PE before elution of the DNA in 50 µl of buffer EB. 
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2.2.3.8. DNA sequencing 
Amplicons were sequenced in both senses using BigDye Terminator kit (Applied 
Biosystems, Warrington, UK). Each reaction contained 7 µl nuclease free water, 1 µl 
BigDye, 1 µl inner sense primer or antisense primer and 1 µl PCR product or purified 
DNA. Reactions were carried out with 25 cycles of 30 s at 96oC, 20 s at 50oC and 4 
min at 60oC. Sequences were read at the Edinburgh Genomics Sequencing Service of 
the University of Edinburgh. 
2.2.3.9. Complete genome sequencing 
Additional primers were designed to obtain genomes of novel EVs and HuVs (Table 
2.7). These primer sets were used to amplify regions of about 0.6 – 2.5 kb with 
identical overlaps between fragments. This helped prevent the possibility of hybrid 
viruses formed by assembly error from the same pigs or monkeys co-infected with two 
or more similar variants. The obtained fragment sequences from one sample were 
aligned and joined to produce a consensus genome sequence using SSE. 
2.2.3.10. Identification of animal species 
Identification of monkey species was determined by mitochondrial DNA (mtDNA) 
analysis as described previously (van der Kuyl et al., 1995) by amplifying and 
sequencing a 386 bp fragment spanning the 12S gene from the extracted DNA. The 
sequences were then subjected to BLAST search on NCBI (https://blast.ncbi.nlm.nih.-
gov/Blast.cgi) to identify the species of monkeys. 
Species identification of the other animals was carried out by colleagues at OUCRU. 
Species of porcupines were identified by morphology and sequencing a 359 bp 
fragment of the cytochrome b as previously described (Brodmann et al., 2001). The 
obtained sequences were compared with reference sequences by BLAST search. 
For rats, species identification was carried out by using protocols recommended by 
CERoPath (Community Ecology of Rodents and their Pathogens in South-East Asia) 
(Herbreteau et al., 2006). Rat species were first identified on the basis of biological 
and morphological characteristics and confirmed by amplification using the basic 
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protocol above and sequencing of a conserved housekeeping gene (cytochrome 
oxidase subunit I, COI). The cycling conditions were similar to the basic protocol 
except for the annealing temperature was at 48°C. The obtained COI sequences were 
submitted to the RodentSEA barcoding tool (http://www.ceropath.org/barcoding_tool-
/rodentsea), which compared the submitted sequences to a collection of reference 
sequences. The comparison was based on Kimura 2 Parameter distances matrix 
computation and phylogenetic tree reconstruction using Neighbour-Joining method 
(see 2.3.3). 
Bats, civets and shrews were speciated based on morphology using published guides 
(Francis & Barrett, 2008; Kruskop, 2013). 
2.3. Computational methods 
2.3.1.  Statistical methods  
Statistical tests implemented in Minitab 17 (http://www.minitab.com) were used to 
compare data between groups of interest when appropriate. They included: 
- Chi square test which was replaced by two-tailed Fishers exact tests if any of 
the cells of a contingency table were below 5 
- Kruskal-Wallis non-parametric test 
- Mann-Whitney test 
2.3.2. Sequence alignment 
Sequence alignment is important and essential for downstream phylogenetic and 
evolutionary analyses. Correct alignment helps to avoid false conclusions on 
phylogeny, genetic diversity and recombination. PCR products were sequenced in both 
directions to allow for dual coverage. Sequences were first imported into DnaBaser 
(www.DnaBaser.com) for assembly. By comparing the quality of signal peaks 
between sense and antisense strands from a sample, DnaBaser could automatically 
identify and resolve mismatches (if any) between the two sequences. Mismatches were 
also highlighted for easy confirmation by visual inspection of chromatograms. 
Assembled sequences were then imported into an SSE version 1.1 (Simmonds, 2012) 
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file which also included at least 1 reference sequence previously downloaded from 
GenBank for each of all (sero)types from a species or genus under study. The 
sequences from studied samples were subjected to initial alignment to the best 
sequence match and subsequent global alignment using Muscle version 3.8 (Edgar, 
2004) implemented within SSE. The global alignment could be at the level of 
nucleotides (for non-coding regions) or codons (for coding regions) which were 
obtained by translation of nucleotide sequences using the standard genetic code 
available in SSE. Alignments were refined where necessary by manual editing. 
2.3.3. Construction of phylogenetic trees 
A phylogenetic tree is a graph that depicts the evolutionary relationships between 
organisms or gene sequences. Its construction has been a standard part of exploratory 
sequence analysis (Holder & Lewis, 2003). Phylogenetic trees can be constructed by 
a variety of methods, some of which are briefly summarized in Table 2.14. 
Table 2.14. Summary of methods commonly used for phylogenetic tree construction. Adapted from 
(Holder & Lewis, 2003). 
* LBA, long-branch attraction, the tendency of distantly related sequences to group closely in a tree 
regardless of their true relationships (Baldauf, 2003). 
Method Advantages Disadvantages 
Neighbour joining Fast 
 
- Loss of information when 
sequences are converted into 
distances 
- Hard to obtain reliable estimates of 
pairwise distances for divergent 
sequences 
- Exposed to LBA* 
 
Parsimony - Fast 
- Robust for short branches 
(closely related sequences/ 
dense sampling) 
- Can perform poorly in case of 
substantial variation in branch 
lengths 
- Exposed to LBA 
Minimum evolution Uses models to correct for 
unseen events (e.g. back 
mutations) 
 
Corrections can break down for 
large distances 
Maximum likelihood Fully captures what data tell 
us about phylogeny under a 
given model 
Computationally intensive and 
therefore slow 
Bayesian Faster than ML 
bootstrapping in assessing 
support for trees and 
provides measures of 
uncertainty 
- The prior must be specified 
- Difficult to determine whether the 
Markov chain Monte Carlo 
approximation has run for long 
enough 
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The use of neighbour-joining (NJ) is extremely popular (Gascuel & Steel, 2006; 
Holder & Lewis, 2003). This distance based method, like others, performs well on low 
divergent sequence data. Furthermore, NJ is fast as it is more computationally efficient 
than maximum parsimony based methods. This feature enables analysis of large 
datasets from a number of operational taxonomic units. However, it can be difficult to 
achieve reliable distance matrix values for distantly related input sequences (Holder & 
Lewis, 2003). 
From many perspectives, maximum likelihood (ML) is the most appealing method for 
phylogeny estimation. The likelihood function has proved to be consistent and 
powerful for statistical inference. ML applies evolutionary models that incorporate 
parameters to govern aspects of the process of evolution, such as the degree to which 
the rate of evolution differs across sites. All possible mutational pathways, including 
unseen events (such as back mutations or complex pathways like A→C→G along the 
branch) compatible with the data are taken into account. As ML corrects for multiple 
mutational events at the same site, it accurately reconstructs the relationships between 
sequences that have been separated for a long time, or are evolving rapidly (Holder & 
Lewis, 2003). The phylogeny with the highest overall likelihood score is selected after 
calculations of the probability of the topology, branch lengths and substitution model 
parameters (Fukami-Kobayashi & Tateno, 1991). However, the main obstacle that 
prevents the widespread use of ML is the computational burden as the algorithm must 
search through a multidimensional space of parameters to find the ML score (Holder 
& Lewis, 2003; Rogers & Swofford, 1998). 
In consideration of advantages and disadvantages of these methods, ML was used in 
this thesis. Unless otherwise stated, phylogenetic trees used for identification of virus 
types and recombination analyses were reconstructed using ML method implemented 
in the Molecular Evolutionary Genetics Analysis (MEGA) software version 5.05 
(Tamura et al., 2011) with 1000 bootstrap replications (see section 2.3.4) and partial 
deletion for missing data. The best substitution models (those with the lowest Bayesian 
Information Criterion scores) were determined for each data set using MEGA prior to 
tree construction. Trees were rooted by inclusion of an outlier (e.g. a sequence 
belonging to a closely related species / genus) specified under each tree. Rooting of a 
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tree provided an estimate of the ultimate common ancestor of all the studied viruses 
(Hall, 2013). 
2.3.4. Bootstrapping 
The bootstrap is a statistical technique that is used to determine the robustness of 
observed phylogenetic groupings within a tree. Sequence data matrix is first randomly 
re-sampled with replacement and trees are then produced from each of the resulting 
pseudo-replicate data sets. The proportion of times that a group of interest is obtained 
in the pseudo-replicates is the bootstrap support value for that group (Alfaro et al., 
2003). Bootstrapping therefore offers an estimate of the reproducibility of a 
monophyletic clade or helps predict whether the same result would be observed if more 
data were collected, not whether the result is correct (Holder & Lewis, 2003). 
Bootstrap proportions are conservative measures of support, so values above the 
threshold of 70% are considered as strong support for a group (Efron et al., 1996; Hillis 
& Bull, 1993; Zharkikh & Li, 1992). In contrast, a grouping with a low bootstrap 
support value implies that if more data were collected, it is highly possible that the 
group would not be reproduced (Holder & Lewis, 2003). 
One major limitation of bootstrapping is that it merely indicates how robust the tree 
phylogeny is and fails to provide an estimate of the probability of an observed tree. 
For example, in case a tree is obtained with long-branch attraction, bootstrapping 
might indicate relatively strong support regardless of their true relationships (Swofford 
et al., 2001). Another limitation of bootstrapping, like ML, is the computational burden 
(Holder & Lewis, 2003).  
2.3.5. Recombination detection methods 
A number of methods have been developed for detection of recombination in a set of 
aligned sequences. They can be classified into four categories (Posada & Crandall, 
2001) of distance methods, compatibility methods, substitution distribution methods 
and phylogenetic methods. Evaluation on the performance of 14 different 
recombination detection methods using empirical data sets (Posada, 2002) showed 
they often give differing or even, contradictory results. For this reason, the author 
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suggested definitive conclusions about the occurrence of recombination should not be 
based on a single method.  
Phylogenetic methods are the most commonly used methods in the literature. These 
methods infer recombination when phylogenies from different genome regions are 
incongruent (Posada, 2002). They were also the basis of recombination analysis in this 
work. Phylogenetic trees constructed from different genome fragments of varying 
sizes were examined for phylogeny violations between bootstrap supported (≥ 70%) 
clades. In order to verify putative events and determine recombination breakpoints, all 
detected violations were further studied by analysis with sequence divergence plot and 
Group Scan (Simmonds & Midgley, 2005) available in the SSE package. The former 
(Simmonds, 2012) uses sliding window with pre-specified fragment length and 
increment to calculate pairwise distances between a query group and control groups. 
Sequence distances are plotted on the y axis of an output graph with genome position 
on the x axis. An abrupt decline into intra-type or intra-species divergence levels 
indicates potential recombination. The latter measures the extent a query sequence is 
embedded within each clade formed by standard phylogenetic analysis of preassigned 
groups. Grouping scores range from 0 (no grouping) to 1 (deeply clustered within a 
clade). To identify potential recombination sites, successive fragments with predefined 
length and increment between fragments are analyzed (in this thesis, a fragment size 
of 300 nucleotides and an increment of 30 were used). An output graph is plotted as 
midpoints of the analysed fragments on the x axis and grouping scores on the y axis. 
A putative breakpoint is determined by point of intersection where abrupt changes in 




Chapter 3. Prevalence of picornaviruses in screened 
samples 
3.1. Introduction 
Numerous logistical and scientific challenges exist in documenting emerging zoonotic 
infections (Keusch et al., 2009). Monitoring is subject to massive ascertainment biases 
(e.g. differences in the efforts invested in different places and at different times). It is 
performed in an ad hoc manner, partly driven by responses to the most recent events 
(e.g. discovery of coronaviruses following the SARS outbreak) and by availability of 
detection and identification technologies. New species pathogenic to humans continue 
to be discovered and determining the number of pathogens that conceivably exist in 
mammalian and other reservoirs is difficult (Woolhouse & Gaunt, 2007). The 
frequency with which humans are exposed to animal pathogens, and the significance 
of those exposure events therefore remains to be clearly determined. Finally, the nature 
of the species barrier and the factors that allow pathogens to cross it and establish 
transmission between humans are critical issues that need to be addressed (Taylor et 
al., 2001).  
All the challenges mentioned above lead to many gaps in current knowledge of 
emerging pathogens. This also holds true for picornaviruses. Six picornavirus genera 
including Enterovirus, Parechovirus, Cardiovirus, Kobuvirus, Cosavirus and 
Hunnivirus were of interest and selected for studies in this thesis as they comprise 
important human and animal pathogens (e.g. HFMD virus, FMD virus), viruses with 
growing evidence for zoonotic potential (EVs, HPeVs) or new members with 
unknown ability to cause disease (EVs, cosaviruses, cardioviruses, HuVs). The list of 
picornaviruses with zoonotic potential is expanding with the number of studies 
conducted. The detection of a significant number of (sero)types of human EV in a 
rabbit (O'Connor & Morris, 1955), a fox (Makower & Skurska, 1957), a bat and rats 
(Gregorio et al., 1972), pigs (Grew et al., 1970; Lomakina et al., 2015), dogs and 
chickens (Graves & Oppenheimer, 1975), non-human primates (Harvala et al., 2011b; 
Oberste et al., 2013a; Oberste et al., 2013b; Sadeuh-Mba et al., 2014) and HPeV 
(Oberste et al., 2013b; Shan et al., 2010) is evidences for cross-species transmission; 
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non-human primates can conversely be a source of picornavirus infections in humans. 
However, whether other picornaviruses, particularly the newly discovered EV types, 
cosavirus, cardiovirus and HuV also have zoonotic potential and disease association, 
and whether other animals carry zoonotic picornaviruses is unknown. Information has 
been reported separately from either humans or animals and from different countries. 
In Vietnam, some of the targeted picornavirus genera have been described only from 
one side (normally humans) of the human-animal interface. The existence (if any) of 
these viruses in non-human hosts and the relationships between viruses in animals and 
humans have never been studied. Among the six picornavirus genera, only Enterovirus 
has been frequently documented from patients with HFMD (Geoghegan et al., 2015; 
Khanh et al., 2012), encephalitis or meningitis (Takamatsu et al., 2013; Tan et al., 
2010; Tan et al., 2014; Taylor et al., 2012) or diarrhoea (Phan et al., 2005). The 
presence of Kobuvirus in river water (Inaba et al., 2014) and human samples (Pham 
et al., 2007), Cardiovirus in rats (Buckwalter et al., 2011) and absence of 
Parechovirus (Tan et al., 2010) in clinical samples have occasionally been reported, 
while no studies on Hunnivirus and Cosavirus have been conducted.  
Meanwhile, it is known that the emergence of zoonotic pathogens in humans depends 
on interactions between humans and the animal reservoir and/or vectors or their 
environment (Gortazar et al., 2014). VIZIONS is responding to the need for active 
monitoring and research programmes on human and animal pathogen reservoirs by 
establishing a model for integrated human and animal surveillance. In the first step to 
address these gaps, the study in this chapter aimed to screen faecal samples collected 
in Vietnam and monkeys in Cameroon for the 6 picornavirus genera. Viruses in 
positive samples are further characterized and described in subsequent chapters. 
3.2. Samples 
As zoonoses can originate from domestic or wild animals (Christou, 2011), samples 
from both these categories were included. More than 1,900 faecal samples from high 
risk human populations and animals collected in Vietnam and over 100 faecal samples 
from monkeys in Cameroon were used in this study (Table 2.1, Chapter 2). 
3.3. Methods 
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RNA was extracted from 10% (w/v) faecal suspensions and used for cDNA synthesis. 
Screening of the synthesized cDNA for the existence of picornaviruses was performed 
using nested PCR which amplified the 5’UTR (EV in monkeys, cardiovirus, cosavirus 
and HuV) or 3D (kobuvirus), and real-time PCR targeting the 5’UTR (enterovirus in 
other samples, parechovirus). Samples were screened in pools of 5 or individually 
depending on the initial prevalence in the first 50 randomly selected samples. 
Individual samples from positive pools were subsequently screened using the same 
methods (Chapter 2). Screening of EV in domestic pigs was completed by Ms. Pham 
Hong Anh at OUCRU. 
3.4. Results 
Viruses present in the screened samples included kobuvirus, EV, cardiovirus and HuV 
(Table 3.1). Among these, kobuvirus was the most common virus, detected in a range 
of hosts (pigs, farm-bred boars, rats, porcupines, civets and humans) with detection 
frequencies from 0.4% in humans to 42.2% in farm-bred boars. It was followed by 
EV, observed at low frequencies in humans (3.2%), farm-bred boars (8.9%), and at 
extremely high frequencies in domestic pigs (79%), monkeys (96.5%). Cardiovirus 
was most commonly detected in rats and porcupines (6.6% and 4.9%, respectively), 
rarely found in pigs and one human sample. Among the screened samples, HuV was 
only evident in rats at relatively high overall frequency (32.5%). Parechovirus and 
cosavirus were absent in all screened samples. All duck boot swabs, chicken boot 
swabs, and samples from shrews and all 30 species of bats were negative for the 
targeted picornaviruses. Therefore, no individual chicken and duck samples were 
considered further for this study. 
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Table 3.1. Detection of picornavirus RNA in screened samples. 
Animal Tested 
Positive (%) 
EV Kobuvirus Cardiovirus Cosavirus Parechovirus HuV 
Pig (Sus scrofa) 682 539 (79.0) 200 (29.3) 1 (0.15) 0 0 Not done 
Farm-bred boar (Sus scrofa) 45 4 (8.9) 19 (42.2) 0 0 0 0/45 
Rat (7 species)b 407 0 103 (25.3) 27 (6.6) 0 0 54 (32.5) a 
Shrew (Suncus murinus) 60 0 0 0 0 0 0 
Porcupine (Hystrix brachyura) 61 0 1 (1.6) 3 (4.9) 0 0 0 
Civet (Paradoxurus hermaphroditus) 30 0 5 (16.7) 0 0 0 0 
Bat (30 species)c 158 0 0 0 0 0 Not done 
Duck (boot swab) 120 0 0 0 0 0 Not done 
Chicken (boot swab) 120 0 0 0 0 0 Not done 
Monkey (3 species)d 113 109 (96.5) Not done Not done Not done Not done Not done 
Humane 250 8 (3.2) 1 (0.4) 1 (0.4) 0 0 0 
a Only 166 rats were screened for HuV. 
b Details of rat species are presented in Figure 6.3, Chapter 6. 
c Details of bat species are presented in Table 2.2, Chapter 2. 
d Details of monkey species are available in Table 1, Chapter 5. 
e Details of positive human samples are available in Table 7.1, Chapter 7.




This is the first large scale study on the prevalence of the six picornavirus genera in 
adult humans (aged 21 – 64 years old) and a wide range of other animal hosts. The 
prevalences of these viruses were different between hosts. 
3.5.1. EV 
Many studies have shown the existence of EVs in pigs, boars, monkeys and humans. 
The overall detection frequency of EVs in domestic pigs (79%) was notably higher 
than those reported in Spain (0%), Italy (7.5%), China (8.3%), Hungary (13.3%) and 
the Czech Republic (50.2%) (Boros et al., 2011b; Buitrago et al., 2010; Prodělalová, 
2012; Sozzi et al., 2010; Yang et al., 2013). In contrast, detection of EV RNA in farm-
bred boars in this study was much lower than prevalences of 50% in Hungary (Boros 
et al., 2012a) and 69.4% in the Czech Republic (Prodělalová, 2012). Differences in 
primer set usage, pig density and farming practices between countries may have 
resulted in a wide range of reported EV prevalence. 
In comparison with detection frequency (96.5%) of EV in non-human primates in the 
current work, other studies have shown lower frequencies of 5.4% (Sadeuh-Mba et 
al., 2014) and 7.4% (Harvala et al., 2011b) in Cameroon, 10% (Harvala et al., 2014) 
in Cameroon and Democratic Republic of Congo, 8.8% (Oberste et al., 2013b) and 
60.2% (Oberste et al., 2013a) in Bangladesh, 66% (Nix et al., 2008) in the US.  
Finally, EV has been frequently documented from human adults, mostly from 
respiratory samples (Billaud et al., 2003; Lu et al., 2014; Parody et al., 2007; Tran et 
al., 2012; Xiang et al., 2012). Detection of EV in faecal samples from human adults 
has been reported only in several studies at high prevalence (96%) in patients with 
meningitis in Finland (Kupila et al., 2005), and in 1 of 3 HFMD patients in China (Li 
et al., 2013). In contrast, EV was less common in the high risk cohort human 
populations (prevalence of 3.2%) in this study who developed different symptoms 
(fever, pharyngitis, flu-like, etc.) at the time of sampling. This may be the result of 
differences in clinical status and geography of studied subjects. 
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Samples from the other animals were negative for EV, which has never or rarely been 
documented from those animals.  
3.5.2. Kobuvirus 
Studies have indicated that PKV is endemic in pigs and distributed worldwide. The 
PKV detection frequency (29.3%) in pigs in the current study was lower than 
previously reported in most other countries ranging from 31.1 – 99% (Barry et al., 
2011; Chen et al., 2013; Khamrin et al., 2010; Khamrin et al., 2009; Okitsu et al., 
2012; Park et al., 2010; Reuter et al., 2010b). However, a lower rate of 13.1% was 
reported in Japan (Amimo et al., 2014). In boars, PKV has only been documented in 
10 of 10 samples in Hungary (Reuter et al., 2013) while the virus was present in 42.2% 
of VIZIONS samples. 
Very little is known about kobuvirus infection frequencies in rats. Only one study 
detected this virus at significantly higher frequency (50%) in rat faecal samples (Firth 
et al., 2014) than that in the current study (25.3%). No kobuvirus has been previously 
reported from porcupines and civets. Therefore, this is the first study showing the 
existence of kobuvirus in these animals at frequencies of 1.6% (95% confidence 
interval [CI] 0 – 4.75%) and 16.7% (95% CI 3.35 – 30%), respectively. 
For humans, most reports of kobuvirus were from children (Chang et al., 2013; 
Kaikkonena et al., 2010; Pham et al., 2007; Reuter et al., 2009; Sdiri-Loulizi et al., 
2008; Yang et al., 2009). Several studies of faecal samples from adults with 
gastroenteritis detected AiV-1 at low frequencies (0.1 – 2%) in Canada (Houde et al., 
2010), Thailand (Saikruang et al., 2014), France (Ambert-Balay et al., 2008) and 
Germany (Drexler et al., 2011). Exceptionally, the highest prevalence of kobuvirus 
reported up to date is 20.1% in gastroenteritis outbreaks associated with oysters in 
Japan (Yamashita et al., 2000). The detection frequency of 0.4% in this chapter, 
therefore, falls within the range described in most previous studies.  
3.5.3. Cardiovirus 
Cardioviruses have been frequently detected from pigs in association with 
reproductive failure or myocardial lesions (Castryck et al., 1996; Koenen et al., 1991; 
Koenen et al., 1996; Love & Grewal, 1986) by viral isolation rather than molecular 
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methods. Similarly cardioviruses have been isolated from rats (Drake et al., 2008; 
Hemelt et al., 1974; Ohsawa et al., 2003). Only one study (Firth et al., 2014) reported 
thera virus and Boone cardiovirus in 14% and 28% of rat faecal samples, respectively, 
by molecular methods. No studies have been performed to detect these viruses in 
porcupines while SAFV has been shown absent in adult faecal samples (Chiu et al., 
2008; Drexler et al., 2008b; Tsukagoshi et al., 2011). This study showed that in 
Vietnam, infection with cardioviruses was rare in pigs (detection frequency of 0.15%), 
humans (0.4%), and less prevalent in rats (6.6%) than previously reported. The current 
study additionally demonstrated the existence of the viruses in porcupines (4.9%, 95% 
CI 0 – 5.42%). 
3.5.4. Parechovirus 
HPeVs of the Parechovirus A species have been detected in monkeys in China (Shan 
et al., 2010) and Bangladesh (Oberste et al., 2013b) at frequencies of 5.2% and 3.1%, 
respectively. HPeVs have also been documented from children at low frequencies 
(Benschop et al., 2008b; Ghazi et al., 2012; Harvala et al., 2011a) and in faecal 
samples from 9/14 Japanese adult patients with myalgia (Mizuta et al., 2013). This 
suggested that infection with HPeV is not limited to the pediatric population. 
However, none of the screened samples were positive for HPeV. The absence of HPeV 
in human adult samples is consistent with a previous study using samples from 
Vietnamese children (Tan et al., 2010). Overall, HPeV infection is not common in 
Vietnam. 
Parechovirus B has been reported from bank voles (Hauffe et al., 2010; Lindberg & 
Johansson, 2002; Niklasson et al., 1999), mice (Johansson et al., 2003) and rats only, 
with a prevalence of 24.4% in voles and mice in the UK (Salisbury et al., 2014). This 
study used the same primer set with the study in the UK. Therefore the absence of 
Parechovirus B likely reflected diffences not in the assay but in the prevalence of the 
virus between vole, mouse and rat species. Parechovirus B was absent in all screened 
samples, including 275 rats purchased and trapped in 5 provinces of the Mekong delta. 
This is in accordance with finding in a seroprevalence study (Nguyen et al., 2015) 
which showed none of the sera from those rats were seroreactive to LV.  




No cosavirus RNA was detected in any screened animal samples, consistent with the 
fact that this virus has been reported from humans only (primarily from children). No 
human samples (all from adults) were positive for cosavirus either although this virus 
has been demonstrated elsewhere from faecal samples. A study in Thailand (Khamrin 
et al., 2012) detected HCoSV RNA in 1 of 150 samples from adults with diarrhea. 
Another study in Nepal (Kapusinszky et al., 2012) showed HCoSV RNA prevalences 
of 12% and 15% in adults with diarrhea and healthy adults, respectively. Finally, 
persistent infection with HCoSV was associated with chronic diarrhea in an adult 
double lung transplant recipient (Campanini et al., 2013). 
3.5.6. Hunnivirus 
Although the first HuV was isolated in 1969 (McFerran et al., 1969), it was only 
recently recognized as a member of a new genus Hunnivirus. As HuVs have been 
detected in some animals such as cattle and sheep in Hungary and Northern Ireland 
(Reuter et al., 2012) with unknown pathogenicity and zoonotic potential, not much 
attention has been paid to this virus genus. Recently a single study detected HuV RNA 
from 19% of rat faecal samples in the US (Firth et al., 2014) – a lower prevalence than 
in the current study. No samples from other screened animals and humans were 
positive for this virus. 
3.5.7. Absence of the screened picornaviruses in bats, chickens and ducks 
Bats, chickens and ducks were included in this study as they are well documented as 
sources of many important zoonotic pathogens such as Middle East respiratory 
syndrome coronavirus (Ziad et al., 2013), Ebola (Leroy et al., 2005), avian influenza 
(Beigel et al., 2005). However, picornaviruses remain a neglected group in studies of 
bats (Kemenesi et al., 2015) as well as chickens and ducks. As a result, among the 
targeted picornaviruses, only CVB4 (Graves & Oppenheimer, 1975), CVB3 (Gregorio 
et al., 1972) and kobu-like viruses (Li et al., 2010) have been identified from bats and 
chickens. This may also indicate that infection with viruses of the 6 picornavirus 
genera in these animals is rare. Therefore, it may be not surprising that none of the 
screened picornaviruses were detected in bats, chickens and ducks. 
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In conclusion, in common with previously published data, the current study showed 
that the infection frequencies of the targeted picornaviruses varied quite considerably 
with hosts. In addition to detection of picornaviruses in hosts previously known to 
carry the viruses, this study demonstrated evidence for their existence in other animals 
(kobuviruses in porcupines and civets, cardioviruses in porcupines). Whether they 
were associated with age of infected hosts, disease (where clinical information was 
available) and whether there was any overlap between viruses circulating in animals 




Chapter 4. Enterovirus and kobuvirus infection in 
domestic pigs and boars 
 
Introduction 
In the last chapter, 682 faecal samples from domestic pigs and 45 from boars were 
screened for picornaviruses. The screening results showed that infection with EV was 
endemic in domestic pigs (detection frequency of 79%) and less common in boars 
(8.9%). In contrast, detection frequency of kobuvirus in boars (42.2%) was 
substantially higher than that in domestic pigs (29.3%). 
In this chapter, I will examine the molecular epidemiology and disease associations of 
these viruses. The genetic diversity of EVs and kobuviruses in pigs and boars, and 
recombination of EV will also be studied. Findings from this chapter will additionally 
help understand if these animals in Vietnam are infected with any EVs or kobuviruses 
that can also infect humans. Together, the findings will elucidate the hypothesis of 
disease association, incomplete genetic characterization and zoonotic potential of these 
viruses. 
Pathogenicity of EVs and kobuviruses infecting pigs and boars  
Before the studies described in this chapter were performed, EVs and kobuviruses 
infecting pigs and boars comprised 5 types in the species Enterovirus G (which also 
consists of 2 ovine EV types), CVA20 (Grew et al., 1970), CVB4 (Lomakina et al., 
2015), swine vesicular disease virus (SVDV) in Enterovirus B and PKV-1 in the 
species Aichivirus C (http://www.picornaviridae.com, accessed October 15, 2013). 
Among these, only SVDV is known to be pathogenic, causing an acute, contagious 
swine vesicular disease characterized by the development of vesicles and erosions on 
the legs and around the mouth (Spickler et al., 2010). Since first described in Italy in 
1966 (Nardelli et al., 1968), outbreaks of SVDV have been documented throughout 
Europe and Asia (Jimenez-Clavero et al., 2005). SVDV is antigenically related to 
human virus coxsackievirus B5 (CVB5) and is classified as a porcine variant of CVB5 
(Brown et al., 1973; Knowles & McCauley, 1997; Seechurn et al., 1990). 




Seroconversion to SVDV in laboratory workers handling the agent has been reported. 
However, no farmers or veterinarians working with infected pigs have been reported 
with seroconversion or disease. Experimental infections have also failed to show 
transmission of CVB5 between pigs (Spickler et al., 2010). In contrast, little is known 
about possible pathogenicity of EV-G and Aichivirus C. EV-G was first isolated from 
skin lesions of pigs (Knowles, 1988). Its ability to cause disease has only been 
indicated in one experimental infection study (Yang et al., 2013) which showed that 
two of the twelve pigs infected with EV-G1 developed flaccid paralysis of the hind 
limbs. Similarly, Aichivirus C has only been reported in association with diarrhoea in 
pigs (Chen et al., 2013; Park et al., 2010).  
Definition of new EV types based on sequence divergence in the VP1 region 
Sequence based methods have been developed to overcome disadvantages (time-
consuming, labor-intensive, costly and limited supply of antisera) of the traditional 
serotyping by virus isolation and neutralization tests. In those methods, different 
genome regions (VP4, VP2, VP1 and 3D) were targeted. Among these, VP1 encodes 
for the most external and immunodominant protein of the picornavirus capsid 
(Rossmann et al., 1985) and recombination has rarely been described in this region 
(Blomqvist et al., 2003; Zhang et al., 2010). As a result, the best region for molecular 
identification of EV type was VP1 (Casas et al., 2001; Perera, 2010) whose sequences 
consistently correlate with serotype designations of EVs (Kiang et al., 2009; Kilpatrick 
et al., 1998; Oberste et al., 1999). For EV-A – EV-D, members of the same serotypes 
show less than 25% nucleotide or 12% amino acid sequence divergence while between 
serotype distances are consistently greater than these thresholds (Oberste et al., 1999). 
These thresholds have been adopted by the ICTV Picornavirus Study Group as an 
alternative to neutralization assays for the identification of EVs and assignments of 
new EV types. This genotypic approach has advantages over serotyping of accuracy, 
speed and ability to identify and assign new types (Oberste et al., 2000; Kiang et al., 
2009). A large number of new EV types have been identified on this basis (Brown et 
al., 2009; Harvala et al., 2011b; Harvala et al., 2014; Oberste et al., 2007; Oberste et 
al., 2002; Oberste et al., 2004b; Sadeuh-Mba et al., 2014; Smura et al., 2007). 




This chapter is comprised of studies published in two papers. The pilot study (Nguyen 
et al., 2014a) examined EVs in 198 samples from pigs only while the larger scale study 
(Nguyen et al., 2015) focused on both EVs in the rest 484 pig, 45 boar samples and 
kobuviruses in all 682 pig and 45 boar samples.  
 
  




Prevalence, genetic diversity and recombination of species G 
enteroviruses infecting pigs in Vietnam 
 
 
Nguyen Van Dung1, Pham Hong Anh2, Nguyen Van Cuong2, 
Ngo Thi Hoa2,5, Juan Carrique-Mas2, Vo Be Hien3, James Campbell2, 
Stephen Baker2,5,6, Jeremy Farrar2, Mark E. Woolhouse4, 
Juliet E. Bryant2,5 and Peter Simmonds1,4 
 
Journal of General Virology (2014a), 95, 549–556 
 
 
1 Infection and Immunity Division, Roslin Institute, University of Edinburgh, Easter 
Bush, Edinburgh EH25 9RG, UK 
2 Oxford University Clinical Research Unit, 764 Vo Van Kiet, W. 1, Dist. 5, Ho Chi 
Minh City, Vietnam 
3 Subdepartment of Animal Health, Dong Thap Province, Vietnam 
4 Centre for Immunity, Infection and Evolution, University of Edinburgh, Ashworth 
Laboratories, Kings Buildings, West Mains Road, Edinburgh EH9 3JT, UK 
5 Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK 
6 London School of Hygiene and Tropical Medicine, Keppel St, Bloomsbury, London 











Prevalence, genetic diversity and recombination of species G 
enteroviruses infecting pigs in Vietnam 
 
Picornaviruses infecting pigs, described for many years as “porcine enteroviruses”, 
have recently been recognized as distinct viruses within three distinct genera 
(Teschovirus, Sapelovirus and Enterovirus). To better characterize the epidemiology 
and genetic diversity of members of the Enterovirus genus, faecal samples from pigs 
from four provinces in Vietnam were screened by PCR using conserved enterovirus 
(EV)-specific primers from the 5’ untranslated region (5’UTR). High rates of infection 
were recorded in pigs on all farms, with detection frequencies of approximately 90% 
in recently weaned pigs but declining to 40% in those aged over 1 year. No differences 
in EV detection rates were observed between pigs with and without diarrhoea [74% (n 
= 70) compared with 72% (n = 128)]. Genetic analysis of consensus VP4/VP2 and 
VP1 sequences amplified from a subset of EV-infected pigs identified species G EVs 
in all samples. Among these, VP1 sequence comparisons identified six type 1 and 
seven type 6 variants, while four further VP1 sequences failed to group with any 
previously identified EV-G types. These have now been formally assigned as EV-G 
types 8 – 11 by the Picornavirus Study Group. Comparison of VP1, VP4/VP2, 3Dpol 
and 5’UTRs of study samples and those available on public databases showed 
frequent, bootstrap-supported differences in their phylogenies indicative of extensive 
within-species recombination between genome regions. In summary, we identified 
extremely high frequencies of infection with EV-G in pigs in Vietnam, substantial 
genetic diversity and recombination within the species, and evidence for a much larger 
number of circulating EV-G types than currently described. 
INTRODUCTION 
A wide variety of viruses infect the domestic pig (Sus scrofa) and many, such as 
rotaviruses and caliciviruses, are associated with severe enteric disease. A large group 
of viruses, collectively termed “porcine enteroviruses”, members of the virus family 
Picornaviridae, have also been implicated in a wide range of disease presentations in 
pigs (Knowles, 2006; Knowles et al., 1979). A better understanding of their 




epidemiology and pathogenicity was achieved once it was recognized that the group 
incorporated members of three different picornavirus genera, Teschovirus, Sapelovirus 
and Enterovirus, with distinct infection profiles and disease associations (Kaku et al., 
2001; Knowles, 2006; Krumbholz et al., 2002). Among these, teschoviruses have been 
identified as the cause of a frequently severe epidemic form of encephalomyelitis, as 
well as a range of other systemic disease manifestations including diarrhoea, 
respiratory disease and myocarditis. Sapeloviruses have also been linked with enteric 
and respiratory disease presentations and more recently, with polioencephalomyelitis 
(Lan et al., 2011). 
The third group, now classified as members of the genus Enterovirus, were originally 
isolated from skin lesions of pigs (Knowles 1988) but have not to date been clearly 
linked to enteric or other disease presentations (Knowles 2006). Enteroviruses (EVs) 
infecting pigs are genetically distinct from other EVs and have recently been assigned 
as members of species G (EV-G) (Knowles et al., 2012), a separate species from those 
infecting humans (species A – D), cows (E and F) and non-human primates (A, B, D, 
H and J). The original isolates of EV-G (PEV-9 and PEV-10) were serologically 
distinct from each other and are now recognized and reassigned as separate EV-G 
types, EV-G1 and -G2. Very recently, molecular methods have identified further 
genetic variants, now classified as EV-G3 and EV-G4 from pigs and wild boars in 
Hungary (Boros et al., 2012a; Boros et al., 2011), EV-G5 from a sheep (Boros et al., 
2012b) and EV-G6 from a pig in Korea (Moon et al., 2012). These type assignments 
were based on sequence divergence of the VP1 gene, where types display 25% 
nucleotide sequence divergence from each other (http://www.picornaviridae.com/); 
these are a substitute for demonstrating serological relationships, which remain as yet 
uncharacterized for these newly assigned types. 
In the current study, we investigated the infection frequency, disease associations and 
genetic diversity of EVs in pigs from Vietnam. This study was part of a larger 
longitudinal cohort research programme within farming communities in Vietnam, 
providing a baseline survey of enteric pathogens on pig farms in the study province, 
Dong Thap, located in the Mekong delta. 





Infection frequency of EV 
Detection frequencies of EV RNA were high within all four surveyed districts of Dong 
Thap province, with 92 of 102 (90%) farms testing EV positive for at least one pig. 
Rates of infection were highest among weaners (93%) aged 7 – 14 weeks, and declined 
moderately with the age of the pigs, with 42% of those older than 1 year of age 
continuing to shed detectable levels of EV RNA (Table 1). Frequencies of EV 
detection in pigs with and without diarrhoea were similar in all age ranges. There was 
no significant association between viral load as determined by EV threshold cycle (Ct) 
values and clinical status (data not shown). 




With diarrhoea Without diarrhoea p-value** 
Pigs tested (N) EV frequency (%) Pigs tested (N) EV frequency (%)  
Suckler < 7 9 89 33 85 1.0 
Weaner 7 – 14 29 97 29 90 0.66 
Grower 15 – 23 10 70 28 71 1.0 
Gilts 24 – 52 0 - 12 58 - 
Sows, boars > 52 22 41 26 42 1.0 
Total - 70 74 128 72 0.74 
* Typical age range for group. 
** Two-tailed Fisher’s exact test. 
Genetic diversity of EV variants 
The genetic diversity of EVs detected in a subsample of 20 positive faecal specimens 
was determined by sequence comparisons in the VP4/VP2 and VP1 regions (Figure 
1). All but one sample could be amplified in the VP4/VP2 region, while 17 of 20 were 
positive in VP1. Consensus sequences from these two regions identified species G EV 
variants in all infected pigs. The latter region was additionally used for type 
assignments; phylogenetic analysis of this region identified six type 1 (EV-G1) 
variants, seven EV-G6 and four further variants that did not cluster with sequences 
from this study or with those previously published and available in public sequence 
databases. These latter variants showed > 25% nucleotide sequence divergence from 
other EV-G types over the VP1 coding sequences and on consultation with the ICTV 









Figure 1. Phylogenetic comparisons of sequences from VP4/VP2 region (nt 810 – 1250) (a) and VP1 
(nt 2469 – 3317) (b) from study samples and available sequences of other EV-G variants from GenBank. 
Maximum-likelihood trees were reconstructed using 500 bootstrap resamples to demonstrate the 
robustness of groupings; values of ≥ 70% are shown. The tree was rooted by inclusion of the more 
divergent EV (bovine) species E variant, GenBank accession no. AF123432 (not shown). The tree was 
drawn to scale; bar shows indicated evolutionary distance. 
 
Pigs infected with type 1 were typically younger (median age 4 weeks, range 3 – 9) 
than those infected with type 6 (median 7 weeks, range 5 – 56) and other types (median 
104 weeks, range 52 – 165), differences that were significantly different despite the 
small sample size (p = 0.018; Kruskal–Wallace non-parametric test; Table 2). In 
contrast, no differences in frequency of diarrhoea or sampling location were observed 
between EV-G types (Table 2, p > 0.05). 
 
 




Table 2. Clinical characteristics of EV-infected pigs 
Sample Location Age* Diarrhoea Ct value EV-G Type 
714133 Cao Lanh 3 No 25.5 1 
724267 Chau Thanh 4 Yes 24.6 1 
724268 Chau Thanh 4 Yes 28.1 1 
724266 Chau Thanh 4 Yes 30.1 1 
734041 Thanh Binh 7 Yes 27.3 6 
734042 Thanh Binh 7 No 30 6 
734148 Thanh Binh 7 No 30.7 6 
714318 Cao Lanh 7 No 29.9 Unk/ND 
714432 Cao Lanh 7 No 31.5 6 
734006 Thanh Binh 9 Yes 29.6 1 
744100 Hong Ngu 9 Yes 31.1 6 
744101 Hong Ngu 9 No 28 6 
734007 Thanh Binh 9 Yes 29.2 Unk/ND 
734123 Thanh Binh 52 Yes 25.9 10 
744032 Hong Ngu 56 No 29.9 6 
744257 Hong Ngu 104 No 28.5 11 
724118 Chau Thanh 165 No 29.6 8 
724167 Chau Thanh Unk No 30.5 1 
724162 Chau Thanh Unk Yes 30.3 9 
724143 Chau Thanh Unk No 28.9 Unk/ND 
ND, Not determined; Unk, Unknown. *Age in weeks; samples ranged by age. 
Recombination in the EV-G genome 
The occurrence of recombination in picornavirus genomes is variable, even between 
closely related viruses in the same genus. We previously hypothesized that the 
generation of recombinants was favoured in genome regions showing restricted 
genetic variability and with consequent greater likelihood of creating biologically 
compatible genome combinations (Simmonds, 2006). Through a sliding window 
comparison of complete genome sequences of EV-G, amino acid sequences 
divergence was greatest in the structural gene (VP4–VP1)-encoding region and much 
more restricted in the non-structural gene block and in the 5’ untranslated region 
(5’UTR, Figure 2).  
Distinct patterns of divergence and codon usage have been observed between 
picornavirus groups that undergo frequent recombination between structural and non-




structural gene regions and those where recombination is infrequent or undetected 
(Simmonds, 2006). EV-G sequences showed characteristics of the former, with mean 
pairwise distances between structural gene sequences of EV-G substantially higher 
than non-structural gene regions (0.23 compared with 0.09, 2.5 : 1). The structural 
gene region additionally showed a higher frequency of non-synonymous to 
synonymous substitutions (dN/dS = 0.20) and more random codon usage (effective 
number of codons (ENc) of 55; Fares et al., 2002) than non-structural genes (dN/dS = 
0.09; ENc of 51). Indeed, the divergence scan (Figure 2) was highly comparable to that 
observed in EV species A – C, each of which is documented to undergo frequent 
recombination between non-structural regions and the 5’UTR, and in species B, 
additionally with VP4 (Oberste et al., 2004; Simmonds, 2006). 
Figure 2. Amino acid sequence divergence across the genome of EV-G types 1 – 6. Divergence values 
were calculated using a window size of 300 bases, incrementing by a codon between windows. The 
genome diagram beneath is plotted to scale with the x-axis. Genome regions sequenced for 
recombination analysis (5’UTR, VP4/VP2, VP1 and 3Dpol) are shown above the graph. 
Sequences from the 3Dpol region fell into four main bootstrap-supported clades on 
phylogenetic analysis of nucleotide sequences (Figure 3a). Membership of the four 
clades (designated A – D) bore little relationship to type assignments based on VP1 




sequences; members of different types were found within each of the four clades, and 
conversely, sequences of the same type were also found in different clades. Pairwise 
distances within and between 3Dpol groups fell into two, largely distinct ranges 
(Figure S1, available in the online Supplementary Material) with a distance threshold 
matching clade membership of approximately 14%, comparable to that dividing 
recombinant forms in other EVs (McWilliam Leitch et al., 2010, 2012). However, 
variants that were closely similar in VP1, such as the subcluster of three sequences 
724167, 714133 and 734006, remained grouped together in 3Dpol (and in VP4/VP2), 
consistent with a degree of retained genetic linkage between the two regions over short 
periods of sequence divergence. 
 
Figure 3. Phylogenetic comparisons of sequences from 3Dpol (nt 6585 – 7121) (a) and 5’UTR (nt 196 
– 470) (b) from the study samples and available sequences of other EV-G variants from GenBank. 
Maximum-likelihood trees were constructed from nucleotide sequences with 500 bootstrap resamplings 
to demonstrate robustness of groupings; values of ≥ 70% are shown. The tree was drawn to scale; bar 
shows indicated evolutionary distance. 
The phylogeny of VP1 and groupings of EV-G variants into types was mirrored in part 
in the VP4/VP2 regions but with some exceptions that were indicative of 
recombination between the two genome regions. The GenBank sequence HM131607 
was assigned as EV-G1 based on its grouping with other type 1 variants in VP1 but it 




adopted a different tree position in VP4/VP2. A more complex change in phylogeny 
occurs for the type 6 variants obtained in the current study; two of these (744032 and 
744101) that cluster with type 6 in the VP1, cluster to form a new clade in VP4 that 
also includes the newly assigned EV-G10 variant, 734123. 
The phylogeny of the 5’UTR was even less congruent with VP1 than VP4/VP2 (Figure 
3b). All but three variants possessed 5’UTR sequences that were nearly identical to 
each other and fell into a separate bootstrap-supported clade that grouped separately 
from the prototype type 1 and type 2 sequences, GenBank accession nos AF363453 
and AF363455. The most divergent 5’UTR sequence was JQ277724, a type 5 variant 
isolated from a sheep and proposed to be an interspecies recombinant virus with a 
5’UTR most similar to those of EV-E and -F (Boros et al., 2012b). 
DISCUSSION 
This study provides evidence for a broad ecology of EV-G and highlights substantial 
genetic diversity and a propensity for intra-species recombination. High rates of EV-
G infection were detected in young pigs; detection frequencies of over 90% in young 
pigs and 40% in adult pigs are consistent with 92 and 20% positivity rates in the 
equivalent age groups reported from the Czech Republic (Prodělalová, 2012) although 
substantially higher than in China (10 and 5%, respectively) (Yang et al., 2013), 
Hungary (Boros et al., 2011), Italy (Sozzi et al., 2010) and Spain (Buitrago et al., 
2010). High rates of infection in young pigs likely reflect their exposure to 
environmental sources of infection and infection with potentially multiple types of 
circulating EV-G strains. Although numbers were relatively small, type 1 infections 
were specifically found in younger pigs (sucklers and weaners; 3 – 9 weeks) and type 
6 infections were primarily detected in the age range 7 – 9 weeks, while all but one of 
the older pigs (age range 52 – 165 weeks) were infected with types 8 – 11. The 
observations are consistent with successive rounds of infection of pigs in Vietnam, 
starting with EV-G1, followed by EV-G6 and thereafter more sporadic infections with 
rarer types. This perhaps mirrors age-associated differences in infection frequencies of 
different EV serotypes in young children (Khetsuriani et al., 2006). However, it is also 
possible that observed associations were the result of different sampling times in 




different farms and districts; this age association requires confirmation with larger 
numbers. 
We found no association between PEV detection and enteric disease (diarrhoea) in this 
cross-sectional study (Table 1). These findings are consistent with a previous study 
that clearly differentiated EV-G from more pathogenic porcine picornaviruses 
(Prodělalová, 2012). In this respect, EV-G infections resemble those of EV species 
infecting humans that are largely non-pathogenic, appear to be ubiquitous and 
frequently detected in the enteric and respiratory tracts of healthy people, but for which 
infections with particular variants may be associated with neurological syndromes. 
There is limited evidence for systemic infections of pigs with EV-G; one experimental 
infection study of specific-pathogen-free pigs showed detectable viral RNA in plasma, 
spinal cord and brain (Yang et al., 2013), and three of 12 inoculated pigs developed 
flaccid paralysis of the hind limbs. These intriguing results suggest the possibility that 
certain EV-G types may be pathogenic. Unfortunately, the study did not provide the 
necessary sequence data to support this conclusion (the cited GenBank accession 
numbers were incorrect in the manuscript) and, indeed, evidence for pathogenic 
variants of EV-G has not been reported elsewhere in the literature, either from field 
epidemiology studies or from laboratory infection trials. 
The genetic diversity of EV-G is incompletely characterized. Both prototype strains 
[EV-G1, originally described as PEV-9, and EV-G2 (PEV-10)] have been detected in 
recent surveys of domestic pig populations (Sozzi et al., 2010; Ren et al., 2012) and 
several further examples of EV-G1 were detected in the current study. A substantial 
proportion of our study group were infected with EV-G6, to date described as a single 
variant from Korea (Moon et al., 2012). Reports of EV-G3, EV-G4 and EV-G5 are 
similarly sparse, in each case restricted to the single publications in which they were 
first described (Boros et al., 2011, 2012a, b). The likelihood that viruses in species G 
are actually highly diverse genetically (and likely serologically) but incompletely 
sampled is supported by observations in the current study in which genetic analysis of 
a relatively small sample identified four new EV types (G8 – G11). Further evidence 
for the currently uncharted diversity of this EV species is provided by analysis of 
partial VP1 sequences published from previous surveys deposited in GenBank (La 




Rosa et al., 2006; Sozzi et al., 2010; Nix et al., 2013). Although sequences in these 
studies were too short for formal type assignments and were not suitable for 
uncovering robust phylogenetic relationships, two surveys of infected pigs in Italy (La 
Rosa et al., 2006; Sozzi et al., 2010) generated sequences potentially representing six 
new types, while a further potential new type was observed in Bolivia (Nix et al., 
2013). Larger scale and more systematic surveying of variants infecting pigs in 
different countries will undoubtedly reveal the existence of much larger numbers of 
EV-G types in the future. 
Several differences in phylogeny relationships were observed between VP1 (used for 
type assignment) and other genome regions (3Dpol, VP4/VP2 and 5’UTR). Changes 
in phylogeny are, by analogy with the better documented human EVs, strongly 
indicative of recombination events occurring during EV-G diversification. EV-G 
shares with other EV species a number of genome properties, such as restricted amino 
acid sequence diversity in NS gene regions and a modularly functioning 5’UTR, that 
favour recombination by increasing the likelihood that a chimeric sequence will be 
biologically viable, as discussed previously in reviews by Simmonds (2006) and 
Lukashev (2005). Previous descriptions of recombination in EV-G are restricted to 
those involving the 5’UTR; Boros et al., (2012b) identified a highly divergent 5’UTR 
sequence on an EV-G variant (EV-G5) that grouped with those from bovine EVs (EV 
species E, F). This probably represents an interspecies recombination event of the type 
documented previously for example between rhinovirus species A and C (Huang et 
al., 2009; McIntyre et al., 2010) and between EV species A and B (Santti et al., 1999). 
Bovine EV 5’UTR sequences in species E and F are similarly interspersed 
phylogenetically. In a second study, the EV-G1 variant Ch-ah-f1 (GenBank accession 
no. HM131607) showed a change in phylogeny relationships in the 5’UTR with the 
prototype EV-G1 and G2 strains (GenBank accession nos AF363453 and AF363455) 
and the type 3 sequence (GenBank accession no. HQ702854). On analysis of the 
expanded dataset in the current study (Figure 3b), this finding is actually a 
manifestation of the separate clustering of the older AF363453 and AF363455 variants 
from the more recently detected EV-G variants, and not a recombination event specific 
to Ch-ah-f1. Remarkably, it appears that all existing types circulating in Europe and 




Asia, including modern versions of EV-G1 and -G2, share a common 5’UTR sequence 
acquired in the period following the original isolation dates of the EV-G prototype 
strains (1973 for EV-G1 and 1975 for EV-G2 respectively; N. J. Knowles, personal 
communication). 
Through the identification of additional phylogenetic incompatibilities in other 
genome regions, the current study additionally identifies extensive recombination 
between structural (VP1) and non-structural gene regions (3Dpol) and within the 
capsid (between VP1 and VP4/VP2). Membership of the four bootstrap-supported 
clades in 3Dpol indeed bears little relationship to their type assignments based on VP1 
sequences (Figure 3a), while further, different, recombination events probably underlie 
the altered position of the type 1 variant, HM131607, and splitting of sequences from 
study samples assigned as EV-G6 into two clades in the VP4/VP2 region (Figure 1a). 
Clades in 3Dpol show a degree of divergence from each other comparable to those 
previously characterized in species A and B human EVs, and which were used to 
subdivide members of the same serotype into a series of recombinant forms 
(McWilliam Leitch et al., 2010, 2012). In EV-G, however, these groups are not 
numerous, and individual 3Dpol clades contain examples of several different types; 
this is rarely observed in species A (EV71) or species B (echoviruses 9, 11 and 30) 
EVs. These differences reflect probable differences in transmission dynamics and 
reservoir sizes, and potentially differences in recombination frequency between 
species. Larger datasets are required to compare timescales of recombination events 
and recombinant form half-lives with those previously established for human EVs and 
parechoviruses (McWilliam Leitch et al., 2009, 2010, 2012; Calvert et al., 2010). 
In conclusion, this study reveals the high frequency of infection with species G EVs 
in pigs in Vietnam, with almost universal infection among post-weaning pigs. EVG 
variants were highly genetically diverse and, although a relatively small number were 
analysed, suggest much greater genetic diversity within species G than has been 
characterized to date. 
 





Study location and design 
The survey was carried out between February and May 2012 in Dong Thap province 
in southern Vietnam. The study included four of 12 districts (Cao Lanh, Chau Thanh, 
Hong Ngu and Thanh Binh) from which a total of 102 farms were randomly selected 
and sampled. From each farm, freshly voided individual faecal samples (~5 g) were 
randomly collected from 10 pigs, plus up to four samples per farm from any pigs with 
frank diarrhoea. Samples were recorded as diarrhoeic or not based on faecal 
consistency. Farmer survey questionnaires were used to collect information on animal 
and farm characteristics as well as farming practices. The study was approved and 
implemented by the Subdepartment of Animal Health Dong Thap province and 
veterinary students from Nong Lam University. A total of 198 faecal samples were 
subsampled from the total sample set, representing one to three randomly selected pigs 
per farm, including all of the 70 diarrhoeic samples. 
Porcine EV screening 
RNA was extracted from 200 µl of 10% (w/v) faecal suspensions using a MagNA Pure 
96 Viral NA small volume kit (Roche) and an automated extractor (Roche). The 
presence of PCR inhibitors and RNA quality control were assessed by spiking samples 
with an RNA internal extraction control (equine arterivirus) prior to extraction. The 
total RNA recovered (60 µl in nuclease-free water) was stored at -80oC until use. 
cDNA was screened for EVs by real-time reverse transcription (RT)-PCR using 
primers from the 5’UTR as described previously (Beld et al., 2004). A total of 20 
samples that were representative of the geographical range and ages of infected pigs 
were selected for further genetic analysis (type identification, recombination 
detection). These were re-extracted from the original specimens using Qiagen RNA 
extraction kits. 
Amplification of VP4/VP2, VP1, 3Dpol and 5’UTR sequences 




These four genome regions were amplified by nested RT-PCR using primers listed in 
Table S1. For each PCR, 6 µl extracted RNA was used for cDNA synthesis followed 
by nested PCR. The reverse transcription step was combined with first-round PCR 
using Superscript III One-Step RT-PCR system with Platinum Taq High Fidelity 
according to the manufacturer’s instructions (Invitrogen). The RT-PCR conditions 
were, sequentially, 43oC for 1 h and 20 cycles of 53oC for 1 min and 55oC for 1 min, 
followed by 70oC for 15 min and 94oC for 2 min. PCR comprised 40 cycles of 94oC 
(30 s), 50oC (30 s), and 68oC (105 s) and a final extension at 68oC for 5 min. After 
that, 1 µl of the first-round reaction was used for the nested PCR with second-round 
primers and GoTaq DNA polymerase (Promega). PCR amplification included 30 
cycles of denaturation (at 94oC for 30 s), annealing (50oC, 30 s) and elongation (72oC, 
90 s) in a thermal cycler. Products of the second-round PCR were visualized by agarose 
gel electrophoresis and sequenced. 
Amplicons were sequenced directly using ABI 7200 BigDye capillary sequencing 
(Applied Biosystems) in a total volume of 10 µl containing 7 µl DNA/RNA-free water, 
1 µl BigDye, 1 µl inner sense primer or antisense primer and 1 µl DNA amplicon. 
Reactions were carried out with 25 cycles of 30 s at 96oC, 20 s at 50oC and 4 min at 
60oC. 
Sequences were imported and aligned using the SSE sequence editor (Simmonds, 
2012) and phylogenetic trees reconstructed using maximum-likelihood methods as 
implemented in the MEGA 5.2 software package (Tamura et al., 2011). The optimum 
maximum likelihood model (lowest Bayesian information criterion score and typically 
greatest maximum-likelihood value) for each sequence dataset was first determined 
and used for phylogenetic reconstruction. Different models were selected for different 
datasets: Tamura–Nei gamma distribution (five rates selected) with invariant sites for 
VP4; general time-reversible gamma distribution (five rates) with invariant sites for 
VP1; Tamura–Nei, gamma distribution (five rates) for 3Dpol and Kimura two-
parameter gamma distribution for the 5’UTR. However, running the datasets with 
second- or third-choice models created trees with identical topologies and with similar 
branch lengths and bootstrap values (data not shown). Phylogenetic analysis of each 
dataset used bootstrap resampling to determine the robustness of grouping. 




Codon usage and pairwise distances were computed using built-in functions in the SSE 
sequence editor. All nucleotide positions were numbered using the annotation 
provided for the EV-G3 sequence, GenBank accession no. HQ702854 
(swine/K23/2008/HUN). 
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Large-scale screening and characterization of enteroviruses and 
kobuviruses infecting pigs in Vietnam 
 
ABSTRACT 
A recent survey of pigs in Dong Thap province, Vietnam identified a high frequency 
of enterovirus species G (EV-G) infection (144/198; 72.7%). Among these was a 
plethora of EV-G types (EV-G1, EV-G6 and four new types EV-G8 to -G11). To better 
characterize the genetic diversity of EV-G and investigate the possible existence of 
further circulating types, we performed a larger scale study on 484 pig and 45 farm-
bred boar faecal samples collected in 2012, 2014, respectively. All samples from the 
previous and current studies were also screened for kobuviruses. The overall infection 
frequency of enteroviruses (EV) remained extremely high (395/484; 81.6%) but with 
comparable detection rates and viral loads between healthy and diarrhoeic pigs; this 
contrasted with less frequent detection of EV-G in boars (4/45; 8.9%). EV was most 
frequently detected in pigs ≤ 14 weeks old (approximately 95%) and declined in older 
pigs. Infections with EV-G1 and EV-G6 were most frequent, while less commonly 
detected types included EV-G3, EV-G4, EV-G8 – EV-G11 and 5 new types (EV-G12 
to -G16). In contrast, kobuvirus infection frequency was significantly higher in 
diarrhoeic pigs (40.9% compared to 27.6%; p = 0.01). Kobuviruses also showed 
contrasting epizootiologies and age associations; a higher prevalence was found in 
boars (42%) compared to domestic pigs (29%) with the highest infection frequency 
among pigs > 52 weeks old. Although genetically diverse, all kobuviruses identified 
belonged to species Aichivirus C. In summary, this study confirms infection with EV-
G was endemic in Vietnamese domestic pigs and exhibits high genetic diversity and 
extensive inter-type recombination. 
INTRODUCTION 
Porcine enteroviruses (PEV) are members of the family Picornaviridae and originally 
consisted of 13 types (PEV-1 to -13). Further studies on their genetic relatedness led 
to the re-assignment of these viruses into three separate picornavirus genera, 
Enterovirus, Sapelovirus and Teschovirus (Kaku et al., 2001; Knowles, 2006; 




Krumbholz et al., 2002; Zell et al., 2001). Of these, PEV-9 and -10 were classified as 
EV-G1 and -G2 serotypes in Enterovirus G with the subsequently characterised EV-
G types EV-G3 through EV-G6 reported in single publications from Hungary and 
South Korea (Boros et al., 2012a; Boros et al., 2012b; Boros et al., 2011a; Moon et 
al., 2012). EV-G7 was subsequently discovered from domestic sheep by Boros and 
Knowles (unpublished). More recently, our molecular characterization of 
enteroviruses in a small number of PCR-positive faecal samples from domestic pigs 
identified a further four types (EV-G8 to -11) within this species. The presence of such 
a large amount of genetic diversity within such a modest number of samples sizes 
suggests that the full range of EV-G types in this virus species has yet to be fully 
characterised (Nguyen et al., 2014a). In contrast to teschoviruses, infections with 
species G enteroviruses have not been linked to any enteric or other disease 
presentations (Knowles, 2006) except for skin lesions (Knowles, 1988) and flaccid 
paralysis in an experimental infection of pigs in China (Yang et al., 2013). Viruses in 
this species have been reported from both healthy and diarrhoeic pigs with no 
statistically significant difference in infection rates between the two groups (Nguyen 
et al., 2014a).  
Porcine kobuvirus (PKV) was first identified in 2008 in Hungary (Reuter et al., 2008). 
While screening 15 faecal samples from pigs for calicivirus (norovirus and sapovirus) 
using reverse transcription-PCR, Reuter et al. (2008) detected, in addition to a band 
specific for sapovirus, a nonspecific, strong band of about 1.1 kb in all tested samples 
visible on agarose gel. The nucleotide sequence of the nonspecific PCR product 
showed most similarity to the 3C/3D region of bovine and human aichiviruses. Upon 
analysis of the obtained complete nucleotide sequence, the new PKV was assigned as 
a member of a new species (Aichivirus C) in the genus Kobuvirus, which also includes 
Aichivirus A and Aichivirus B species, originally detected in humans and oxen, 
respectively. Aichivirus C consists of a single type, PKV-1. The existence of PKV-1 
in pigs has been well documented in different countries worldwide (Amimo et al., 
2014; Barry et al., 2011; Chen et al., 2013; Di Bartolo et al., 2015; Fan et al., 2013; 
Khamrin et al., 2010; Khamrin et al., 2009; Okitsu et al., 2012; Park et al., 2010; 




Reuter et al., 2013; Sisay et al., 2013) but in Vietnam, PKV-1 has been only reported 
from river water (Inaba et al., 2014). 
We have performed this larger scale screening study to better understand of the 
prevalence, genetic diversity and disease association of enteroviruses and kobuviruses 
infecting pigs and farm-bred boars (hereafter referred to as ‘boars’) in Vietnam. 
RESULTS 
Detection of EV 
EV RNA was detected in all but one (103 of 104; 99%) of farms containing domestic 
pigs and in 3 from 6 (50%) farms housing boars. 395 from 484 (81.6%) samples from 
domestic pigs and 4/55 (8.9%) of boar samples were PCR-positive (Table 1). Pigs of 
14 weeks of age or younger were the most frequently infected with faecal detection 
frequencies of nearly 95%. Lower detection frequencies were observed in older pigs 
with the lowest rate (50.5%) in pigs > 1 year of age. Combining screening data with 
that of our previous samples, we found no significant difference in the frequency of 
detection of EV infection between the two groups in all ranges of age (Table 1). The 
lack of any direct causative role of EV-G in enteric disease in pigs was further 
demonstrated by our observation that pigs with diarrhoea showed slightly lower EV-
G RNA viral loads than found in healthy pigs (p = 0.008, Mann-Whitney test; Figure 
1). 
Table 1. Detection of EV and PKV in pigs 
* Data were presented in pair of diarrhoeic/non-diarrhoeic samples. 
† Fisher exact test or Chi-squared test 
‡ Only samples from the previous and current studies with available data (age, clinical status) were 

















Suckler < 7 11/78 90.9/93.6 0.56 63.6/59 1 63.6/53.8 0.75 
Weaner 7 – 14 32/147 93.8/94.6 1 18.8/25.9 0.4 18.8/24.5 0.49 
Grower 15 – 23 8/117 75/82.9 0.63 25/16.2 0.62 25/13.7 0.32 
Gilts 24 – 52 0/68 -/70.6 - -/26.5 - -/17.6 - 
Matured pigs > 52 28/106 39.3/48.1 0.4 67.9/25.5 2.7x10-5 28.6/13.2 0.08 
  Total 79/516‡ 72.2/79.1 0.17 43/28.7 0.01 29.1/23.3 0.26 





Figure 1. Box plot of log10 EV RNA copies/ml of EV-G screen positive sample suspensions from 
healthy and diarrhoeic pigs. Median values are shown. Mann-Whitney test was applied to compare 
medians between groups. 
Detection of kobuviruses 
The overall detection frequencies of kobuviruses in domestic pigs and boars were 
29.3% (200/682) and 42.2% (19/45), respectively. In contrast to EV-G, kobuviruses 
were significantly associated with diarrhoea in pigs, with an infection frequency of 
40.9% (36/88) in diarrhoeic pigs and an infection frequency of 27.6% (164/594) in 
asymptomatic pigs (p = 0.01; Chi-squared test). This positive association was, 
however, most marked in pigs aged > 52 weeks at which the highest prevalence 
(67.9%) was recorded. For pigs ≤ 23 weeks old, infection frequencies were highest in 
sucklers and generally decreased with age.  
In order to elucidate whether PKV viral loads were associated with clinical status of 
pigs, a real-time PCR protocol was developed. The assay had a detection limit of 100 
PKV RNA copies per reaction and an amplification efficiency of 89% (data not 
shown). It showed good specificity (no false positive in 20 samples negative by nested 
PCR) and sensitivity (97/100 samples positive by nested PCR were detected by real-
time PCR). The median log10 viral load (7.7) of PKV in 41 matured pig samples was 




significantly higher than that (6.4) in the group of 56 younger pig samples (p = 0.0003; 
Mann-Whitney test; Figure 2a). However, there was no significant difference in the 
viral loads (medians of log10 viral loads of 7.99 and 7.56) between matured pigs with 
and without diarrhoea (p = 0.22 by Mann-Whitney test; Figure 2b).  
The differences in the coinfection rates were not significant in all categories of age 
between the two groups of diarrhoeic and non-diarrhoeic pigs (p > 0.05). Co-infection 
with EV and PKV was most common in youngest pigs (Table 1). 
 
Figure 2. Log10 PKV RNA copies/ml of pig sample suspensions in different age groups (a) and in 
healthy or diarrhoeic matured pig (b). Bars show median values. Mann-Whitney test was applied to 
compare medians between groups. 
Genetic characterization of porcine EV 
A range of EV variants in a subsample of 177 positive samples representing all 
sampling districts, Ct value ranges, ages and clinical status of infected pigs, and four 
boar positive samples were typed by sequencing of the VP1 region. All VP1 sequences 
obtained from 130 samples (including four from boars) clustered with the species G 
enteroviruses (Figure 3). Phylogenetic and sequence distance analysis of this region 




showed the most commonly identified previously described type was EV-G1 (n = 57 
sequences, 3 boar-derived), followed by EV-G6 (n = 29), EV-G11 (n = 9), EV-G4, 
EV-G8, EV-G9 (6 of each type), EV-G3 (n = 5) and EV-G10 (n = 2). The other 10 
VP1 nucleotide (nt) sequences were substantially divergent (> 25%) from other EV-G 
types and have been assigned as new types EV-G12 to EV-G16 by the ICTV 
Picornavirus Study Group (Figure 3). 
 
Figure 3. Phylogenetic comparisons of VP1 sequences (nt 2469 – 3317) from study samples and 
available sequences of other EV-G variants from GenBank. Maximum-likelihood trees were 
reconstructed using 1000 bootstrap resamples to demonstrate the robustness of groupings; bootstrap 
support values of ≥ 70% are shown. The tree was rooted using bovine enterovirus (BEV), GenBank 
accession no. AF123433, as an outgroup. The tree was drawn to scale; bar indicates estimated number 
of substitutions per site. 




Analysis of data shows that young pigs were more frequently infected with EV-G1 
and EV-G6 compared to other EV-G types, with median ages of 2 and 1.75 months, 
respectively. Meanwhile, other types were generally found in older pigs (median age: 
4 months) (Supplementary data; Table S3). These differences were statistically 
significant (p < 0.0001, p = 0.0001 by Mann-Whitney test; Figure 4).  
 
Figure 4. Box plot of EV types by pig ages. The y-axis is displayed in a log10 format. Bars show median 
values. Mann-Whitney test was applied to compare medians between groups. 
Sequence and phylogenetic analysis of PKV 
184 VP1 sequences were obtained from 173 positive samples, including 15 from boars 
(Figure 5). Co-infection with two kobuvirus variants was detected in 11 samples by 
sequencing of VP1. All the VP1 sequences in the current study clustered within species 
Aichivirus C with nucleotide and amino acid sequence distances ranging from 0 – 
22.3% (mean = 14.3%) and 0 – 17.6% (mean = 8.5%), respectively. In comparison to 
VP1 sequences of Aichivirus C available in GenBank, the novel sequences produced 
here showed 9.1 – 23.6% and 0.45 – 17.5% nucleotide and amino acid distances, 
respectively. In the resulting phylogeny, sequences from Vietnam were segregated into 




six groups (1 – 6) with sequences from boars representing five distinct lineages, while 
those from domestic pigs clustering in three large groups. Groups 1, 2, and 3 appeared 
to be most closely related to sequences from China (KJ452348, KF539763, 
KF157926), while groups 4, 5 and 6 were most closely related to sequences from USA 
(JX987506), Hungary (GQ249161.1) and Thailand (AB624490), respectively. To test 
whether specific groups were associated with diarrhoea, association index values were 
calculated using genetic groups 1, 3 and 6 for group assignments and diarrhoea/non-
diarrhoea as the associated variable. The calculated association index values of 0.45, 
0.85 and 0.66 for the three groups, respectively, provided no evidence for difference 
in clinical outcomes between groups.   
 
Figure 5. Phylogenetic comparisons of VP1 sequences (nt 3005 – 3838) from study samples and 
available sequences of other PKV variants from GenBank. The tree was rooted using human kobuvirus 
(NC 001918) and bovine kobuvirus (GU245693) as outgroups. The tree was drawn to scale; bar 
indicates estimated number of substitutions per site. 




Recombination of new types EV-G8, 9 
To perform a recombination analysis, coding region complete sequences of two new 
types were obtained by overlapping PCR amplifications. Phylogenetic relationships 
between EV-G8 and EV-G9 and other EV-G types for which complete genome 
sequences were available were inconsistent in several different regions of the genome 
(5’UTR, VP4/VP2, VP1 and 3D), indicative of recombination (Figure 6). Most 
obviously, while sequences from the 5’UTR and VP4/VP2 and VP1 regions of the two 
novel EV-G types (EV-G8 and G9) clustered separately from all other known EV-G 
types, sequences from the 3D regions of these novel viruses clustered together and 
formed a well-supported monophyletic clade (Figure 6). To identify sites where 
recombination is likely to have occurred, a nucleotide distance scan (Figure 7a) and 
grouping scan (Figure 7b) were performed using EV-G9 as the reference sequence. G9 
was equally divergent from G8 in P1 as it was from other types, but divergence values 
between G8 and G9 plunged at the boundary of P1/P2 to values equal to or lower than 
the mean pairwise distance of sequences within EV-G9. The analysis localised the 
breakpoint to the middle of the 2A region. 
 
Figure 6. Phylogenetic comparisons of sequences from 5’UTR (nt 107 – 809) (a), VP4/VP2 (nt 810 – 
1752) (b), VP1 (nt 2469 – 3317) (c), and 3D (nt 5934 – 7316) (d) from the study samples and available 
sequences of other EV-G variants from GenBank. 





Figure 7. (a) Nucleotide sequence divergence within EV-G9 and between EV-G9 sequences and other 
EV-G types. Y-axis values show mean pairwise distances between 300 base windows across the 
genome, incrementing by 30 bases between fragments. (b) Group Scan analysis of the sequence 734087-
G9. Sequence fragments of 300 bases incrementing by 30 bases, 100 bootstrap replicates, were 
compared with sequences from other types. To show gene boundaries, the P2 & P3 regions have been 









This is the first large scale study of the prevalence and genetic diversity of 
enteroviruses and kobuviruses in pigs and boars, providing substantial new 
information on their high infection frequencies and co-circulation of multiple types 
and lineages of both viruses in domestic pig and boars in Vietnam.  
The overall detection frequency of EVs in domestic pigs (81.6%) was notably higher 
than those reported in Spain (0%), Italy (7.5%), China (8.3%) and the Czech Republic 
(50.2%) (Buitrago et al., 2010; Prodělalová, 2012; Sozzi et al., 2010; Yang et al., 
2013). In contrast, detection of EV RNA in boars in this study was much lower than 
the 50% and 69.4% prevalence reported in Hungary (Boros et al., 2012a) and the 
Czech Republic (Prodělalová, 2012), respectively. High rates of EV infection in young 
pigs (detection rate > 90%) suggested that these viruses maintain endemic transmission 
in this population. Infection rates declined with the age of the pigs, to 50.5% in matured 
pigs, consistent with a limited period of active infection by and faecal excretion of 
circulating EV-G types, followed by clearance and likely immunity to reinfection. The 
greater likelihood of encountering the most actively circulating EV-G types (1 and 6) 
early in life may account for their increased detection in younger pigs (Figure 4). 
Because of the more limited circulation of other EV-G types, first exposure may be 
delayed and therefore account for the increased age range of pigs in which these types 
are detected.  
Even though domestic pigs and boars are typically reared separately, we found that 
EV-G1 infected both animal populations. Furthermore, variants were phylogenetically 
interspersed, indicating transmission events between the two populations. How this 
occurs is currently unclear as the boars were sampled in farms without domestic pigs 
and vice versa.  
Our study provided no evidence that infections with EV-G caused diarrhoea, with 
comparable detection frequencies in pigs with and without symptoms (Table 1), 
consistent with a previous study (Prodělalová, 2012). To date, only G1 virus has been 
specifically associated with disease in pigs, based on observations from the 
experimental infection of pigs in China in which two of twelve two week-old-specific-




pathogen-free pigs exhibited flaccid paralysis of the hind limbs with EV RNA detected 
in plasma, spinal cord and brain. In that experiment, the sample supernatant (not EV 
isolate) was filtered through 0.22 μm microfilters before inoculation (Yang et al., 
2013; Zhang et al., 2012). The sample was negative for a number of pathogens in pigs 
(e.g. porcine teschoviruses, porcine circovirus type 2, porcine reproductive and 
respiratory syndrome virus, classical swine fever virus, porcine epidemic diarrhoea 
virus, porcine rotavirus, hepatitis E virus). However, findings from our study indicate 
that this must be a rare outcome of infection given the absence of any evident 
neurological disease in pig farms where EV-G1 (and other enterovirus types) circulate 
extensively.  
Genetic diversity and recombination in EV-G 
Findings of four new types (G8 – G11) from only 20 positive samples in our previous 
study suggested that the genetic diversity of species G enterovirus had not been 
completely characterized (Nguyen et al., 2014a). This conclusion was supported by 
the detection of five more novel types from 130 positive samples in the current study. 
There is no doubt that more new EV-G types will continue to be detected from pigs 
from different countries in the future. To further characterize the genetic diversity of 
EV-G and potential occurrence of recombination between types, almost complete 
genome sequences of EV-G8 and EV-G9 were obtained and compared to those of 
other EV-G types. Collectively, EV-Gs show generic characteristics, such as patterns 
of divergence, codon usage, non-synonymous to synonymous substitutions that occur 
in other picornaviruses prone to extensive recombination, including EV species A – C 
(Nguyen et al., 2014a; Oberste et al., 2004b; Simmonds, 2006). Consistent with these 
predictions, recombination in the EV-G genome was detected, with breakpoints 
located at the border of the 5’UTR and VP4 of the EV-G5 prototype sequence (Boros 
et al., 2012b). Our previous study additionally identified other recombination 
occurring in the HM131607 – G1 genome and other enterovirus sequences from 
domestic pigs in Vietnam (Nguyen et al., 2014a). In the current study, sequences of 
EV-G8 and G9 variants showed significant phylogenetic incongruence between 3D (in 
which G8 and G9 sequences grouped together) and other regions (5’UTR, VP4/VP2 
and VP1 – where G8 clustered separately from G9 sequences). This inconsistency in 




tree topology is strongly suggestive of recombination. Fragments 3 (nt 2395 – 3390) 
and 4 (nt 2679 – 5419) of the G9 variants, both amplified by a single PCR (Figure S1), 
had a long identical overlapping region that was distinct from the corresponding region 
of G8. This helped rule out the possibility of hybrid viruses formed by assembly error 
from co-infection of individual pigs with two or more EV variants. When comparing 
the G8 and G9 variants, a nucleotide sequence divergence scan (Figure 7a) showed 
considerable divergence in P1; from the middle of 2B to the end of the coding region, 
however, divergence declined substantially to levels even lower than that observed 
within G9 sequences alone. The grouping scan (Figure 7b), which quantifies degrees 
of grouping with pre-defined groups (types), similarly identified a recombination 
breakpoint in the middle of the 2A region. 
Infection frequencies, diversity and disease associations of PKV 
In accordance with previous studies (Chen et al., 2013; Park et al., 2010), our study 
showed an association between PKV detection and the presence of diarrhoea in 
matured pigs (Table 1), indicating its potential aetiological role in gastrointestinal (GI) 
disease, at least in older pigs. In marked contrast to EV infections, however, the highest 
detection rates were observed in diarrhoeic pigs > 52 weeks old (matured pigs). This 
contrasts with reports from other countries where pigs younger than 6 months, 
particularly sucklers, were most susceptible to PKV infection (Chen et al., 2013; Park 
et al., 2010). Furthermore, we found viral loads of PKV in matured pigs to be 
significantly higher than that in the younger pigs.  
This observation of increasing detection frequencies with age may simply reflect the 
possibility that PKV circulates less extensively than other enteric viruses, such as EV-
G, and that infections are skewed towards older age groups with greater cumulative 
exposure. Another hypothesis to explain increasing detection frequencies and greater 
viral loads in older animals is that PKV infections are naturally persistent, and pigs 
may sequentially acquire long-term infections with one or more PKV variants over 
time. Although frequencies of persistence in PKV and other kobuviruses are poorly 
documented, genomes of all members of this genus possess structured RNA genomes 
(Davis et al., 2008a; Simmonds et al., 2004), a generic property associated with 




persistence in several other picornavirus genera and among other families of positive-
stranded RNA viruses. High rates of detection in older pigs and boars without 
diarrhoea and the lack of association between viral load and symptomatic infection in 
matured pigs indeed questions a direct aetiological link between PKV and GI disease. 
It is possible, for example, that the greater detection frequency of PKV in cases of 
diarrhoea was secondary to altered mucosal immunity and inflammatory processes 
consequent to bacterial or other viral infections causing diarrhoea (Frémont et al., 
2013). These processes may serve to re-activate normally relatively quiescent 
infections with PKV. Consistent with this possible incidental association with GI 
disease, comparison of the phylogeny of VP1 sequences from diarrhoeic and non-
diarrhoeic pigs provided no evidence for the existence of specific lineages associated 
with GI disease. Formal testing of the association of this trait with phylogenetic 
position by calculation of association index values (Wang et al., 2001) confirmed this 
lack of association. 
VP1 sequences of PKV variants clustered in six genetically diverse groups that showed 
the closest relatedness to sequences from China, USA, Hungary and Thailand. VP1 
contains a number of neutralization domains and the gene encoding this protein has 
been extensively used for (sero)type identification. Aichivirus C is currently classified 
as a single type, PKV-1, which includes variants with uncorrected VP1 nucleotide 
sequence distances ranging from 0 – 22.6%. There is no information on the extent of 
antigenic, neutralization or protective immunity differences between variants of PKV, 
or whether members of different genetic groups identified in VP1 correspond to 
serotypes of other enteroviruses. By analogy with other EVs, enterovirus species A – 
D (sero)types show > 25% nucleotide sequence distances from each other in VP1 
(Oberste et al., 1999) while different rhinovirus serotypes in the same genus indeed 
show divergences of ≥ 12 – 13% (McIntyre et al., 2013b). As PKV VP1 sequence 
distances lie between these two thresholds, prediction of their serological properties 
using this type of comparative approach is problematic. However, the detection of 
different PKV variants in the same samples is more consistent with them being 
antigenically distinct and lacking cross-protection, comparable to what is observed 




with different serotypes of PV and foot and mouth disease virus (Alexandersen & 
Donaldson, 2002; Alexandersen et al., 2002).  
Conclusions. This large-scale study showed high prevalence and genetic diversity of 
EV-G and PKV in pigs and boars in Vietnam. These are clearly widely distributed, 
with endemic infections circulating in both domestic pigs and boars, and demonstrate 
the ease with which enteric viruses likely transmitted by faecal/oral routes can become 
established in and transmit within farmed animal populations. While the pathogenicity 
of neither virus is clearly established in either this or previous studies, further genetic 
and epizootiological characterization of these viruses will contribute to our 
understanding of their transmission patterns and the farming practices that affect their 
spread. Future studies may also provide new insights into the factors that underlie the 
transmission and dissemination of more specifically pathogenic viruses, such as 
rotaviruses, that present a much greater challenge to animal welfare and productivity.     
MATERIALS AND METHODS 
Faecal samples were collected from 104 farms in four districts of Dong Thap province 
between February and May 2012. At each farm, 10 freshly voided samples from 
randomly selected healthy pigs and up to four samples from pigs with diarrhoea were 
collected. From this collection, a subsample of 198 samples, including 70 diarrhoeic 
samples, were screened in a previous study (Nguyen et al., 2014a). In the current study, 
we extended the screening of enteroviruses to the 18 remaining diarrhoeic samples and 
466 samples representing three to five healthy pigs per farm. In addition, 45 faecal 
samples collected in April 2014 from healthy farm-bred boars that were housed in 
typical livestock pens on six farms in Dak Lak province were also included. All 727 
samples from pigs and boars were also screened for kobuviruses. 
Screening and typing of enteroviruses. RNA was extracted from faecal samples 
using a MagNA Pure 96 Viral NA small volume kit (Roche) and an automated 
extractor (Roche) as described previously (Nguyen et al., 2014a). Reverse 
transcription using SuperScript III Reverse Transcriptase (Invitrogen, UK) was 
performed according to the manufacturer’s instruction. Enteroviruses were screened 
by a real-time PCR protocol (Beld et al., 2004). Typing of enteroviruses from 177 




positive samples, including 10 from diarrhoeic pigs, representing ranges of geography, 
Ct values and ages of infected pigs, was performed by amplification and sequencing 
of VP1 region as described previously (Nguyen et al., 2014a). VP1 products of the 
nested PCR were sequenced on both strands using the BigDye Terminator v3.1 
(Applied Biosystems) and primers for second round PCR. 
Screening and characterization of kobuviruses. Synthesized cDNA was screened 
for kobuviruses by nested PCR using primers targeting the 3D region of all known 
kobuviruses (Supplementary Data; Table S1). The conditions for amplification (using 
GoTaq DNA polymerase from Promega, UK) were 95oC for 5 min, 30 cycles of 
denaturation (94°C, 30 s), annealing (54°C, 30 s), and elongation (72°C, 45 s). 
Kobuviruses in positive samples were characterized by amplification and sequencing 
of VP1 region with similar amplification conditions for enterovirus VP1 as described 
previously (Nguyen et al., 2014a) but using an annealing temperature of 58oC in both 
rounds. 
PKV viral load measurement. Using PKV sequences available from GenBank, 
primers and a probe targeting the 5’UTR region were designed to develop a real-time 
PCR protocol for measurement of PKV viral load. The 200 bp target region in the 
5’UTR amplified from a positive sample was cloned into pGEM-T Easy Vector 
(Promega, UK). The linearised recombinant plasmid was used as template for 
transcription using MEGAscript T7 transcription kit (Ambion, UK) as previously 
described (McLeish et al., 2012). RNA transcripts were used to assess the detection 
limit and efficiency of the assay before application on a subsample of 100 positive 
samples. These samples were selected to represent healthy and diarrhoeic pigs of all 
age groups, with focus on the group with disease association (matured pigs). The 
specificity of the assay was checked with 20 randomly selected negative pig samples 
that were negative for PKV but positive for EV. Each reaction of 20 µl total volume 
contained primers (PKV_332s, PKV_533a), probe (PKV_505a_probe) at final 
concentrations of 0.4 µM and 0.2 µM, respectively, cDNA (5 µl) and 10 µl of 
SensiFAST Probe Hi-ROX Kit (Bioline, UK) Master Mix. After initial denaturation at 
95oC (5 min), amplification was performed in 45 cycles of 95oC for 10 s and 60oC for 




35 s (acquisition step). All primers and probe used in this study for kobuviruses are 
listed in Table S1, Supplementary data. 
Complete genome sequencing of enteroviruses. Primers were designed using VP1 
sequences available from this study and reference sequences from GenBank to obtain 
nearly complete genome of viruses representing EV-G8 and EV-G9 (Supplementary 
data; Figure S1; Table S2). Nested PCR amplifying regions from about 700 bp to 2.5 
kb in length was performed. For each reaction, 6 μl extracted RNA was used for cDNA 
synthesis in combination with first round PCR using Superscript III one-step RT-PCR 
System with Platinum Taq High Fidelity (Invitrogen, UK). Then 1 μl of the first-round 
reaction was used as template for second-round PCR with amplification (using GoTaq 
DNA polymerase from Promega, UK) conditions as follows: 95oC for 5 min, 30 cycles 
of denaturation (94°C, 30 s), annealing (50°C, 30 s), and elongation (72°C, 60 s) in a 
thermal cycler. SequalPrep long PCR kit (Life Technology, UK) was used according 
to the manufacturer’s instruction instead of GoTaq DNA polymerase to amplify 
fragments longer than 2 kb. 
Sequence analysis. Sequences were imported into SSE (Simmonds, 2012) for 
alignment and calculation of sequence divergence values from reference sequences of 
known enterovirus types. Maximum Likelihood trees were constructed as described in 
our previous study (Nguyen et al., 2014a) using the MEGA 5.2 software package 
(Tamura, 2011) with 1000 bootstrap re-samples and best fitting models (Tamura–Nei, 
gamma distribution for EV VP4/VP2 and VP1, Tamura 3-parameter model, gamma 
distribution for EV 5’UTR and 3D, general time-reversible gamma distribution with 
invariant sites for kobuvirus VP1). Nucleotide distance scans and Grouping Scan 
(Simmonds & Midgley, 2005) implemented in SSE were applied to identify 
recombination breakpoints. Analysis of phylogenetic groupings was performed by 
determining association index values (Wang et al., 2001) using the program in SSE 
with 100 bootstrap replicates. 
Statistical analyses. Fisher exact test, Chi-squared test and Mann-Whitney test 
incorporated in Minitab 17 were used to compare data between groups of interest when 
appropriate as specified. 




Nucleotide sequence accession numbers. Sequences obtained in this study have been 
assigned the following GenBank accession numbers: KT265880 to KT266194. 
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In this chapter, the epidemiology, disease association, genetic diversity and 
recombination of EVs and kobuviruses infecting pigs and boars were examined. 
Diarrhoea in pigs did not correlate with EV but kobuvirus infection. However, the 
specific role of kobuviruses remains undetermined. Viruses in positive samples belong 
to species Enterovirus G and Aichivirus C which are different from the corresponding 
viruses reported from humans. Detection of four previously known types and nine new 
types of EV-G indicated the diversity of this species which has not been completely 
characterised. Meanwhile, analysis of PKV VP1 sequences highlighted the need of 
serological studies for classification of Aichivirus C into (sero)types. Further studies 
are required for better understanding of their specific disease association and factors 





Chapter 5. Genetic characterization of enteroviruses 
in monkeys 
Introduction 
Chapter 3 demonstrated active infection with EVs in monkeys in Cameroon was 
extremely common with a detection frequency of EV RNA in faecal samples of 96.5%. 
The genetic diversity of those EVs infecting these primate species will be characterised 
and compared with EVs previously detected in humans and other NHPs in this chapter. 
NHPs, in general, are of interest because their close genetic relationship with humans 
may facilitate the exchange of zoonotic pathogens between humans and NHPs. In fact, 
this has been shown by detection of a large number of human EV serotypes in NHPs 
with unknown transfer direction (Harvala et al., 2011b, Oberste et al., 2013a, Oberste 
et al., 2013b, Harvala et al., 2014, Sadeuh-Mba et al., 2014). NHPs may thus act as a 
potential source of new human epidemics (Harvala et al., 2011b). The current work is 
a larger scale continuation of previous studies of EV infection in African primates 
(Harvala et al., 2011b, Harvala et al., 2012, Harvala et al., 2014) and is in line with 
the remit of this thesis looking for zoonotic sources of human infections.  
Picornavirus taxonomy and species definition 
Picornaviruses have now been classified into species and genera on the basis of their 
phylogenetic relationships, usually with supporting information such as genome 
organization, biological properties and host range (http://www.ictvonline.org/codeOf-
VirusClassification.asp). The ultimate aim of taxonomy is to produce a hierarchical 
system of species, genus, family and order that reconstructs phylogeny and reflects the 
degree of biological similarity. The classification of viruses, however, has particular 
difficulties due to the rapidity with which they evolve (Knowles et al., 2010). The 
continual discovery of candidates for novel picornaviruses makes the classification of 
this virus family, which is still in flux, more complicated (Knowles et al., 2012).  
Although species is a basic unit of taxonomy, its definition was only considered in 
preparation for the publication of the Seventh ICTV Report in 2000 (King et al., 2000). 
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That was when the ICTV began to grapple with the problem of defining it: how to 
define species in rapidly mutating organisms? Previously, the designation of 
picornavirus species had been the prerogative of the Picornavirus Study Group who 
had referred each serotype as a separate “species”. Under the modern definition, in 
contrast, “a picornavirus species is a class of phylogenetically related serotypes or 
strains which would normally be expected to share (i) a limited range of hosts and 
cellular receptors, (ii) a significant degree of compatibility in proteolytic processing, 
replication, encapsidation and genetic recombination, and (iii) essentially identical 
genome maps" (Knowles et al., 2010). 
The core concept behind the contemporary virus taxon is exclusivity which prevents 
one taxon from containing another at the same level. No species, for example, may 
contain another species (this is one of the reasons why “Poliovirus” lost its species 
status). The availability of precise measures of genetic distance has made the current 
emphasis on the phylogeny possible. Previous picornavirus classifications used criteria 
such as pathogenicity observed in experimental infection of animals or cultured cells, 
but these have been found to often correlate poorly with their underlying genetic 
relationships. However, some relics of this old nomenclature are still in use, such as 
coxsackievirus A24 a member of species EV-C while other coxsackieviruses are in 
species EV-A, EV-B (Knowles et al., 2010). 
Species demarcation criteria in the Enterovirus genus  
The criteria for classification into species of members in the Enterovirus genus, as well 
as other picornavirus genera, have been re-examined in each ICTV report. The latest 
report (Knowles et al., 2012) stated that in practice, members of a species in this genus 
have a genome base composition (G + C) which varies by no more than 2.5%, and 
share:  
- > 70% aa identity in the polyprotein  
- > 60% aa identity in P1  
- > 70% aa identity in the non-structural proteins 2C + 3CD  
- a limited range of host cell receptors  
- a limited natural host range  
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- a significant degree of compatibility in proteolytic processing, replication, 
encapsidation and genetic recombination.  
Role of recombination in maintenance of picornavirus species 
Recombination plays an important role in the microevolution of such viruses with high 
mutation rates as picornaviruses. On a short time and space scale, it is viewed as a 
mechanism for removal of deleterious mutations whereby recreating a functional 
genome from impaired ones. It is also a means to increase the genomic diversity of 
picornaviruses (Lukashev, 2010) as demonstrated by frequent emergence of new 
picornavirus recombinant forms (Cabrerizo et al., 2014; Gaunt et al., 2015; 
McWilliam Leitch et al., 2009; McWilliam Leitch et al., 2012). Over the long term, 
recombination in most picornaviruses functions as a driving force which helps 
preserve the integrity of species by frequent shuffling diverging genome fragments. 
This hypothesis implies that viruses of the same species must undergo recombination 
with each other over a limited period of time (probably on a time scale of decades), 
and therefore restrict their sequence divergences below a certain threshold. Such 
degree of diversity is thought to be biologically compatible enough to allow emergence 
of viable recombinants. Without recombination, a high mutation rate would lead to the 
formation of a new species or severe deterioration of the virus sequence (Lukashev, 
2010). 
Impact of recombination on classification of EVs 
In general biology, a species is defined as “a group of organisms able to interbreed and 
produce fertile offspring” (Tisdall, 1981). It can be inferred from this definition that 
all organisms of a species have a common gene pool and restricted divergence. 
Recombination in EVs can be viewed as an analogue of such reproductive strategy in 
higher organisms (Lukashev, 2010). On analysis of EV-B sequences, Lukashev et al. 
(2003) noticed that recombination strictly occurred within this species. Consequently, 
the possibility of natural recombination was proposed as an additional species criterion 
in EVs (Lukashev et al., 2003).  
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Nonetheless, some complicated issues relating to the inclusion of this criterion arose 
on a more thorough examination of genus EV. Due to closely relatedness and identity 
in the genome sequences, a number of simian EVs were classified in species EV-A 
with human EVs. However, these two EV groups do not recombine with each other 
and would eventually evolve into different species. Similarly, SVDV no longer 
recombines with other EV-B viruses after the host switch from humans to pigs (Zhang 
et al., 1999) and would most likely diverge from EV-B to form a new species within 
decades (Lukashev, 2010). As another example, CVA1, CVA19 and CVA22 form a 
monophyletic clade throughout the genome without evidence of recombination with 
other serotypes in species EV-C (Brown et al., 2003). Unlike other human EVs, these 
three EV-C serotypes are unable to grow in cell culture, probably due to different 
receptor usage. These viruses may also be on the process of speciation (Lukashev, 
2010). On the other hand, recombination between EV species (e.g. Rhinovirus A and 
C) also occurs although at a rarer frequency and only in highly conserved regions such 
as the 5’UTR (Simmonds, 2010). 
The genetic diversity and recombination of EVs in monkeys were investigated in this 
chapter and published in 2014 (Nguyen et al., 2014b).
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High Rates of Infection with Novel Enterovirus Variants in Wild 
Populations of Mandrills and Other Old World Monkey Species 
 
ABSTRACT 
Enteroviruses (EVs) are a genetically and antigenically diverse group of viruses 
infecting humans. A mostly distinct set of EV variants have additionally been 
documented to infect wild apes and several, primarily captive, Old World monkey 
(OWM) species. To investigate the prevalence and genetic characteristics of EVs 
infecting OWMs in the wild, fecal samples from mandrills (Mandrillus sphinx) and 
other species collected in remote regions of southern Cameroon were screened for EV 
RNA. Remarkably high rates of EV positivity were detected in M. sphinx (100 of 102 
screened), Cercocebus torquatus (7/7), and Cercopithecus cephus (2/4), with high 
viral loads indicative of active infection. Genetic characterization in VP4/VP2 and 
VP1 regions allowed EV variants to be assigned to simian species H (EV-H) and EV-
J (including one or more new types), while seven matched simian EV-B variants, SA5 
and EV110 (chimpanzee). Sequences from the remaining 70 formed a new genetic 
group distinct in VP4/2 and VP1 region from all currently recognized human or simian 
EV species. Complete genome sequences were obtained from three to determine their 
species assignment. In common with EV-J and the EV-A A13 isolate, new group 
sequences were chimeric, being most closely related to EV-A in capsid genes and to 
EV-B in the nonstructural gene region. Further recombination events created different 
groupings in 5’ and 3’ untranslated regions. While clearly a distinct EV group, the 
hybrid nature of new variants prevented their unambiguous classification as either 
members of a new species or as divergent members of EV-A using current International 
Committee on Taxonomy of Viruses (ICTV) assignment criteria. 
IMPORTANCE 
This study is the first large-scale investigation of the frequency of infection and 
diversity of enteroviruses (EVs) infecting monkeys (primarily mandrills) in the wild. 
Our findings demonstrate extremely high frequencies of active infection (95%) among 
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mandrills and other Old World monkey species inhabiting remote regions of 
Cameroon without human contact. EV variants detected were distinct from those 
infecting human populations, comprising members of enterovirus species B, J, and H 
and a large novel group of viruses most closely related to species A in the P1 region. 
The viral sequences obtained contribute substantially to our growing understanding of 
the genetic diversity of EVs and the existence of interspecies chimerism that 
characterizes the novel variants in the current study, as well as in previously 
characterized species A and J viruses infecting monkeys. The latter findings will 
contribute to future development of consensus criteria for species assignments in 
enteroviruses and other picornavirus genera. 
INTRODUCTION 
Enteroviruses (EVs), members of the genus Enterovirus within the family 
Picornaviridae, are notable for their genetic and antigenic diversity with more than 
300 types identified thus far. EVs are currently classified into nine species (labelled 
alphabetically as EV-A to EV-H and EV-J). This subdivision of the Enterovirus genus 
is based on degrees of sequence divergence, host range, similarities in replication, and 
a generally observed restriction of recombination between members of the same 
species (1). The enteroviruses infecting humans comprise EV-A to -D, while the 
remaining five contain viruses infecting primarily cattle (EV-E and EV-F; both termed 
bovine enteroviruses), pigs (EV-G; porcine enteroviruses) and monkeys (EV-H and 
EV-J; both simian enteroviruses) (1). However, EV variants classified as species A, B, 
and D have also been detected in several monkey and ape species (2 – 13). 
The first simian EVs were discovered in the 1950s and 1960s in primate cell cultures 
or from primate tissue specimens used in biomedical research. These EVs were 
obtained from Old World monkey (OWM) species Macaca mulatta (rhesus macaque), 
Macaca fascicularis (cynomolgus monkey), Chlorocebus aethiops (African vervet 
monkey), and Papio cynocephalus (baboon) (2 – 7, 14). Subsequent genetic 
characterization indicated that some isolates were similar to human viruses (A13, 
SV19, SV43, and SV46 in species A; SA5 in EV-B), while others were genetically 
distinct (9 – 11) and now classified into two separate species (e.g., SV4 and SV28 in 
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EV-H and SV6 in EV-J). More recent genetic characterization of EVs infecting captive 
primates (mostly rhesus macaques [83%]) in the Yerkes National Primate Center in 
the United States and at the Dhaka Zoo in Bangladesh identified four further simian 
EV types (EV92 in species A; EV103, EV112, and EV115 in species J) (13, 15), 
whereas no simian EVs were detected in synanthropic (e.g., pet) monkeys (12). 
To investigate whether EVs also circulated in apes, we recently performed large-scale 
screening of fecal samples collected from wild populations of chimpanzees (Pan 
troglodytes) and gorillas (Gorilla gorilla) primarily in Cameroon. From these fecal 
samples, four EV types (EV76, EV89, and EV119 in species A; EV111 and EV120 in 
species D) and a novel species B variant (EV110) were identified (16, 17). However, 
as previously discussed (17), whether these represent endogenous infections in these 
species or have been acquired from contact with humans or monkeys remains unclear; 
remaining wild-living chimpanzee and gorilla populations are small and highly 
fragmented. The overall detection frequencies were however moderate (9 to 11%), and 
the populations sampled had minimal contact with human populations in sample 
collection areas. 
To understand more about the natural circulation of EVs in wild primate populations, 
we analyzed a large collection of samples from mandrills (Mandrillus sphinx) and 
smaller numbers of other OWMs in isolated areas of Cameroon. Mandrills were 
selected because populations and groupings are large and more likely to support 
endogenous populations of EVs than apes. Genetic characterization of the extensive 
numbers of variants detected demonstrated the broad diversity of species and types 
circulating in these populations in the wild. A wider phylogenetic comparison of 
complete genome sequences of OWM, ape, and human EVs was performed to 
determine their species relationships to other simian and human EVs. 
MATERIALS AND METHODS 
Samples. Atotal of 102 mandrill (Mandrillus sphinx), 7 red-capped mangabey 
(Cercocebus torquatus), and 4 moustached monkey (Cercopithecus cephus) stool 
samples were included in this study (Table 1; see Tables S1 and S2 in the supplemental 
material). Samples were collected from natural habitat areas of mandrills - remote and 
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sparsely populated forested southern areas of Cameroon with minimal human contact 
(18). Samples were preserved in RNAlater (Ambion, Austin, TX), stored at room 
temperature at base camps for a maximum of 3 weeks, and subsequently transported 
to a central laboratory in Yaoundé, Cameroon, for storage at -20°C/-80°C. For all fecal 
samples, the species origin was also determined by mitochondrial DNA (mtDNA) 
analysis as described previously (19). Fecal DNA was extracted using the QIAamp 
stool DNA minikit (Qiagen, Valencia, CA). 
Sample extraction and amplification. RNA was extracted from fecal samples as 
previously described (20) and tested for enterovirus (EV) by one-step reverse 
transcriptase (RT)-PCR assay targeting the 5’ untranslated regions (5’UTRs) (see 
Table S3A in the supplemental material) (21). To estimate viral loads in EV-positive 
samples, samples were retested by real-time PCR calibrated using defined copy 
numbers of EV RNA transcripts (22). Additional primer sets were used to obtain 
sequence data from VP4 and VP1 region as described (Table S3B) (16, 17). The 
amplification of VP1 required two sets of primers, which amplify overlapping regions 
from each species, and additional primers specific for the species B variant SA5 (as 
indicated in the primer name). For each PCR, 6 µl extracted RNA was amplified by a 
combined RT and first-round PCR using Superscript III one-step RT-PCR system 
(Invitrogen, United Kingdom), and 1 µl of the first-round reaction was used for the 
nested PCR with second-round primers. PCR amplification included 30 cycles of 
denaturation (94°C, 20 s), annealing (50°C, 18 s), and elongation (72°C, 90 s) in a 
thermal cycler. 
Whole-genome sequencing. The whole genomes of EV variants representing three of 
the predominant types infecting mandrills were sequenced (samples GR2815, 
CPML8109, and CPML3961). Primers were designed using sequence data in the VP4 
and VP1 regions available from the current study and sequences of viruses in species 
J. One microliter of cDNA synthesized by using random hexamer primers and 
Superscript III reverse transcriptase (Invitrogen, United Kingdom) was used as the 
template for nested PCR. The amplification conditions were the same as those of the 
second-round PCR mentioned above. Assemblies were created from sets of 
approximately 1.5kb sequence fragments in which the regions of overlap were 
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identical between fragments; this prevented generation of possible hybrid viruses from 
samples from monkeys that may be coinfected with two or more EV variants. 
Direct sequencing of PCR products. Positive second-round PCR products were 
sequenced in both directions using the inner sense and inner antisense primers used in 
the second round of amplification, using BigDye Terminator v3.1 (Applied 
Biosystems). Nucleotide sequences were assembled, annotated, and aligned using the 
SSE sequence editor version 1.1 (23). 
Genetic analysis of EV sequences. Sequence comparisons were made between the 
Old World monkey-derived sequences obtained in the current study with all available 
sequences from VP1, VP4, 3Dpol, 5’UTR, and 3’UTR sequences of variants 
previously reported for other nonhuman primates. All data sets additionally included 
a single representative sequence derived from complete genome sequences of each 
human EV type. Calculation of pairwise distances between sequences and divergence 
scans were performed using SSE. Phylogenetic trees constructed using maximum 
likelihood methods as implemented in the MEGA 6 software package (24). The 
optimum maximum likelihood model (lowest Bayesian information criterion score and 
typically greatest maximum likelihood value) for each sequence data set was first 
determined and used for phylogenetic reconstruction. For each genome region 
(5’UTR, VP4/VP2, VP1, and 3CD), this was general time reversible (GTR) with a 
gamma (γ) distribution (5 rates) and invariant sites (I) (GTR plus γ plus I). 
Phylogenetic analysis of each data set used 100 bootstrap resamplings to determine the 
robustness of grouping. 
Nucleotide sequence accession numbers. Sequences obtained in the current study 
have been submitted to GenBank and have been assigned the accession numbers 
KJ420625 to KJ420749. 
RESULTS 
EV RNA detection frequencies and viral loads. RNA was extracted from 102 
mandrill, 7 red-capped mangabey, and 4 moustached monkey fecal samples and 
screened for EV RNA sequences using primers targeting a region of the 5’ untranslated 
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region (5’UTR). From these fecal samples, 100 of 102 mandrill samples (98%), all 
red-capped mangabey samples, and two moustached monkey samples were positive. 
Sampling sites were located throughout southern Cameroon (Figure 1; see Tables S1 
and S2 in the supplemental material). The mean viral loads of EV in mandrill fecal 
samples were about 10-fold higher than those from a representative set of human 
samples tested in the same assay (25) (Figure 2), with mean threshold cycle (Ct) values 
of 27.5 compared to 29.8 in human samples (p = 0.001 by the Kruskal-Wallis test). 
Table 1. Detection frequencies in study samples using primers from different genome regions 
Species 
Detection frequency (no. of positive 
samples/total no. of samples tested) 
5'UTR VP4/2 VP1 
Mandrillus sphinx 100/102 88/100 39/88 
Cercocebus torquatus  7/7 3/7 0/3 




Figure 1. Collection sites in Cameroon of samples used in the 
current study. The collection sites in Cameroon were abbreviated 
as follows: CP, Campo, locations Oveng, Melen, and Grothes 
(CPOV, CPLM, and CPGR, respectively); DJ, Djoum; EK, Ekom; 
LM, Lomie; GR, Gribi. C. A. R., Central African Republic, 
EQUA.Gui., Equatorial Guinea, D. R. Congo, Democratic 
Republic of the Congo. 
 
 Figure 2. Comparison of Ct values of 
EV RNA detected by real-time PCR in 
faecal samples collected from mandrills 
with those in human samples. Each 
symbol represents the value for one fecal 
sample. Bars show mean values. 
Statistical significance was performed 
using Kruskal-Wallis nonparametric test 
(above graph). 
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EV type assignments. To genetically characterize EV variants infecting these OWMs, 
sequences were amplified from the VP4/2 region. A total of 88 of 100 samples from 
mandrills were positive, from which 84 were successfully sequenced, as were 3 of 7 
mangabey samples and two Cercopithecus (moustached monkey) samples (Figure 
3A). For the purposes of further type identification and new type assignments, 
sequences were amplified in the VP1 region from 39 mandrill samples (Figure 3B). 
The viruses identified fell into three previously identified enterovirus species. Four 
could be assigned to species H that includes the simian viruses A-2 plaque virus and 
SEV-A (isolated from the OWM species Macaca mulatta). VP1 sequences showed 
14.5 to 15.5% nucleotide sequence divergence from previously characterized simian 
variants in this species, suggesting that they should be classified as EV-H1. However, 
the four samples containing species H viruses were collected from the same site on the 
same day; due to the nature of sampling from the jungle floor and their high sequence 
identity, it was likely that they originated from the same group or possibly even the 
same mandrill. 
Other variants grouped with the simian enteroviruses SA5 and EV-B110 within 
species B. Five of these variants could be assigned as EV110 (20.6% to 20.8% 
divergence in VP1), a recently described EV type detected in a chimpanzee from 
Cameroon (17), while a further two could be assigned as SA5 (15.5% divergence in 
VP1) that was originally isolated from a vervet monkey (Cercopithecus aethiops [4]). 
VP4/2 sequences of a further 10 variants clustered in species J (7 derived from 
mandrills and 3 derived from mangabeys), a species into which the simian viruses SV6 
(M. mulatta), EV103 (Macaca nemestrina), and EV108 (Papio cynocephalus) are 
currently assigned. From these, a VP1 sequence was obtained from sample 
CPOV3336, which was > 25% divergent from assigned types within this species. It is 
likely, however, that several other variants correspond to further EV-J types based on 
their sequence divergence in VP4/2. 
 





Figure 3. Maximum likelihood analysis (GTR plus γ plus I model) of VP4/partial VP2 region (A) and 
whole VP1 (positions 743 to 1168 and 2477 to 3376, respectively, numbered using the PV3 reference 
sequence) (B). Sequences amplified from study samples are shown as white and solid black symbols, 
while those previously assigned within EV species A to D, J, and H are color coded according to the 
key (human EV-B and EV-C sequences were monophyletic and have been collapsed to clarify 
presentation of simian sequences). Bootstrap resampling of maximum likelihood (ML) trees was 
performed to indicate robustness of grouping (values of ≥ 70% shown). 
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The remainder of viruses form a monophyletic group in both VP4/2 (67 mandrill 
sequences and 2 Cercopithecus sequences) and VP1 (30 mandrill sequences). In the 
VP1 region, sequences showed substantial nucleotide sequence divergence from each 
other and supported their assignment into 5 types (Figure 3B) based on > 25% pairwise 
nucleotide distances. How these should be named is dependent on their final species 
assignment, and this remains uncertain based on phylogenetic analysis of VP1 and 
VP4/2 region sequences. 
Species assignment. To clarify the species assignment of the new, predominantly 
mandrill, group and investigate its relationships with other simian and human EVs, 
complete genome sequences were obtained from variants representing 3 of the 5 
putative types (samples GR2815, CPML8109, and CPML3961) within the group. This 
allowed current molecular demarcation criteria of amino acid sequence identity in the 
polyprotein, P1, and combined nonstructural gene region 2C plus 3CD (1) to be used 
for species assignments (Table 2). 
Table 2. P1, 3CD, and whole-genome amino acid sequence distances between mandrill 
variants and other species 
 Amino acid sequence distancea 
Species and subgroup Whole genome P1 2C + 3CD 
EV-J 0.264 0.384 0.1682 
EV-C 0.403 0.514 0.2934 
EV-A  
      All 0.351 0.3714 0.3334 
      A1 0.3595 0.379 0.341 
      A2 0.3235 0.346 0.3074 
EV-B  
       All 0.2981 0.5107 0.158 
      Human 0.2996 0.511 0.1596 
      SA5 0.2489 0.493 0.0613 
EV-C 0.4034 0.514 0.2934 
EV-D 0.375 0.463 0.2853 
EV-H 0.3905 0.465 0.3085 
 
a Amino acid sequence distances below species assignment thresholds are shown in boldface 
type (complete coding region, 30%; P1, 40%; 2C plus 3CD, 30%). 
As suspected from the differences in phylogenetic groupings between the new variants 
and other EV species (Figure 3B), amino acid sequence distances between this group 
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and species J and A viruses in P1 were close to but consistently below the 40% 
previously proposed species assignment threshold (38.4% and 37.9%, respectively; 
Table 2). Furthermore, if species A viruses were divided into the two subclades 
apparent in VP1 (one comprising exclusively human serotypes, termed A1), and the 
other simian and more recently discovered human-derived types EV76, -89, -90, and -
91 (termed A2) (26), then further problematic relationships arise. The new mandrill 
variants showed only 34.5% divergence from the predominantly simian A2 group. A2 
variants themselves show only 38.9% divergence from species J. 
Sequence divergence in the combined 2C plus 3CD region did not resolve the species 
status of the mandrill sequences and indeed revealed further inconsistent sequence 
relationships with other variants. With a proposed 30% amino acid divergence 
threshold, new variants showed remarkably low divergence from both EV-J (16.8%) 
and EV-B (15.8%). Furthermore, mandrill variants and the simian species B isolate 
SA5 showed only 6.1% divergence. These interrelationships are mirrored by the 
greater than expected sequence similarity of EV-J to EV-B (21.8% divergence). These 
inconsistencies in sequence relationships in different genome regions were not 
resolved by comparison of whole polyprotein sequences, where mandrill variants 
showed below-species divergence thresholds (set at 30%) of 26.4% with EV-J and 
29.8% with EV-B. 
Information for the mandrill variants that contribute to the other species assignment 
criteria (1) was largely unresolved or ambiguous, including host range (infects at least 
two different OWM species), host cell receptors (unknown), and compatibility in 
proteolytic processing, replication, encapsidation, and genetic recombination 
(unknown). However, the three variants show a narrowly constrained range of GC 
compositions (44.3% to 44.6%; threshold range of 2.5%). 
Chimerism in EV genomes. It is possible that the difficulty associated with a species 
designation of the new variants using conventional criteria had originated from their 
possession of chimeric genomes comprising sequences originating from different EV 
species. To investigate this, relationships between inter- and intraspecies distances in 
P1 and 3CD were compared (Figure 4). For the presumed nonchimeric human species 
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A, B, and C sequences, sequence distances in P1 were approximately proportional to 
those in 3CD (Figure 4A). Comparison of variants assigned to different species 
invariably showed distances of > 40% in P1 and > 25% in 3CD (including EV-D; not 
shown). The main exception to the linear relationship between distances was the 
frequently suppressed variability of 3CD sequences between different types within a 
species. As documented elsewhere, this originates through promiscuous intertype 
recombination in the non-structural gene regions, where different types within a 
species frequently share a pool of less-divergent NS gene region sequences (27 – 30). 
Species A and C, however, contain subgroups with more divergent NS gene region 
sequences (15% to 23%; Figure 4A). In species A, these represent distances between 
subgroups corresponding to the previously described EV-A1 (all human) and -A2 
groups (EV76, -89, -90, and -91) (26). In species C, they originate from the previously 
identified more-divergent variants CAV1, CAV19, and CAV22 (31) and EV104 (32). 
 
 
Figure 4. (A) Distributions of pairwise amino acid distances in P1 (positions 743 to 3376) and 3CD 
regions (positions 5429 to 7360) between representative human-derived sequences within EV-A, EV-B, 
and EV-C. Color coding has been used to identify within- and between-species sequences distances for 
each. The 40% amino acid distance threshold for species assignments using P1 is shown as vertical gray 
broken line. (B) Pairwise distances between three representative mandrill sequences with EV species A to 
D, J, and H. 
 
An equivalent comparison of sequences from the mandrill group with other species 
showed combinations of P1 and 3CD regions that were markedly inconsistent with 
Chapter 5. Genetic characterization of enteroviruses in monkeys 
134 
 
relationships between human-derived viruses (Figure 4B). Only comparisons with EV-
C, EV-D, and EV-H produced pairwise distances consistently above 40% (P1) and 25% 
(3CD) indicative of unambiguous separate species status. In contrast, most sequence 
comparisons of mandrill viruses with species B and J variants were in the intraspecies 
range in 3CD, with divergence values of 15% to 23% that were comparable to those 
between subgroups of EV-A and EV-C (Figure 4A). Furthermore, mandrill sequences 
differed by only 6.8 to 7.3% from SA5, which are typical of within-recombination pool 
distances in human EV-A – EV-C (Figure 4A). Mandrill viruses showed the opposite 
relationship with EV-A with P1 distances of < 40% (intraspecies range) but > 25% in 
3CD (interspecies). 
Comparison of sequence distances in P1 and 3CD sequences therefore provided 
evidence for chimerism (from previous interspecies recombination) in the mandrill 
sequences between these regions. To identify sites where sequence exchanges 
occurred, divergence plots were constructed between mandrill sequences and the 
nonrecombinant human species A to D (Figure 5A) and with simian viruses A13, SA5, 
and species H and J (Figure 5B). As expected from their consistent sequence 
relationships in VP1 and 3CD, divergence between mandrill viruses and human 
species A, C, and D and simian species H were comparable across the EV coding 
region (Figure 5A and B). Comparison with species B, however, identified highly 
divergent capsid sequences, and an abrupt decline into interspecies divergence levels 
at the P1/P2 (VP1/2A) boundary. A different breakpoint was observed with the simian 
EV-B sequence SA5 (Figure 5B), situated approximately 400 bases downstream from 
P1/P2 within 2A. 
Comparison of mandrill viruses with simian variants EV-J and A13 provided evidence 
for further chimerism, with sequences from the P2 region (shaded area in Figure 5B) 
close to the within species range (20% to 35%) and comparable to distances from EV-
H. However, in P3, distances were substantially lower in the within-species range. 
These observations provide evidence for further genetic exchanges in the evolution of 
mandrill viruses, one or more of which are likely ancestral to their split from EV-J. 




Figure 5. Amino acid sequence divergence between mandrill sequences and A1 and A2 subgroups in 
EV-A, human variants in species B to D (A) and simian viruses in species A, B, J, and H (B). The values 
on the y axes show mean pairwise distances between 300-base windows across the coding region, in 
increments of 30 bases between fragments. To show gene boundaries, the P2 region has been shaded 
gray, and a representation of gene positions in the EV polyprotein (drawn to scale) is shown above the 
graphs. 
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Genetic exchange of 5’- and 3’UTR sequences. To investigate the genetic 
relatedness of noncoding regions at the ends of the EV genomes, phylogenies were 
constructed from whole 5’UTR and 3’UTR and compared to those of 3CD (Figure 6) 
and previously constructed trees from structural gene regions VP4/2 and VP1 (Figure 
3). Sequence relationships in both noncoding regions were distinct from those of 
coding regions and from each other, with consistent separate groupings of simian-
derived viruses from human variants and in the case of the 5’UTR, the existence of 
individual clades containing human variants of more than one species, EV-A and -B in 
one and EV-C, -D, and -A in another (33). In the 3’UTR, mandrill viruses, EV-J and 
SA5 grouped together as observed in 3CD, but this group excluded A13 and human 
species B. The other striking phylogeny difference was the complete separation of 
human A2 viruses from A1 that were in turn distinct from simian A2 viruses. Although 
the 3’UTR was short and tree construction was intrinsically less robust than for other 
genome regions, these observations provide evidence for genetic exchanges, additional 
to those between nonstructural gene regions and distinct from those occurring in the 
5’UTR. 
DISCUSSION 
This study is the first large-scale investigation of infection frequencies and genetic 
characterization of enteroviruses infecting Old World monkeys in the wild. The 
extraordinarily high prevalence of active infection and genetic diversity of EVs found 
provides evidence for the extensive circulation of these viruses in wild primate 
populations. The sampling strategy that concentrated collection on remote areas with 
no or minimal human contact and the reclusive nature of the species (34) helped rule 
out human sources of infection in monkeys, as did the finding of virus variants that 
were consistently genetically distinct from human enteroviruses. Primate sampling of 
faeces has been commonly used to investigate infection frequencies of simian 
immunodeficiency virus (18), and collection methods used for the current study were 
specifically designed to avoid environmental contamination. Furthermore, samples 
showed generally high viral loads (mean Ct values of 27.5), indicating substantially 
higher viral loads than typically found in human samples (Figure 2) and demonstrating 
active infections in the sampled populations. 




Figure 6. Phylogenetic analysis of parts of 5’UTR (A), 3CD (B), and 3’UTR (C). (A) 5’UTR, positions 
1 to 742; (B) 3CD, positions 5429 to 7366; (C) 3’UTR, positions 7377 to 7431. Bootstrapped ML trees 
were constructed as described for in the legend to Figure 3 with the exception of the 3’UTR where its 
short sequence length (55 bases) precluded meaningful model fitting. The tree is therefore shown as a 
phenogram by neighbor joining of uncorrected nucleotide p-distances. 
The nature of the sampling, however, prevented more-focused investigations of EV 
persistence and disease associations in mandrills or other monkey species. This 
limitation additionally prevented clear attribution of samples to individual (different) 
monkeys. This sampling bias is exemplified by the four species H variants that 
originated from samples collected on the same day from the same site. It is likely that 
they originated from members of the same group (and thus are epidemiologically 
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linked infections) or conceivably from the same mandrill. The development of genetic 
fingerprinting for mandrills and other monkey species, as used in ape samples, would 
be needed to investigate this further. Nevertheless, the vast majority of EV variants 
characterized in the study were genetically distinct from each other and originated 
from widespread sampling (throughout southern Cameroon) over a prolonged period 
(2008 to 2012). In the main, therefore, they represent independent infections. 
Infection frequencies of greater than 95% in mandrills were substantially higher than 
the 10% detected in apes (chimpanzees and gorillas) from similar sampling areas (16). 
Although little is known about possible differences in susceptibility or persistence of 
EV infections in OWMs, apes, and humans, a major factor likely contributing to the 
circulation of EVs in mandrills is the large and highly interactive populations of 
mandrills in the wild, which typically live in hordes of between 500 and 1,000 (34). 
This population size and their interactions with other groups of mandrills and other 
OWMs may create the necessary conditions to permit ongoing transmission of acute 
virus infections over long periods. Indeed, even under captive conditions, infections 
with EV variants found previously in monkeys were frequently detected even in small 
isolated OWM populations in a primate center and a zoo (13, 15), while only human 
serotypes were detected among nonhuman primates living in human environments 
(12). Our findings support the broader hypothesis that EV infections are prevalent in 
at least one OWM species and continue to circulate in the absence of human contact 
or intervention.  
The EV types detected in the current study fell into species H and J and a large, new 
group of currently undefined taxonomic status within the Enterovirus genus. No 
variants that corresponded to types or species found in humans were detected, 
confirming the absence of human sources of infection in mandrills and other sampled 
OWM species. Among the 89 EV variants characterized by VP4/2 sequencing, several 
could be classified as members of species H type 1 variants previously detected in a 
simian organ cultures from an Asian ape, M. mulatta (SV2, SV4, and SV28) (6) but 
also from human subjects with hepatitis in the early 1960s (35, 36). Others grouped in 
species J, a group now listed as containing six assigned types (but with sequences 
available from only three [SV6, EV103, and EV108]), to which the sequence of 
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CPOV_3336 may contribute an additional type based on its divergent VP1 sequence. 
Although most EV-J variants have been identified in African OWMs, the originally 
described SV6 isolate originated in an Asian macaque (6). Finally, several mandrill-
derived variants could be classified as members of the simian subgroup of species B, 
one corresponding to SA5 and the other to EV110, previously identified in 
chimpanzees from the same geographical area as the mandrill samples (Lomie [LM] 
in Figure 1) (17). 
Genetic characterization of the remaining, predominantly mandrill-derived EVs was 
performed by extensive sequence analysis of VP4/2 and complete VP1 sequences. 
From the latter, the existence of at least 5 types differing by > 25% in nucleotide 
sequence could be inferred, although their definitive assignment awaits their species 
designation. Determining this, however, may prove problematic because they 
reproduced the previously identified hybrid nature of many simian enterovirus 
genomes (9, 10); variants such as A13 were identified as showing closer sequence 
relatedness to one species in the capsid-encoding region (EV-A) and to another in the 
NS region (EV-B). The subsequent characterization of further simian viruses, the 
identification of subgroups with species A (A1 and A2 [26]) and B (human viruses and 
SA5) and the new complete genome sequence data from mandrill derived viruses 
provided the opportunity for a reevaluation of the occurrence of recombination in the 
genomes of simian (and human) viruses, from which various species classification 
possibilities might be proposed. 
Genome configurations. Despite the seeming complexity of sequence relationships 
between simian and human viruses in different genome regions (Figure 4 to 6 and 
Figure 6 in reference 9), structural and nonstructural gene regions of all OWM 
monkey-derived viruses ultimately show only three genome configurations. 
(i) Group 1. Group 1 comprises SV19, SV43, SV46, and EV92 which form part 
of the A2 subgroup in species A, along with the human viruses EV76 and EV89 to -
91 (that may indeed be zoonotically acquired) (26). 
(ii) Group 2. Group 2 comprises A13 (in species A2 in P1), EV-J, and the mandrill 
viruses. All three possess P1 sequences classified as or closely related to EV-A with 
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pairwise distances below (A13 and mandrill viruses) or around the species assignment 
threshold (EV-J) of 40% for this region (Table 2; Figure 4B). However, all of these 
viruses possess species B-like NS gene regions, differing from each other and from 
EV-B by 6% to 21% in the 2C plus 3CD region and a well-defined breakpoint at the 
P1/P2 boundary (Figure 4B; see Figure S1 in the supplemental material). This 
commonality is further manifested by similar distributions of pairwise distances to 
other EV species (Figure 4B and Figure S2). 
(iii) Group 3. Group 3 is represented by SA5 that is most closely related to human 
EV-B sequences throughout its genome. Several further examples of this group 
potentially exist among samples obtained in the current study from mandrills. Group 
3 viruses likely represent the source of the species B-like NS gene regions of group B 
viruses, through recombination, accounting for the remarkably similar 3CD sequences 
of SA5 and mandrill viruses (6% divergence). 
As previously discussed (9, 33, 37), there is further recombination between coding 
regions and 5’UTRs and 3’UTRs within human and simian enteroviruses. Sequence 
relationships in the 5’UTR and 3’UTR are distinct, although both regions show 
different propensities for species mergers and splits. For example, human species A1 
and B variants are phylogenetically interspersed in the 5’UTR, as are species C and D 
along with some A2 viruses, while EV-J, simian EV-B (SA5) and mandrill viruses 
group closely together in the 3’UTR. A common feature, however, is the universally 
distinct grouping of simian- and human-derived viruses from each other in both 
regions. This observation is consistent with the existence of host range determinants 
in these genome regions and their potentially limiting effect on the occurrence of 
zoonotic infections. Further genetic characterization of simian viruses and in vitro 
studies are required to formally examine this hypothesis. 
Enterovirus classification. The final classification of mandrill and other OWM 
viruses obtained in the current study may necessitate an update to the current species 
assignment criteria (1). By definition, viruses such as those obtained in the current 
study, A13 and EV-J which show evidence for interspecies chimerism between capsid 
and NS gene regions cannot simultaneously fulfill criteria 2 (< 40% divergence in P1) 
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and 3 (< 30% divergence in 2C plus 3CD) for any one species. This phenomenon 
similarly limits the use of divergence thresholds for complete coding region sequences 
(criterion 1). As the capsid likely possesses elements that primarily determine EV host 
and cellular tropisms and other biological properties, it may perhaps be appropriate to 
regard P1 divergence as the primary criterion for species assignment, although this 
will require further discussion with the International Committee for the Taxonomy 
Study Group. 
Findings in the current study additionally highlight the need to reexamine the species 
assignment threshold for P1, currently set at 40%. Pairwise distances between EV-A 
(particularly A2) types, A13, mandrill viruses, and EV-J are mostly below this 
threshold (Figure 4B), and simian viruses in these groups all possess a common (EV-
B-like) NS gene region (and mostly group together in the 3’UTR). A slight elevation 
of the 40% threshold would allow their assignment as species A and would 
substantially simplify the current classification of simian EVs (i.e., all members of 
groups 1 and 2 described above would be classifiable as EV-A). Although this would 
create a species containing both nonrecombinant and recombinant viruses, this is not 
different from EV-C, which also contains variants with evidence for chimerism in NS 
gene regions and in the 5’UTR (31, 32). 
The alternative would be to lower the P1 threshold 40% to 32% so that EV-J and the 
mandrill viruses could be classified as separate species. The immediate problem with 
this is that this reduction would have the undesirable effect of splitting species C and 
A. As described above, the other problem is that structural gene sequences of EV-A, 
EV-J, and mandrill viruses fail to form clearly resolvable monophyletic clusters when 
included in the same data set (Figure 3A and B), and bootstrap support for these 
groupings requires the whole P1 region (see Figure S3 in the supplemental material). 
The diversity of simian viruses is likely considerably undersampled, and it is likely 
that further viruses showing loose sequence affiliations to these variants will be 
characterized in the future and create further complications with EV-J and mandrill EV 
species assignments. 
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Overall, this study provides substantial new information on the genetic diversity and 
prevalence of naturally occurring enteroviruses in wild primate populations. It is 
increasingly clear that relationships between variants infecting humans and nonhuman 
primates are complex, notwithstanding the growing evidence for zoonotic infections 
in both directions (12, 38) and continuing uncertainty about the timescales for the 
original divergence of types and species and appearance of interspecies chimeras. 
Understanding which genome regions ultimately determine host range and disease 
outcomes are essential in assessment of the risk of simian enteroviruses as potential 
zoonotic and pathogenic infections in humans. 
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The study described in this chapter identified both known and novel EVs naturally 
circulating in wild monkeys with remarkable genetic diversity. The chimeric nature of 
novel EV genomes presents additional difficulties for their classification into types 
and species which will require re-examination of the current species demarcation 
criteria of the Enterovirus genus. None of the identified EVs overlapped in host range 
with those reported from humans despite the close genetic relationship of primates as 
well as increasing evidence of other EVs capable of infecting both NHPs and humans. 
For EVs detected in both humans and NHPs in previous studies (Harvala et al., 2011b, 
Oberste et al., 2013a, Oberste et al., 2013b, Harvala et al., 2014, Sadeuh-Mba et al., 
2014), further analyses (e.g. time scaled trees in BEAST) can be performed to 




Chapter 6. Genetic characterization of 
picornaviruses in rodents and civets  
6.1. Introduction 
6.1.1. Rodents and civets as hosts of zoonotic pathogens 
Rodents are members of Rodentia, the largest order of mammals. With over 2,200 
living species including rats, mice, voles, prairie dogs, squirrels, porcupines, beavers, 
chipmunks, and guinea pigs, Rodentia comprises about 43% of all mammal species 
(Huchon et al., 2002). Many rodents live in close proximity to humans, thereby serving 
as a potential source of zoonotic infection in humans (Nguyen et al., 2015). Rodents 
have been known to host pathogens that cause more than 60 human diseases (Meerburg 
et al., 2009) and viruses with unknown zoonotic potential (e.g. HuVs, kobuviruses, 
rosaviruses). Pathogens from rodents can be transmitted to humans either directly or 
indirectly through their saliva, urine, faeces or via their arthropod ectoparasites such 
as ticks, mites, and fleas (Meerburg et al., 2009). A summary of the main zoonotic 
diseases caused by viral agents transmitted from rodents to humans are listed in Table 
6.1. A few cases of human infection with picornaviruses such as EMCV-1 (see section 
6.1.2) and FMDV, which can also infect rodents, have been confirmed by virus 
isolation and detection of a specific immune response (Brown, 2001). 
Table 6.1. Viral pathogens that may be transmitted by rodents to humans, adopted from 
(Meerburg et al., 2009) 
 
Disease Agent 
Hantavirus Pulmonary Syndrome Bunyaviridae 
Hemorrhagic Fever with renal syndrome  
(+ other hemorrhagic fevers) 
Bunyaviridae 
Nephropathia epidemica Bunyaviridae 
Crimean-Congo hemorrhagic fever Bunyaviridae 
Borna disease Bornaviridae 
Omsk hemorrhagic fever Flaviviridae 
Kyasanur Forest Disease Flaviviridae 
Apoi Virus Disease Flaviviridae 
Tick-borne encephalitis Flaviviridae 
Powassan encephalitis Flaviviridae 
Chapter 6. Genetic characterization of picornaviruses in rodents and civets 
148 
 
Lymphocytic Choriomeningitis virus Arenaviridae 
Lassa Fever Arenaviridae 
South American arenaviruses Arenaviridae 
North American arenaviruses Arenaviridae 
Colorado Tick Fever Reoviridae 
Venezuelan equine encephalitis Togaviridae 
Western equine encephalitis Togaviridae 
Hepatitis E Caliciviridae 
Cowpox Poxviridae 
Contagious viral animal diseases (Classical 
Swine Fever, Foot and Mouth Disease) 
Picornaviridae 
(FMDV); Flaviviridae 
Although no picornaviruses have been reported from civets, these animals were 
identified as a transmitting host of pathogens including those that have an important 
impact on human health such as H5N1 (Peiris et al., 2007) and SARS coronaviruses 
(Wang & Crameri, 2014). 
6.1.2. Kobuvirus, cardiovirus and HuV infection in rodents 
Viruses within genera Cardiovirus, Kobuvirus and Hunnivirus that can infect rodents 
include members of Cardiovirus A (EMCV-1 and -2), Cardiovirus B (TMEV, TRV), 
Cardiovirus C (Boone cardiovirus 1 and 2), Aichivirus A (murine kobuvirus 1), and 
Hunnivirus A. These viruses are generally host-specific and distinct from members 
within these genera exclusively detected in humans (VHEV and SAFV in Cardiovirus 
B, AiV-1 in Aichivirus A). A prominent exception is EMCV-1, which has been isolated 
from over 30 host species including humans (Knowles et al., 2010). However, whether 
the infrequent detection of EMCV-1 (as well as VHEV) in humans truly represents a 
genuine infection has been questioned, and it has been proposed that its presence in 
cell culture isolates arose through contamination of the cell lines or reagents used for 
isolation of the viruses (Lipton, 2008; Oberste et al., 2009).  
The pathogenicity of members of these genera is incompletely characterised, although 
kobuviruses are known to cause gastroenteritis in humans, cattle and swine (Reuter et 
al., 2011). The pathogenicity of HuVs remains to be determined. Meanwhile, infection 
with the cardioviruses, TMEV and EMCV results in a rapidly fatal encephalitis or 
persistent infection in the central nervous system of mice (Lehrich et al., 1976; Lipton, 
1975).  
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6.1.3. Rodent and civet consumption in Vietnam 
Rodent meat is a popular source of protein for consumption by humans in Vietnam, 
particularly in the Mekong Delta, where rats are commonly sold live in wet markets 
(Nguyen et al., 2015). The total annual consumption of rat meat in Vietnam is 3,300 – 
3,600 tonnes (Khiem et al., 2003). As rodents are reservoirs or carriers of a significant 
number of zoonotic pathogens (Meerburg et al., 2009) and viruses with unknown 
zoonotic potential, there are potential and demonstrated health risks associated with 
exposure to these animals. A previous study (Khiem et al., 2003), however, showed 
none of the surveyed rat catchers or processors were aware of infection risks from 
contact with live rats. Consequently, no precautions were taken for the handling of 
rodents (Figure 6.1). 
 
Figure 6.1. Direct contact during handling of rats without protection measures puts handlers at risks of 
acquiring zoonotic infections. 
Moreover, Vietnam now has a growing demand for wild animal products as a result of 
a rising population and increasing urban prosperity (Drury, 2011). This leads to 
commercial wildlife farming (such as civets, porcupines, bamboo rats, wild boars, 
snakes) as a possible solution to meeting that growing demand (Cooper, 1995). The 
Asian palm civets (Paradoxurus hermaphroditus) are additionally farmed for the 
production of civet coffee (Deutsch & Murakhver 2012) during which the cherry 
coffee beans pass through the civet's digestive tract before being defecated with other 
faecal matter and collected. Meanwhile, human exposure to livestock is known as an 
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important risk factor for cross-species transmission of zoonotic pathogens (Mackenzie, 
2005; Pham et al., 2006). 
In assessing the potential zoonotic risks of picornaviruses to humans, 437 faecal 
samples from rodents and civets in Vietnam were screened in Chapter 3. Screening 
showed detection of kobuviruses in 103/407 rodents, 5/30 civets; cardioviruses and 
HuVs in 27/407 and 54/166 screened rodents, respectively. This chapter provides 
further information on the prevalence of infections in the screened animal species, the 
genetic diversity of these viruses and their relationships to those documented from 
humans. The hypothesis of this chapter is that these animals may carry picornaviruses 
that can also infect humans. 
6.2. Materials and methods 
6.2.1. Materials 
RNA extracted from rodent and civet positive samples (Chapter 3) was used for 
characterisation of viruses in this chapter. 
6.2.2. Identification of rodent species 
Rodent species were identified on the basis of biological and morphological 
characteristics and confirmed by sequencing of a housekeeping gene (COI) (Chapter 
2). 
6.2.3. VP4/VP2, VP1 amplification 
Characterization of viruses in positive samples was performed by amplification and 
sequencing of VP4/VP2 and VP1 regions. For these regions, the RT step was 
combined with the first round PCR using Superscript III one-step RT-PCR System 
with Platinum Taq DNA Polymerase (Invitrogen, UK) in a total volume of 20 µl 
containing 6 µl of extracted RNA. Cycling conditions were 45oC for 30 min, 94°C for 
2 min followed by 40 cycles of 94°C for 15 s, 55°C for 30 s, 68°C for 1 minute/kb. 
Then 1 µl of the first-round reaction was used for the nested PCR with second-round 
primers and GoTaq DNA polymerase (Promega, UK). PCR amplification included 
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95oC for 5 min followed by 30 cycles of denaturation (94°C, 30 s), annealing (55°C, 
30 s), and elongation (72°C, 90 s) in a thermal cycler. 
VP4 and VP1 PCR products were sequenced on both strands using the BigDye 
Terminator v3.1 (Applied Biosystems) and primers for second round PCR. All primers 
used for screening and genetic characterization of viruses in this study are listed in 
Table 2.6 (Chapter 2). 
6.2.4. Complete genome sequencing of novel HuVs 
Additional primers were designed to amplify regions of up to 2.2 kb in length with 
overlaps (Table 2.5; Chapter 2; Figure 6.2). The RT was combined with the first round 
PCR as described for VP4/VP2, VP1 above. SequalPrep long PCR kit (Life 
Technology, UK) was used for second round PCR according to the manufacturer’s 
instruction instead of GoTaq DNA polymerase to amplify fragments longer than 2 kb. 
 
Figure 6.2. Schematic diagram of the HuV genome and amplified fragments (in parentheses) with 
numbers indicating the positions of each fragment for complete genome of novel types. 
6.2.5. Sequence analysis 
Sequences were first imported into DnaBaser (www.DnaBaser.com) for assembly 
before import into SSE (Simmonds, 2012) for alignment and calculation of sequence 
uncorrected distance against reference sequences. Maximum Likelihood trees were 
constructed using the MEGA 5.2 software package (Tamura et al., 2011) with 1000 
bootstrap re-samples and the best fit models (general time-reversible, gamma 
distribution for cardiovirus, kobuvirus and HuV VP1, Tamura–Nei, gamma 
distribution for cardiovirus VP4/VP2). Amino acid p distance scan implemented in 
SSE was applied to show variability across a genome. Distance values were calculated 
using a window size of 300 bases, incrementing by 30 bases between windows.  
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Sequences obtained from this chapter have been deposited in GenBank under 
accession numbers KT944114 – KT944214. 
6.3. Results 
6.3.1. Species identification 
Species identification showed that the 407 rodents belonged to seven species. Among 
these, Rattus argentiventer was most frequently identified (n = 104; 25.6%) while the 
least frequently sampled species, Rattus nitidus, accounted for 2.5% (10/407) of 
samples. All 32 bamboo rats were members of the species Rhizomys pruinosus (Figure 
6.3). 
6.3.2. Prevalence of picornavirus RNA  
Kobuvirus RNA was the most commonly detected viral RNA, detectable in 16.7% 
(5/30) of civets and 25.3% (103/407) of rodents. Cardiovirus and HuV RNA was only 
found in rodents with detection frequencies of 6.6% (27/407) and 32.5% (54/166), 
respectively. Six of seven rodent species were positive for the targeted picornaviruses 
with infection frequencies varying according to rodent species and viruses but with 
consistent absence of the screened viruses in Rattus nitidus. Kobuvirus RNA was most 
common in Rhizomys pruinosus (81.3%; 26/32) while cardiovirus and HuV RNA was 
more commonly found in Rattus exulans (18.4%; 14/76) and Rattus tanezumi (50%; 
7/14), respectively, than in other rodent species (Figure 6.3). 
 
Kobuvirus     Cardiovirus    HuV 
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Figure 6.3. Prevalence of the screened picornaviruses by hosts. Columns were labelled with number of 
positive samples / number of samples tested for kobuvirus (in purple), cardiovirus (in red) and HuV (in 
green). ND, not done. 
6.3.3. Genetic characterization of picornaviruses in rodents and civets 
To genetically characterize picornaviruses in positive samples, sequences were 
amplified from the VP4/VP2 region of cardioviruses and VP1 of all viruses. VP4/VP2 
sequences were obtained from 18 of the 27 rodents positive for cardiovirus. Of these, 
three clustered with sequences of Boone cardioviruses, five sequences grouped with 
EMCV and ten were most similar to TRV sequences. All of these sequences were 
separate from human cardioviruses (SAFV) (Figure 6.4a). Despite attempts to amplify 
the VP1 region of cardioviruses in positive samples, only three variants, assigned as 
Cardiovirus A based on VP4/2 region sequences could be successfully obtained in this 
region. VP1 sequences confirmed their species assignment (Figure 6.4b) although they 
all showed substantial nucleotide sequence divergence from EMCV-1 reference 








Figure 6.4. Phylogentic relationships between cardioviruses detected in Vietnamese rats (highlighted 
in bold) and reference sequences in the regions (a) and (b) VP4 (nt 1295 – 1583) and (c) VP1 (nt 3005 
– 3832).  
Sixty three VP1 sequences could be amplified from 1 of 5 civets and 58 of 109 rodents 
positive for kobuviruses, including four co-infections in rats (Figure 6.5). Bamboo rat 
derived kobuvirus sequences were highly similar to each other (nucleotide sequence 
distances in the range of 0 – 2.9%). These sequences formed a group that clustered 
closely with nucleotide sequence distances of 11.6 – 23.6% to other Vietnamese rat 
kobuviruses. Interestingly, kobuvirus VP1 sequences recovered from five rat species 
grouped together and showed nucleotide sequence distances of 0 – 21.8%. One 
sequence derived from a civet was most similar to feline kobuvirus. All of the 
sequences in this study additionally formed a large group with reference sequences 
((human cardiovirus) 
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which were previously reported from animals and recently classified as members of 
species Aichivirus A. 
 
Figure 6.5. Phylogenetic relationships between kobuvirus VP1 (nt 3005 – 3838) sequences detected in 
Vietnamese rats and a civet (highlighted in bold) and reference sequences.  
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In contrast, seventeen HuV VP1 sequences obtained from rats were more divergent, 
even those from the same rat species (Figure 6.6). Four of these sequences grouped 
with a sequence (KJ950971) from New York rats (nucleotide sequence distances of 
14.5 – 28.3%) while the others formed a group separate from all known sequences 
available from GenBank. Sequence distances between the latter group and reference 
sequences were 45.5 – 49.3%, indicating the existence of novel, highly divergent HuVs 
in these rodent populations. 
 
Figure 6.6. Phylogenetic relationships between HuV VP1 (nt 2597 – 3298) sequences detected in 
Vietnamese rats (highlighted in bold) and reference sequences. 
6.3.4. Analysis of HuV coding region complete sequences 
Almost complete genomes of three novel HuVs (05VZ-75-RAT099, 83GR-70-
RAT106, 83GR-70-RAT130) were sequenced and further characterized. An amino 
acid distance scan (Figure 6.7) demonstrated similar divergence patterns across the 
coding region between the obtained genomes and each reference sequence. In the P1 
region, the sequence distance of Vietnamese HuVs compared to New York HuV 
(35.4%) was almost as high as to ovine (37.5%) and bovine HuVs (36%). From the 
border of P1/P2, however, Vietnamese HuVs were substantially less divergent from 
New York rat HuV than the ovine and bovine HuVs. The combined 2C + 3CD region 
of Vietnamese HuVs was 3.9%, 18% and 18.6% different from the reference 
sequences from rats, oxen and sheep, respectively. Remarkably, sequence distance 
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scan also showed that the 2B region was substantially more variable than the other 
non-structural proteins (Figure 6.7). This divergence pattern is a distinct feature of 
HuV genomes in comparison with other picornaviruses whose non-structural proteins 
are relatively equally conserved.  
 
Figure 6.7. Amino acid distance scan across the coding region of (a) Vietnamese HuVs against reference 
sequences and (b) between Vietnamese HuVs. 




6.4.1. Prevalence and host range of the screened picornaviruses 
This is the first large scale study investigating kobuviruses, cardioviruses and HuVs in 
rodents and civets. The absence of cardioviruses and HuVs in bamboo rats and civets 
was consistent with the fact that these viruses have not been reported from these 
animals. However, studies in this chapter have documented, for the first time, the 
relatively frequent detection of cardioviruses in civets, kobuviruses in bamboo rats and 
kobuviruses, HuVs in five different rat species. These findings provided new 
information on the existence of these viruses in a much wider range of hosts than 
previously documented. Before this work, only one study (Firth et al., 2014) reported 
the prevalence of kobuviruses and HuVs in rat (Rattus norvegicus) faecal samples of 
50% and 19%, respectively. These figures contrast with the corresponding detection 
frequencies of 30% and 47.4% in the current study. Kobuvirus infection in bamboo 
rats was more common with a frequency of 81.3% (Figure 6.3). Firth et al. additionally 
reported prevalence of 28% (37/133) and 14% (19/133) of Boone cardiovirus and TRV 
respectively while the overall detection frequency of cardioviruses in Rattus 
norvegicus in this study was 5% (2/40). Although rodents are thought to be the natural 
host of EMCV-1 (Tesh & Wallace, 1978), little is known about its prevalence in wild 
rodent populations as only seroprevalence studies, not molecular surveillance, have 
been conducted, mostly in response to encephalomyocarditis outbreaks in pigs and 
other non-rodent mammals (Philipps et al., 2012). 
6.4.2. Classification and zoonotic potential of the detected picornaviruses 
Viruses in positive samples were further characterized by amplification and 
sequencing of capsid coding regions. VP1 sequences were successfully amplified from 
only 51.8% (59/114) of samples positive for kobuviruses (Figure 6.5), and 31.5% 
(17/54) of HuV positive rat samples (Figure 6.6). This may be because the primers 
were designed using a relatively limited number of reference sequences from similar 
viruses available in GenBank and which did not match all kobuvirus and HuV 
sequences present in the samples. These primers should be re-examined and validated 
before use in future studies when more sequence data are available.  
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Characterization by sequencing of the VP1 region indicated low genetic diversity of 
kobuviruses infecting Vietnamese rodents. Highly similar kobuvirus VP1 sequences 
recovered from five rat species and bamboo rats (Figure 6.5) suggested that these 
viruses have low host species specificity, and they could cross the species barrier, to 
transmit between different rodent species. This is a characteristic that may lead to its 
establishment and emergence in new hosts. Understanding the receptor usage for cell 
entry of kobuviruses in rodents and other host species would potentially help predict 
the host range of these viruses. Despite the ability to infect different rodent species and 
VP1 sequences clustering in species Aichivirus A, the identified rodent kobuviruses 
were distinct from human kobuvirus (AiV-1). Whether these variants can be classified 
as different serotypes is currently uncertain. As previously discussed (Nguyen et al., 
2015), VP1 sequence distance thresholds for assignment of (sero)types may be 
different between picornavirus species even in the same genera. This is demonstrated 
by (sero)type assignment thresholds of > 25% in the VP1 nucleotide sequences of 
Enterovirus A – D and but only ≥ 12 – 13% of Rhinovirus A – C of genus 
Enterovirus. Sequence distances of kobuvirus VP1 lie between these two thresholds 
and their antigenic / neutralisation properties that might define serotype specificity 
cannot be readily predicted.  
In contrast to kobuviruses, VP1 sequences of the novel HuVs were considerably 
divergent (45.5 – 49.3%) from previously known sequences (Figure 6.6). The amino 
acid distances of the three novel HuV variants against the ovine and bovine HuV 
sequences (GenBank accession numbers HM153767 and JQ941880) of 36 – 37.5% in 
P1 and 18 – 18.6% in the combined 2C + 3CD regions were comparable to those 
corresponding figures of 31.4 – 32.1% and 18.6 – 19.3% of the New York rat HuV 
(KJ950971). The novel HuVs may, therefore, represent new genotypes/(sero)types of 
Hunnivirus A or potentially new species. More information on the patterns of genetic 
variability and host associations of this genus is required, however, to establish degrees 
of divergence appropriate for these taxonomic divisions.  
Cardioviruses in the positive samples could be identified as variants of Boone 
cardioviruses (including Bandicota indica and Rattus argentiventer derived 
sequences), TRV like viruses (from R. exulans) and EMCV (from B. indica, R. 
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argentiventer and R. tanezumi) on the basis of the VP4/VP2 region (Figure 6.4). This 
is an evidence for a wider host range of Boone cardioviruses and TRVs which had 
previously been documented from R. norvegicus (Drake et al., 2008; Firth et al., 2014; 
Gohndrone & Riley, unpublished). 
In spite of being isolated from various hosts including mouse, hamster, chimpanzee 
and rhesus monkey, EMCV strains are serologically identical (Dick, 1949; Warren et 
al., 1949) and were therefore assumed to belong to a single serotype (EMCV-1) 
(Knowles et al., 2012). The second EMCV serotype (EMCV-2) was discovered in a 
wood mouse and described seven decades after the first description of EMCV (Philipps 
et al., 2012). More recently, Yeo et al. reported sequences (KC310737, KC310738) 
from two isolates that reacted to polyclonal antiserum raised to EMCV and showed 
closer VP1 sequence distances to EMCV-1 than EMCV-2 (Yeo et al., 2013), 
indicating they could be variants of EMCV-1. These sequences represent the most 
divergent sequences of EMCV-1 described to date with maximum nucleotide and 
amino acid distances of 29.1% and 15%, respectively, to all other known EMCV-1 
sequences in the VP1 region. In the current study, only three cardiovirus VP1 
sequences could be amplified from 18 samples positive by VP4/VP2 PCR. The high 
sequence divergence in the VP1 region may have resulted in amplification failure in 
most of the positive samples. The obtained VP1 (Figure 4b) sequences clustered most 
closely to EMCV-1 with sequence distances of 32.4 – 38.6% and 28 – 32.7% to 
EMCV-1 sequences at the nucleotide and amino acid levels, respectively. As these 
distances are remarkably higher than those of within EMCV-1 sequences, a 
neutralization test would be needed to confirm the serotype assignment of Vietnamese 
rat cardioviruses as EMCV-1 or a new serotype.  
In conclusion, the study in this chapter demonstrated the existence of kobuviruses, 
HuVs and cardioviruses in different host species of Vietnamese animals from most of 
which these viruses had never been reported. Although similar sequences were 
recovered from different rodent species, the identified kobuviruses as well as 
cardioviruses were genetically different from viruses reported from humans to date 
and may therefore have no zoonotic potential. This study additionally highlighted the 
incomplete characterization of the genetic diversity of genus Hunnivirus by detection 
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of sequences highly divergent from all previously known sequences. The study 
reported in the next chapter using human samples from high risk cohort will elucidate 
if any zoonotic events relating to the targeted picornaviruses occurred in Vietnam over 




Chapter 7. Genetic characterization of 
picornaviruses in human samples 
 
7.1. Introduction  
7.1.1. Detection of EVs, kobuviruses and cardioviruses in humans 
Among twelve species of genus Enterovirus, members of seven species can infect 
humans (EV-A to -D, Rhinovirus A to C). Except for rhinoviruses currently unique to 
humans, EV-A to -D additionally include viruses that can also infect NHPs and pigs or 
have only been reported from NHPs (more details presented in Chapter 1). Similarly, 
kobuviruses detected from humans belong to species Aichivirus A with recent 
recognition of animal kobuviruses (canine kobuvirus 1, feline kobuvirus 1 and murine 
kobuvirus 1) as members of this species (http://www.picornaviridae.com/kobuvirus/-
kobuvirus.htm). Meanwhile, VHEV and EMCV-1 have been infrequently isolated 
from human samples (Goldfarb & Gajdusek, 1992; Kirkland et al., 1989; Oberste et 
al., 2009; Verlinde & Van Tangeren, 1953), and SAFV is a novel cardiovirus reported 
from patients without disease manifestations attributable to the virus (Himeda & 
Ohara, 2012). Comparison of viruses identified from animals in my studies in Chapters 
4 – 6 with those documented from humans to date revealed no overlaps. This chapter 
characterises picornaviruses in human positive samples from high risk populations due 
to their frequent occupational exposure to animals to determine whether any zoonotic 
events occurred in the studied populations. 
7.1.2. People at high risk of zoonotic infections 
All humans are at some risk of zoonotic infections, but some populations are at higher 
risk (Pimentel & Taylor, 2015). Lack of understanding of how diseases spread, 
frequent hand-to-mouth contact, and improper hand washing put children at increased 
risk of acquiring zoonoses. Immunocompromised individuals, such as HIV/AIDS 
patients, organ-transplant recipients or pregnant women, are also more likely to be 
infected with zoonotic pathogens. In addition, as mentioned in Chapter 1, the 
continuum of contacts between humans and animals has created the human–animal 
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interface, a key factor for cross-species transmission (Gortazar et al., 2014). Most of 
zoonotic pathogens are transmitted through either direct or indirect contact 
(Woolhouse & Gowtage-Sequeria, 2005). Therefore, agricultural workers, 
veterinarians, market sales people, slaughterhouse workers, etc. who are in frequent 
and close contact with animals through such as bushmeat practice, the trading of 
animal foods, animal practices, wet markets, the domestication of animals have high 
risk of contracting zoonotic infections (Pike et al., 2010). This results in an urgent 
need for co-ordinated surveillance of at-risk human populations and animals 
populations to which people are exposed. 
In the VIZIONS project, participants are eligible for inclusion if they meet all the 
following criteria: i) they are involved in raising, slaughtering, or processing livestock 
or wildlife; ii) give informed consent for study participation; iii) are willing to have 
their animals sampled. Children < 1 year of age are not included. 
7.1.3. High risk cohort in this study 
VIZIONS high risk human populations geographically matched to the screened animal 
samples were of interest. As most animal samples were taken in Dak Lak and Dong 
Thap, these two provinces were targeted for sampling of humans. The cohort members 
considered to be at high risk of acquiring a zoonotic infection as a consequence of 
occupational exposure to animals in this study included (1) farmers, (2) animal health 
workers, (3) abattoir workers, and (4) market sales workers. From this cohort, a total 
of 250 faecal samples including 100 from Dong Thap and 150 from Dak Lak provinces 
were collected and screened for picornaviruses in Chapter 3. The sampled people were 
aged from 21 – 64 years old. The screened samples (Table 7.1) were taken at enrolment 
(56 samples) or when cohort members developed illness (194 samples) such as fever, 
flu, acute pharyngitis, diarrhoea. Among these, there were samples positive for 
cardiovirus, kobuvirus and EV. This chapter characterises the picornaviruses in 
positive samples by amplification, sequencing and comparison of their informative 
genome regions (VP4/VP2, VP1) to reference sequences. Findings in this chapter will 
provide the answer for the hypothesis that the studied high risk populations may be 
infected with viruses detected in animals previous chapters. 
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Table 7.1. Number of human samples by occupation category 
Occupation category Number of sample 
Farmer 104 
Abattoir worker 73 
Animal health worker 38 
Market sales worker 35 
Total  250 
7.2. Materials and methods 
7.2.1. Materials 
RNA extracts of the positive samples were used for investigation of the virus 
characteristics. 
7.2.2. Methods 
The full VP1 region of EV and kobuvirus isolates, and the VP4/VP2 region of 
cardioviruses in positive samples were amplified using one-step RT-nested PCR 
protocols. In case VP1 was not successfully amplified, EVs in positive samples were 
confirmed by sequencing of the 5’UTR. PCR products were checked using agarose gel 
electrophoresis before sequencing on both directions. Sequences were imported into 
SSE (Simmonds, 2012) for alignment and calculation of sequence distances from 
reference sequences. Maximum Likelihood trees were constructed using the MEGA 
5.2 software package (Tamura, 2011) with 1000 bootstrap re-samples and best fitting 
models (Tamura and Nei model with gamma distribution for cardiovirus VP4/VP2; 
Hasegawa-Kishino-Yano model with gamma distribution for kobuvirus VP1; and 
General Time Reversible model with gamma distribution for EV VP1) as described in 
Chapter 2.  
Sequences obtained in this chapter are presented in Appendix 2. 
7.3. Results 
Screening of 250 samples from human high risk cohort by qPCR or nested PCR 
(Chapter 3) revealed 1, 1 and 8 samples positive for cardiovirus, kobuvirus and EV, 
respectively. In this chapter, characterizations of the positive viruses were performed 
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by amplification and sequencing of the VP4/VP2 or VP1 regions. One VP4/VP2 
sequence was obtained from the sample positive for cardiovirus. The sequence 
clustered with human SAFVs with JN652233.1 (SAFV-2) as the most similar sequence 
(Figure 7.1a).  
A kobuvirus VP1 sequence obtained from the single positive sample clustered with 
AiV-1 sequences in lineage II (Pham et al., 2008) of species Aichivirus A (Figure 7.1b) 
with nucleotide sequence distances of 86 – 97%. The most similar sequence was 
KC167086.1 reported from a Korean patient (Han et al., 2014).  
VP1 sequences were obtained from 5 of the 8 EV positive samples (Figure 7.1c & d). 
Based on their grouping and nucleotide sequence distances (< 25%) to reference 
sequences in this genome region, EVs could be identified as variants of serotypes E9, 
CVB4, CVA5 and EV71. VP1 amplification failure in the 3 other samples may be due 
to low viral loads indicated by their high Ct values of 38 – 39. The BLAST results 
(performed on October 20, 2015; Table 7.2) of the 5’UTR sequences from these 3 
samples showed 99 – 100% identity to EV71 sequences reported from Vietnam 
(KJ686199.1) and Thailand (KR045298.1). However, as recombination is frequently 
documented in this region (Haddad-Boubaker et al., 2007; Simmonds & Welch, 2006), 
no EV types could be assigned for these viruses. 
All of the identified picornaviruses have been documented from humans only. The 
infected patients were from all categories of occupation and most of them developed 
different clinical symptoms (Table 7.2). 
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Country of the most 
similar sequence 
05VZ-14-89-07 48 Poultry slaughterer Flu-like 29/01/2015 
Cu M'gar,  
Dak Lak 
EV71 100% HM358817.1 Malaysia 
05VZ-14-67-02 25 Farmer Flu-like 13/06/2015 
Cu M'gar, 
Dak Lak 
EV 99% KR045298.1 Thailand 
05VZ-14-20-02 31 Farmer Flu-like 29/07/2015 
Buon Ma Thuot, 
Dak Lak 
EV 100% KJ686199.1 Vietnam 
05VZ-14-03-03 42 Farmer Fever 10/03/2015 
Buon Ma Thuot, 
Dak Lak 
CVA5 95% KP289363.1 China 
05VZ-14-22-02 33 Farmer Fever 24/09/2014 
Buon Ma Thuot, 
Dak Lak 
E9 98% JN655888.1 China 




Buon Ma Thuot, 
Dak Lak 
EV 100% KJ686199.1 Vietnam 
05VZ-75-01-04 24 Pig slaughterer No (enrolment) 17/03/2013 
Cao Lanh, 
Dong Thap 
CVB4 95% KF412987.1 India 
05VZ-75-60-11 22 Pig slaughterer No (enrolment) 02/06/2013 
Cao Lanh,  
Dong Thap 
E9 97% AB746185.1 Japan 
05VZ-75-08-01 37 Market sales worker Gastroenteritis 19/04/2013 
Cao Lanh, 
Dong Thap 
AiV-1 97% KC167086.1 South Korea 
05VZ-75-06-03 25 Farmer No (enrolment) 17/03/2013 
Cao Lanh, 
Dong Thap 











Figure 7.1. Phylogenetic analysis of a) cardiovirus VP4/VP2 region (nt 1295 – 1583), b) kobuvirus VP1 region (nt 2991 – 3821), c) and d) EV VP1 region (nt 2477 – 
3376). Sequences obtained in the current study are highlighted in red. Reference sequences from animals and humans are highlighted in blue and black, respectively.




7.4.1. Direct identification of viral RNA from clinical samples 
In this thesis, RNA directly extracted from samples was screened in Chapter 3 using 
established real-time PCR or nested PCR protocols. Viruses in the positive human 
samples were characterized in this chapter by direct amplification and sequencing of 
informative genomic regions from the RNA extracts. This is in contrast with some 
previous studies which identified picornaviruses using virus isolation followed by 
amplification of the viruses. The isolation step was performed by inoculation of 
sample supernatants into animals or cell cultures (Kirkland et al., 1989; Oberste et al., 
2009; Sarmanova & Chumachenko, 1960; Verlinde & Van Tangeren, 1953). The 
methods used in the previous studies presented several disadvantages. Firstly, virus 
isolation is laborious and time-consuming. Secondly, some viruses grow poorly or are 
even unable to grow in cell culture (Bochkov & Gern, 2012). Thirdly, detection of 
some viruses (e.g. VHEV, EMCV-1) in human samples (Kirkland et al., 1989; 
Verlinde & Van Tangeren, 1953) turned out to be inconclusive and was suspicious of 
contamination from the used animals or cell lines (Lipton, 2008; Oberste et al., 2009). 
These drawbacks could be overcome by direct detection and characterization of 
viruses from clinical samples using established real-time PCR and nested PCR 
protocols which have been proved as more sensitive, efficient and quick alternatives 
to the conventional methods (Kupila et al., 2005).  
The identification of virus types on the basis of the capsid gene regions using RT-
nested PCR and sequencing additionally has advantages over neutralization tests for 
which antisera are in shortage of supply. Some studies used a one-step RT-PCR, 
consisting of only a first round PCR, for EV typing (Kiang et al., 2009; She et al., 
2010). The authors suggested that contamination is less likely to occur in a “closed 
system”. However, VP1 amplification by the one-step RT-PCR was ineffective in 
about one third of tested isolates and significant non-specific products were also 
amplified in reactions with successful amplification of VP1 (She et al., 2010). On the 
contrary, with a second round PCR, the one-step RT-nested PCR protocols used in 
this thesis greatly reduce non-specific amplification and are much more sensitive, 
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resulting in successful amplification of viruses with low titres. Furthermore, the one-
way system with separate and dedicated lab spaces for each step (Chapter 2) efficiently 
prevents the occurrence of contamination. 
7.4.2. Genetic diversity and disease association of the identified picornaviruses 
With VHEV and EMCV-1 suspected of being contaminating viruses, SAFV may be 
the only genuine human cardiovirus. Despite high seroprevalence (75 – 90%) in both 
children and adults (Zoll et al., 2009a), SAFV has been detected at low frequencies 
by molecular methods from patients with different illnesses such as fever of unknown 
origin (Jones et al., 2007), respiratory tract infection (Abed & Boivin, 2008; 
Tsukagoshi et al., 2011), gastroenteritis (Chiu et al., 2010; Drexler et al., 2008; Ren 
et al., 2009), aseptic meningitis (Himeda et al., 2011), sudden death syndrome 
(Nielsen et al., 2012), nonpolio AFP and healthy children (Blinkova et al., 2009). 
Taken together, these findings indicate SAFVs probably cause mainly asymptomatic 
infections or nonspecific symptoms and rarely result in severe disease (Nielsen et al., 
2012). SAFV was detected from a person with no clinical symptoms in the current 
study. This is the first report of SAFV in Vietnam. 
AiV-1 has been extensively documented as a possible etiologic agent of human 
gastroenteritis in Japan (Yamashita et al., 2000), Pakistan (Yamashita et al., 1995), 
Japan, Bangladesh, Thailand and Vietnam (Pham et al., 2007), France (Ambert-Balay 
et al., 2008), Tunisia (Sdiri-Loulizi et al., 2008), Hungary (Reuter et al., 2009), China 
(Yang et al., 2009) and Finland (Kaikkonena et al., 2010). The P1 region sequences 
of AiV-1 were divided into two lineages, I and II, on the basis of their sequence 
distances and groupings (Pham et al., 2008). The two sequences (those with 
underlined accession numbers in Figure 7.1b) previously identified from Vietnamese 
children (Pham et al., 2008) clustered in lineage I while the sequence recovered in this 
study grouped in lineage II. 
EVs may cause a wide spectrum of symptoms, from asymptomatic to serious or even 
life-threatening illness in some cases (Bessaud et al., 2008) and the pathogenicity 
varies between types. In this study, EVs were detected in 8 samples from patients with 
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flu-like symptoms or fever or diarrhoea and pharyngitis (Table 7.2) – all symptoms 
that can be caused by EVs and pathogens other than picornaviruses (Kociolek & 
Shulman, 2012; Patel & Thillainayagam, 2009). From those samples, 4 EV types (E9, 
CVB4, CVA5, EV71) were identified. As non-picornavirus pathogens have not been 
determined from these samples, whether the identified EVs as well as AiV-1 were the 
causative agents of these symptoms in the infected patients was uncertain. 
7.4.3. Zoonotic origin of picornaviruses 
People in this study were at high risk of zoonotic infections due to frequent and close 
occupational contact with animals, especially slaughterhouse workers, animal health 
workers. Meanwhile, high infection frequencies of EVs, kobuviruses in pigs, 
cardioviruses, kobuviruses and HuVs in rats, and kobuviruses in civets were 
demonstrated in Chapter 3. However, no identified animal picornaviruses (Chapters 4 
& 6) were detected in human samples. This suggests that these animals may not be the 
sources of picornavirus infections in humans in Vietnam.  
In a broader view, studies have only shown rare detection of human EVs in a bat and 
some rats (Gregorio et al., 1972), pigs (Grew et al., 1970; Lomakina et al., 2015), 
chickens (Graves & Oppenheimer, 1975), and NHPs as the most frequently reported 
source of zoonotic EVs (Harvala et al., 2011b; Oberste et al., 2013a; Oberste et al., 
2013b; Sadeuh-Mba et al., 2014) and HPeVs (Oberste et al., 2013b; Shan et al., 2010). 
In other words, among the targeted picornaviruses, those reported with zoonotic 
potential are restricted to viruses of genera Enterovirus and Parechovirus in a limited 
number of hosts to date. 
7.4.4. Limitations of this study 
A limitation of this study was the small sample size (250 human samples screened). A 
large sample size is particularly important to obtain sufficient data for such viruses 
with low prevalence (from 0 – 3.2%) in the studied human populations as cosaviruses, 
parechoviruses, kobuviruses, cardioviruses and EVs. For this reason, it is apparent that 
a much larger sample size is required to capture most of the targeted picornaviruses 
circulating in Vietnam. From that, there will be more opportunities to detect rare 
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zoonotic events. This is especially necessary providing that only few studies have been 
performed on picornaviruses in Vietnam. Most previous picornavirus surveillances 
focused on EV71 and CVA16 as causes of HFMD (Geoghegan et al., 2015; Khanh et 
al., 2012; Phan et al., 2007) or just detected EVs without further genetic 
characterization (Tan et al., 2010; Tan et al., 2014; Taylor et al., 2012). A recent 
survey (unpublished) within the VIZIONS project on the same targeted picornaviruses 
in 683 hospitalised diarrhoeic patients, mostly children, identified 20 human EV types 
in species EV-A to -C, including CVA24 (the most common type) and EV71 – two 
types also reported from NHPs (Sadeuh-Mba et al., 2014). 
Moreover, infections with the targeted picornaviruses are transient. Studies showed 
the shedding durations in stool of EV and HPeV are up to 11 weeks (Chung et al., 
2001) and 93 days (Kolehmainen et al., 2012), respectively. Although PCR is a quick 
and sensitive method for detection of pathogens, it is not suitable for samples collected 
outside of the detectable shedding period. This is supported by the survey of 683 
hospitalised diarrhoeic patients, mostly children younger than 2 years of age, 
mentioned above. All children had received oral PV vaccine but PV vaccine strains 
were detected in only 3 patients. In contrast, specific antibodies against these 
picornaviruses normally persist for years or decades (Dotzauer & Kraemer, 2012). 
Serology testing for antibodies would provide a better way to measure total exposure. 
However, detection of antibodies confirms infections rather than GI carriage. 
In summary, this chapter characterizes picornaviruses in human positive samples. In 
common with most previous studies, the results showed a clear distinction between 
the identified human viruses and animal viruses detected in the previous chapters as 
well as documented in literature. It indicates that no zoonotic events by the screened 
picornaviruses were detected or may have occurred in the studied populations during 




Chapter 8. Concluding remarks 
The study was carried out to investigate the existence, genetic diversity, disease 
associations and potential animal sources of picornavirus infections in humans. Its 
main hypotheses are the targeted picornaviruses may have a contribution to diseases 
in humans and animals, and animals are infected with zoonotic picornaviruses in 
Vietnam. These were where knowledge gaps existed in the general literature and 
specifically in the context of Vietnam. The study aimed to answer the following 
questions: 
1) How prevalent and diverse are picornaviruses in studied samples and in 
comparison with other regions of the world? 
2) Are the identified viruses associated with disease and age of infected humans 
and animals? 
3) Which viruses are circulating among different animal species and geographic-
matched human populations?  
4) Which animals may be the sources of picornavirus infections in humans? 
The main empirical findings are chapter specific, with prevalence of picornaviruses in 
screened samples presented in Chapter 3; and subsequent characterization of 
picornaviruses in the positive samples from domestic pigs and boars, monkeys, rodents 
and civets, and human samples in Chapters 4 – 7. This chapter will synthesize the main 
findings to answer the four research questions. 
8.1. Prevalence of picornaviruses in screened samples 
More than 2,000 faecal samples from humans and a wide range of animals were 
screened for six picornavirus genera. In accordance with previous studies, the current 
work showed the existence of EV and kobuvirus in pigs and farm-bred boars (with 
frequencies of 8.9 – 79%); a high infection frequency of EV in monkeys from 
Cameroon (96.5%), cardiovirus in rats (6.6%), kobuvirus, cardiovirus and EV RNA 
detectable in human samples at low frequencies (0.4 – 3.2%), and absence of the 
screened picornaviruses in bats, chickens, ducks and shrews. Novel findings were 
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detection of kobuvirus in civets (16.7%) and a porcupine (1.6%); cardiovirus in 
porcupines (4.9%); kobuvirus and HuV in a wider range of rodent species than 
previously documented (Chapter 3). 
8.2. Association of the identified viruses with disease and age of infected humans 
and animals 
Among the screened animals, clinical information and age data were available from 
pigs. In common with previous studies (Chen et al., 2013; Park et al., 2010), the current 
work showed a clear correlation of PKV but not EV infection with diarrhoea. 
However, the association was only observed in matured pigs (> 1 year of age). The 
role of PKV remains to be determined as there were no significant differences in its 
viral loads and VP1 sequences between groups of diarrhoeic and healthy pigs. 
EV infection frequencies were highest in young pigs and generally decreased with pig 
age. This may reflect the role of acquired immunity in older pigs. For most EVs, 
immunity to reinfection is believed to be lifelong (Pepper et al., 2011), as is protection 
provided by live PV vaccination (Doan et al., 2012). On the contrary, infection 
frequencies of kobuvirus were not clearly correlated with age, with high prevalence in 
the youngest pigs, significantly lower prevalence in weaner to gilts but most common 
in matured diarrhoeic pigs. Rather than playing a direct causative role, it is also 
possible that diarrhoea secondary to infection with other pathogens may alter gut 
mucosal immunity and induce inflammatory processes that reactivate and increase the 
excretion of kobuviruses harboured in the GI tract to detectable levels.  
In contrast to pigs, the lack of clinical information of other studied subjects (other 
animals) or screening for other non-picornavirus pathogens (human samples) 
prevented any conclusion on the association of other picornaviruses with disease and 
age of infected humans and animals. 
8.3. Diversity of the identified viruses 
Viruses in the positive samples were characterized by sequencing of the VP4/VP2 or 
VP1 region. Application of VP1 type assignment on the basis of sequence distances 
 Chapter 8. Concluding remarks 
174 
 
provides a quick and consistent method to identify the genetic diversity of EVs. 
Characterization of EVs infecting Vietnamese pigs and farm-bred boars showed high 
genetic diversity with 14 of 16 types in species EV-G to date, nine of which were novel 
(EV-G8 to -G16). Detection of the novel types demonstrates incomplete 
characterization of this virus species. Inter-type recombination was observed between 
EV-G8 and -G9 genome sequences (Chapter 4). Some EVs detected in monkeys 
belonged to species EV-B (SA5, EV-B110), EV-H (EV-H1) but the majority were 
unassigned EVs. Analysis of complete genome sequences of these novel EVs revealed 
recombination with a breakpoint locating at the border of P1 and P2. The hybrid nature 
of the new variants warrants the need to re-examine criteria for assignment of EVs into 
species (Chapter 5). Meanwhile, EVs infecting humans were identified as variants of 
E9, CV-B4 (members of EV-B) and EV-71, CV-A5 (EV-A) (Chapter 7). 
For other picornaviruses, despite the lack of studies for VP1 sequence distance 
thresholds as alternatives for identification of serotypes, distances and phylogenetic 
analyses of VP4/VP2 or VP1 sequences helped demarcate their groupings. The 
identified kobuviruses included PKV (Aichivirus C) in pigs and farm-bred boars 
(Chapter 4), viruses in rodents and a civet clustering in species Aichivirus A (Chapter 
6), and AiV-1 (Aichivirus A) in a human sample (Chapter 7). Rodent derived 
cardioviruses grouped with TRV, EMCV and Boone cardiovirus (Chapter 6) while 
cardiovirus in a human sample was identified as SAFV (Chapter 7). HuVs from 
rodents were highly divergent from the known HuVs and may represent novel types 
in species Hunnivirus A (Chapter 6). 
8.4. Absence of overlaps between viruses circulating among humans and other 
animals  
Cross-host exposures are an essential pre-condition for virus transfer to new hosts 
(Pike et al., 2010; Parrish et al., 2008). However, in this work, in spite of high infection 
frequencies of picornaviruses in animals and frequent contact with those animals of 
the studied human cohort, no overlaps at the type level defined by the ICTV 
Picornavirus Study Group were observed between picornaviruses detected in human 
and animal samples in Vietnam.  
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Therefore, the findings mentioned above reaffirm that the process of cross-species 
transmission is also driven by many other factors. In order to switch to a new host, a 
virus must have the ability to efficiently infect the appropriate cells of the new host. 
This process can be constrained by multiple host barriers, at different steps and levels 
such as binding to receptors, entry or fusion, trafficking within the cell, genome 
replication, and gene expression. The evolutionary relatedness of the hosts may also 
play a role in host switching. Viral host switches have occurred between closely or 
distantly related hosts as demonstrated by HIV establishment in humans from 
chimpanzees and transmission of avian influenza to humans. Currently, it appears 
impossible to predict the susceptibility of a new host. Each of these host barriers would 
require corresponding changes in the virus, resulting in difficulties for the virus to 
overcome the species barriers (Parrish et al., 2008). 
The non-overlaps between human and animal viruses in this thesis indicate that the 
screened animals may not be a source of picornavirus infections in humans. This is 
consistent with limited despite growing evidence of zoonotic transmission of 
picornaviruses to date. Among the screened viruses, only a small number of EV and 
HPeV serotypes with zoonotic potential have been reported from a rabbit, a fox, a bat, 
rats, dogs, chickens and NHPs with unknown transmission direction (Harvala et al., 
2011b), while SVDV evolved from CVB5 in pigs in the recent decades. CVB4 and 
CVA20 are the known reverse zoonotic picornaviruses which have switched host from 
humans to pigs (Brown et al., 1973; Grew et al., 1970; Knowles & McCauley, 1997; 
Lomakina et al., 2015; Seechurn et al., 1990).  
The absence of zoonotic events presented here also has an impact on the current 
knowledge of documented zoonoses. In a review (Woolhouse and Gowtage-Sequeria, 
2005), viruses were regarded as zoonotic or not at the species level. This work shows 
that at more detailed levels (e.g. type), human and animal viruses, although belonging 
to the same species, are clearly distinct and may have no zoonotic potential. Moreover, 
human pathogens have undergone major reclassification, such as EV68 and EV70, 
which are now assigned to the same species (EV-D) but which were treated as two 
separate species in the review (Woolhouse and Gowtage-Sequeria, 2005). With recent 
detection of human viruses in animals (e.g. EVs and HPeVs in NHPs), the zoonotic 
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status of species has now changed as well (such as EV-A to -D). These highlight the 
need to re-evaluate the actual number of virus species claimed to be zoonotic (816 
[58%] of 1,407 human pathogen species) in that review. 
8.5. Future directions 
In this thesis, RNA of viruses in species EV-G was detected in 79% of pig samples, of 
which EV-G1 and -G6 were the most common. However, no human samples from the 
high risk cohort populations were positive for these porcine EVs. This indicates EV-G 
viruses either have no zoonotic potential or rarely infect humans or their infections did 
occur in the studied cohort but in a short time and the acute infections were cleared at 
the time of sampling. PCR screening of a larger number (thousands) of human samples 
will provide a better understanding of their zoonotic potential. Alternatively, 
development of specific serological assays for seroprevalence studies of EV-G1 and -
G6 would enable a better estimate of total human exposure to be made. These EV-G 
viruses may be similar to LV, which studies (Jääskeläinen et al., 2013b; Niklasson et 
al., 1999) have shown high seroprevalence in patient serum samples while no LV RNA 
has been detectable in human samples to date.  
Furthermore, NHPs are the most frequently documented source of EVs and HPeVs 
with zoonotic potential to date. It is possible that for picornaviruses, the close genetic 
relationships between humans and NHPs support the transmission of picornaviruses 
between these two groups. In this thesis, only NHPs from remote areas with minimal 
human contact were screened for EVs. The identified EVs were separate from human 
EVs. More NHPs, particularly those with frequent human contact should be included 
in future studies. In Ho Chi Minh City, Vietnam, there is a tourist attraction site called 
Can Gio Monkey Island, which houses a population of about 1,500 long-tailed 
monkeys (Macaca fascicularis) in the natural condition where tourists can come in 
close proximity to feed and touch them. The large population of monkeys and their 
close contact with humans can facilitate the exchange and maintenance of 
picornaviruses and other viruses between the two groups. This monkey population may 
be a suitable sampling site for picornavirus studies in the future. 




In conclusion, the work undertaken within this PhD has focused on the existence, 
genetic characterization, zoonotic events and contribution to disease in studied humans 
and animals of picornaviruses. In addition to detection of known viruses, some novel 
variants of picornaviruses (EVs in pigs, boars and monkeys; cardioviruses, 
kobuviruses and HuVs in rodents) were discovered. The detected viruses show high 
genetic diversity, possibly no zoonotic potential, and evidence for recombination 
between EV genomes. Among these, only infection with kobuvirus was associated 
with diarrhoea in pigs while the contribution of viruses present in samples to patients’ 
clinical status was inconclusive. Larger scale screening of human and other animal 
samples (e.g. NHPs in Vietnam) by PCR and serology methods will provide a better 
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Hober, D., Sané, F., Riedweg, K., Moumna, I., Goffard, A., Choteau, L., Alidjinou, E. K. 
& Desailloud, R. (2013). Viruses and Type 1 Diabetes: Focus on the Enteroviruses. 
In Type 1 Diabetes. Edited by A. Escher & A. Li. 
Holder, M. & Lewis, P. O. (2003). Phylogeny estimation: traditional and Bayesian 
approaches. Nat Rev Genet 4, 275-284. 
Holmblat, B., Jégouic, S., Muslin, C., Blondel, B., Joffret, M.-L. & Delpeyroux, F. (2014). 
Nonhomologous Recombination between Defective Poliovirus and Coxsackievirus 
Genomes Suggests a New Model of Genetic Plasticity for Picornaviruses. mBio 5, 
e01119-01114. 
Holmes, E. C. (2009). The evolutionary genetics of emerging viruses. The Annual Review of 




Holmes, E. C. & Rambaut, A. (2004). Viral evolution and the emergence of SARS 
coronavirus. Philosophical Transactions of the Royal Society B: Biological Sciences 
359, 1059-1065. 
Holmes, E. C., Simon-Loriere, E. (2011). Why do RNA viruses recombine? Nat Rev 
Microbiol 9, 617-626. 
Holtz, L. R., Finkbeiner, S. R., Kirkwood, C. D. & Wang, D. (2008). Identification of a 
novel picornavirus related to cosaviruses in a child with acute diarrhea. Virology 
Journal 5, 159-159. 
Houde, A., Poitras, E., Leblanc, D., Ward, P., Onglis, G. D., Boras, V. F., Loisy-Hamon, 
F. & Lebeau, B. (2010). Aichi virus in Alberta, Canada: a one year examination of 
human diarrheic stool samples by RT-PCR: Formatex. 
Hubbard, G. B., Soike, K. F., Butler, T. M., Carey, K. D., Davis, H., Butcher, W. I. & 
Gauntt, C. J. (1992). An encephalomyocarditis virus epizootic in a baboon colony. 
Lab Anim Sci 42, 233-239. 
Huchon, D., Madsen, O., Sibbald, M. J. J. B., Ament, K., Stanhope, M. J., Catzeflis, F., 
de Jong, W. W. & Douzery, E. J. P. (2002). Rodent Phylogeny and a Timescale for 
the Evolution of Glires: Evidence from an Extensive Taxon Sampling Using Three 
Nuclear Genes. Molecular Biology and Evolution 19, 1053-1065. 
Hughes, J. M., Wilson, M. E., Pike, B. L., Saylors, K. E., Fair, J. N., LeBreton, M., 
Tamoufe, U., Djoko, C. F., Rimoin, A. W. & Wolfe, N. D. (2010). The Origin and 
Prevention of Pandemics. Clinical Infectious Diseases 50, 1636-1640. 
Hyypiä, T., Hovi, T., Knowles, N. J. & Stanway, G. (1997). Classification of enteroviruses 
based on molecular and biological properties. J Gen Virol 78, 1-11. 
Inaba, M., Katayama, H., Tran, N. V. T. & Furuami, H. (2014). Detection of genus 
Kobuvirus for evaluation as virus indicator for fecal contamination source track from 
Nhue River in Hanoi, Vietnam. In Southeast Asian Water Environment 5, 1st edn. 
Edited by H. Yamamoto, H. Furumai, H. Katayama, C. Chiemchaisri, U. Puetpaiboon, 
C. Visvanathan & H. Satoh. London: IWA Publishing. 
Isakov, O. & Shomron, N. (2011). Deep Sequencing Data Analysis: Challenges and 
Solutions. In Bioinformatics - Trends and Methodologies. Edited by M. A. Mahdavi 
InTech. 
Jääskeläinen, A. J., Kolehmainen, P., Kallio-Kokko, H., Nieminen, T., Koskiniemi, M., 
Tauriainen, S. & Lappalainen, M. (2013a). First two cases of neonatal human 
parechovirus 4 infection with manifestation of suspected sepsis, Finland. Journal of 
Clinical Virology 58, 328-330. 
Jääskeläinen, A. J., Kolehmainen, P., Voutilainen, L., Hauffe, H. C., Kallio-Kokko, H., 
Lappalainen, M., Tolf, C., Lindberg, A. M., Henttonen, H., Vaheri, A., 
Tauriainen, S. & Vapalahti, O. (2013b). Evidence of ljungan virus specific 
antibodies in humans and rodents, Finland. Journal of Medical Virology 85, 2001-
2008. 
Jegouic, S., Joffret, M.-L., Blanchard, C., Riquet, F. B., Perret, C., Pelletier, I., Colbere-
Garapin, F., Rakoto-Andrianarivelo, M. & Delpeyroux, F. (2009). Recombination 
between Polioviruses and Co-Circulating Coxsackie A Viruses: Role in the 





Jimenez-Clavero, M. A., Escribano-Romero, E., Ley, V. & Spiller, O. B. (2005). More 
recent swine vesicular disease virus isolates retain binding to coxsackie–adenovirus 
receptor, but have lost the ability to bind human decay-accelerating factor (CD55). 
Journal of General Virology 86, 1369-1377. 
Johansson, E. S., Niklasson, B., Tesh, R. B., Shafren, D. R., Travassos da Rosa, A. P. & 
Lindberg, A. M. (2003). Molecular characterization of M1146, an American isolate 
of Ljungan virus (LV) reveals the presence of a new LV genotype. J Gen Virol 84, 
837-844. 
Jones, B. A., Grace, D., Kock, R., Alonso, S., Rushton, J., Said, M. Y., McKeever, D., 
Mutua, F., Young, J., McDermott, J. & Pfeiffer, D. U. (2013). Zoonosis emergence 
linked to agricultural intensification and environmental change. Proceedings of the 
National Academy of Sciences of the United States of America 110, 8399-8404. 
Jones, M. S., Lukashov, V. V., Ganac, R. D. & Schnurr, D. P. (2007). Discovery of a Novel 
Human Picornavirus in a Stool Sample from a Pediatric Patient Presenting with Fever 
of Unknown Origin. Journal of Clinical Microbiology 45, 2144-2150. 
Jones, P., Cordonnier, N., Mahamba, C., Burt, F. J., Rakotovao, F., Swanepoel, R., 
André, C., Dauger, S. & Bakkali Kassimi, L. (2011). Encephalomyocarditis virus 
mortality in semi-wild bonobos (Pan panicus). Journal of Medical Primatology 40, 
157-163. 
Joo, H. S. (1999). Encephalomyocarditis virus. In Diseases of swine, 8th edn, pp. 139-144. 
Edited by B. E. D. A. Straw, S.; Mengeling, W. L. and Taylor, D. J.: Iowa State 
University Press, Ames. 
Kaikkonena, S., Räsänena, S., Rämeta, M. & Vesikari, T. (2010). Aichi virus infection in 
children with acute gastroenteritis in Finland. Epidemiology and Infection 138, 1166-
1171. 
Kaku, Y., Sarai, A. & Murakami, Y. (2001). Genetic reclassification of porcine 
enteroviruses. Journal of General Virology 82, 417-424. 
Kapoor, A., Victoria, J., Simmonds, P., Slikas, E., Chieochansin, T., Naeem, A., Shaukat, 
S., Sharif, S., Alam, M. M., Angez, M., Wang, C., Shafer, R. W., Zaidi, S. & 
Delwart, E. (2008). A highly prevalent and genetically diversified Picornaviridae 
genus in South Asian children. Proceedings of the National Academy of Sciences of 
the United States of America 105, 20482-20487. 
Kapusinszky, B., Phan, T. G., Kapoo, A. & Delwart, E. (2012). Genetic diversity of the 
genus Cosavirus in the family Picornaviridae: A new species, recombination, and 26 
new genotypes. PLoS ONE 7, e36685. 
Keele, B. F., Van Heuverswyn, F., Li, Y., Bailes, E., Takehisa, J., Santiago, M. L., 
Bibollet-Ruche, F., Chen, Y., Wain, L. V., Liegeois, F., Loul, S., Ngole, E. M., 
Bienvenue, Y., Delaporte, E., Brookfield, J. F. Y., Sharp, P. M., Shaw, G. M., 
Peeters, M. & Hahn, B. H. (2006). Chimpanzee Reservoirs of Pandemic and 
Nonpandemic HIV-1. Science 313, 523-526. 
Kemenesi, G., Zhang, D., Marton, S., Dallos, B., Görföl, T., Estók, P., Boldogh, S., 
Kurucz, K., Oldal, M., Kutas, A., Bányai, K. & Jakab, F. (2015). Genetic 
characterization of a novel picornavirus detected in Miniopterus schreibersii bats. 
Journal of General Virology 96, 815-821. 




Keusch, G. T., Pappaioanou, M., Gonzalez, M. C., Scott, K. A. & Tsai, P. (2009). 
Sustaining Global Surveillance and Response to Emerging Zoonotic Diseases. 
Washington (DC): National Academies Press (US). 
Kew, O., Morris-Glasgow, V., Landaverde, M., Burns, C., Shaw, J., Garib, Z. a., André, 
J., Blackman, E., Freeman, C. J., Jorba, J., Sutter, R., Tambini, G., Venczel, L., 
Pedreira, C., Laender, F., Shimizu, H., Yoneyama, T., Miyamura, T., van der 
Avoort, H., Oberste, M. S., Kilpatrick, D., Cochi, S., Pallansch, M. & de Quadros, 
C. (2002). Outbreak of Poliomyelitis in Hispaniola Associated with Circulating Type 
1 Vaccine-Derived Poliovirus. Science 296, 356-359. 
Kew, O., Sutter, R., de Gourville, E., Dowdle, W. & Pallansch, M. (2005). Vaccine-derived 
polioviruses and the endgame strategy for global polio eradication. Annu Rev 
Microbiol 59, 587–635. 
Khamrin, P., Chaimongkol, N., Malasao, R., Suantai, B., Saikhruang, W., 
Kongsricharoern, T., Ukarapol, N., Okitsu, S., Shimizu, H., Hayakawa, S., 
Ushijima, H. & Maneekarn, N. (2012). Detection and molecular characterization of 
cosavirus in adults with diarrhea, Thailand. Virus Genes 44, 244-246. 
Khamrin, P., Maneekarn, N., Hidaka, S., Kishikawa, S., Ushijima, K., Okitsu, S. & 
Ushijima, H. (2010). Molecular detection of kobuvirus sequences in stool samples 
collected from healthy pigs in Japan. Infection, Genetics and Evolution 10, 950-954. 
Khamrin, P., Maneekarn, N., Kongkaew, A., Kongkaew, S., Okitsu, S. & Ushijima, H. 
(2009). Porcine kobuvirus in piglets, Thailand. Emerging Infectious Diseases 15, 
2075-2076. 
Khanh, T. H., Sabanathan, S., Thanh, T. T., Thoa, L. P. K., Thuong, T. C., Hang, V. T. 
T., Farrar, J., Hien, T. T., Chau, N. V. V. & van Doorn, H. R. (2012). Enterovirus 
71–associated Hand, Foot, and Mouth Disease, Southern Vietnam, 2011. Emerging 
Infectious Diseases 18, 2002-2005. 
Khetsuriani, N., Lamonte, A., Oberste, M. S. & Pallansch, M. (2006). Neonatal enterovirus 
infec-tions reported to the national enterovirus surveillance system in the United 
States, 1983–2003. Pediatr Infect Dis J, 889-893. 
Khiem, N. T., Cuong, L. Q. & Chien, H. V. (2003). Market study of meat from field rats in 
the Mekong Delta. In Rats, mice and people: rodent biology and management, pp. 
543-547. Edited by G. R. Singleton, L. A. Hinds, C. J. Krebs & D. M. Spratt. Canberra 
(Australia): Australian Centre for Internationa Agricultural Reserach: ACIAR 
Monograph. 
Kiang, D., Newbower, E. C., Yeh, E., Wold, L., Chen, L. & Schnurr, D. P. (2009). An 
algorithm for the typing of enteroviruses and correlation to serotyping by viral 
neutralization. Journal of Clinical Virology 45, 334-340. 
Kilpatrick, D. R., Nottay, B., Yang, C.-F., Yang, S.-J., Da Silva, E., Peñaranda, S., 
Pallansch, M. & Kew, O. (1998). Serotype-Specific Identification of Polioviruses by 
PCR Using Primers Containing Mixed-Base or Deoxyinosine Residues at Positions of 
Codon Degeneracy. Journal of Clinical Microbiology 36, 352-357. 
King, A. M. Q., Brown, F., Christian, P., Hovi, T., Hyypia, T., Knowles, N. J., Lemon, S. 
M., Minor, P. D., Palmenberg, A. C., Skern, T. & Stanway, G. (1999). Family 
picornaviridae. In Virus taxonomy Seventh report of the international committee for 
the taxonomy of viruses. Edited by M. H. V. Van Regenmortel, C. M. Fauquet, D. H. 




Mayo, D. J. McGeoch, C. R. Pringle & R. B. Wickner. NewYork, NYp 996: 
AcademicPress. 
King, A. M. Q., Brown, F., Christian, P., Hovi, T., Hyypiä, T., Knowles, N. J., Lemon, S. 
M., Minor, P. D., Palmenberg, A. C., Skern, T. & Stanway, G. (2000). 
Picornaviridae. In Virus Taxonomy Seventh Report of the International Committee for 
the Taxonomy of Viruses, pp. 657-673. Edited by M. H. V. Van Regenmortel, C. M. 
Fauquet, D. H. L. Bishop, C. H. Calisher, E. B. Carsten, M. K. Estes, S. M. Lemon, J. 
Maniloff, M. A. Mayo, D. J. McGeoch, C. R. Pringle & R. B. Wickner. New-York, 
San Diego: Academic Press. 
Kirkland, P. D., Gleeson, A. B., Hawkes, R. A., Naim, H. M. & Broughton, C. R. (1989). 
Human infection with encephalomyocarditis virus in New South Wales. Med J Aust 
151, 176-177. 
Knowles, N., Hovi, T., King, A. & Stanway, G. (2010). Overview of taxonamy. In The 
picornaviruses. Edited by E. Ehrenfeld, E. Domingo & R. Roos. Washington, DC: 
ASM Press. 
Knowles, N. & Wadsworth, J. (2010). The complete genome sequence of a picornavirus 
isolated from a harbour (common) seal (Phoca vitulina). In in EUROPIC : XVI 
Meeting of the European Study Group on the Molecular Biology of Picornaviruses. 
St. Andrews, Scotland. 
Knowles, N. J. (1988). The association of group III porcine enteroviruses with epithelial 
tissue. Vet Rec 122, 441–442. 
Knowles, N. J. (2005). A pan-picornavirus RT-PCR: identification of novel picornavirus 
species. In EUROPIC 2005: XIIIth Meeting of the European Study Group on the 
Molecular Biology of Picornaviruses, p. A06. Lunteren, The Netherlands. 
Knowles, N. J. (2006). Porcine enteric picornaviruses. In Diseases of Swine. Edited by B. E. 
Straw, J. J. Zimmermann, S. D. D’Allaine & D. J. Taylor: Ames: Blackwell. 
Knowles, N. J., King, H. T., Lindberg, A. M., Pallansch, M., Palmenberg, A. C., 
Simmonds, P., Skern, T., Stanway, G., Yamashita, K. & Zell, R. (2012). 
Picornaviridae. In Virus taxonomy: classification and nomenclature of viruses: Ninth 
Report of the International Committee on Taxonomy of Viruses, pp. 855–880. Edited 
by A. M. Q. King, M. J. Adams, E. B. Carstens & E. J. Lefkowitz. San Diego: Elsevier 
Academic Press. 
Knowles, N. J. & McCauley, J. W. (1997). Coxsackievirus B5 and the Relationship to Swine 
Vesicular Disease Virus. In The Coxsackie B Viruses, pp. 153-167. Edited by S. Tracy, 
N. Chapman & B. J. Mahy: Springer Berlin Heidelberg. 
Knox, C. M., Luke, G. A., Dewar, J., Felipe, P. & Williams, B. J. (2012). Rotaviruses and 
emerging picornaviruses as aetiological agents of acute gastroenteritis. South Afr J 
Epidemiol Infect 27, 141-148. 
Kociolek, L. K. & Shulman, S. T. (2012). Pharyngitis. Annals of Internal Medicine 157, 
ITC3-1. 
Koenen, F., De Clercq, K. & Strobbe, R. (1991). Isolation of encephalomyocarditis virus in 
the offspring of swine with reproductive failure in Belgium. Vlaams Diergeneeskd 
Tijdschr 60. 
Koenen, F., Vanderhallen, H., Castrick, F., Miry, C. & Fockedey, M. (1996). 




outbreak in fattening pigs in Belgium. In Proceedings of the 14th International Pig 
Veterinary Society Congress, Bologna, Italy, p. 96. Bologna, Italy. 
Kolehmainen, P., Oikarinen, S., Koskiniemi, M., Simell, O., Ilonen, J., Knip, M., Hyöty, 
H. & Tauriainen, S. (2012). Human parechoviruses are frequently detected in stool 
of healthy Finnish children. Journal of Clinical Virology 54, 156-161. 
Korpela, P. J. & Hyypiä, T. (1998). Diagnosis and Epidemiology of Echovirus 22 Infections. 
Clinical Infectious Diseases 27, 129-136. 
Kriesel, J. D., Hobbs, M. R., Jones, B. B., Milash, B., Nagra, R. M. & Fischer, K. F. (2012). 
Deep Sequencing for the Detection of Virus-Like Sequences in the Brains of Patients 
with Multiple Sclerosis: Detection of GBV-C in Human Brain. PLoS ONE 7, e31886. 
Krumbholz, A., Dauber, M., Henke, A., Birch-Hirschfeld, E., Knowles, N. J., Stelzner, 
A. & Zell, R. (2002). Sequencing of Porcine Enterovirus Groups II and III Reveals 
Unique Features of Both Virus Groups. Journal of Virology 76, 5813-5821. 
Kruskop, S. V. (2013). Bats of Vietnam: Checklist and an Identification Manual: KMK. 
Kuiken, T., Fouchier, R., Rimmelzwaan, G. & Osterhaus, A. (2003). Emerging viral 
infections in a rapidly changing world. Elsevier 14, 641–646. 
Kupila, L., Vuorinen, T., Vainionpää, R., Marttila, R. J. & Kotilainen, P. (2005). 
Diagnosis of Enteroviral Meningitis by Use of Polymerase Chain Reaction of 
Cerebrospinal Fluid, Stool, and Serum Specimens. Clinical Infectious Diseases 40, 
982-987. 
Kwok, S. & Higuchi, R. (1989). Avoiding false positives with PCR. Nature 339, 237-238. 
Lai, M. M. (1992). RNA recombination in animal and plant viruses. Microbiological Reviews 
56, 61-79. 
Lea, S., Abu-Ghazaleh, R., Blakemore, W., Curry, S., Fry, E., Jackson, T., King, A., 
Logan, D., Newman, J. & Stuart, D. (1995). Structural comparison of two strains of 
foot-and-mouth disease virus subtype O1 and a laboratory antigenic variant, G67. 
Structure 3, 571-580. 
Lea, S., Hernéndez, J., Blakemore, W., Brocchi, E., Curry, S., Domingo, E., Fry, E., 
Ghazaleh, R. A., King, A., Newman, J., Stuart, D. & Mateu, M. G. (1994). The 
structure and antigenicity of a type C foot-and-mouth disease virus. Structure 2, 123-
139. 
Lederberg, J., Hamburg, M. A., Smolinski, M. S., Health, B. G., Medicine, I. & Century, 
C. E. M. T. H. (2003). Microbial Threats to Health:: Emergence, Detection, and 
Response: National Academies Press. 
Lee, W. M., Monroe, S. S. & Rueckert, R. R. (1993). Role of maturation cleavage in 
infectivity of picornaviruses: activation of an infectosome. Journal of Virology 67, 
2110-2122. 
Lehrich, J. R., Arnason, B. G. W. & Hochberg, F. H. (1976). Demyelinative myelopathy in 
mice induced by the DA virus. Journal of the Neurological Sciences 29, 149-160. 
Leitch, E. C. M., Harvala, H., Robertson, I., Ubillos, I., Templeton, K. & Simmonds, P. 
(2009). Direct identification of human enterovirus serotypes in cerebrospinal fluid by 
amplification and sequencing of the VP1 region. Journal of Clinical Virology 44, 119-
124. 
Leroy, E. M., Kumulungui, B., Pourrut, X., Rouquet, P., Hassanin, A., Yaba, P., Delicat, 
A., Paweska, J. T., Gonzalez, J.-P. & Swanepoel, R. (2005). Fruit bats as reservoirs 




Levorson, R. E. & Jantausch, B. A. (2009). Human parechoviruses. Pediatr Infect Dis J 28, 
831-832. 
Lewis, J. K., Bothner, B., Smith, T. J. & Siuzdak, G. (1998). Antiviral agent blocks 
breathing of the common cold virus. Proceedings of the National Academy of Sciences 
of the United States of America 95, 6774-6778. 
Li, J., Lin, C., Qu, M., Li, X., Gao, Z., Zhang, X., Liu, Y., Huang, Y., Wang, X., Jia, L., 
Li, X., Liu, G., Yan, H., Chen, L. & Wang, Q. (2013). Excretion of enterovirus 71 
in persons infected with hand, foot and mouth disease. Virology Journal 10, 31-31. 
Li, L., Pesavento, P. A., Shan, T., Leutenegger, C. M., Wang, C. & Delwart, E. (2011). 
Viruses in diarrhetic dogs include novel kobuviruses and sapoviruses. Journal of 
General Virology 92, 2534-2541. 
Li, L., Victoria, J. G., Wang, C., Jones, M., Fellers, G. M., Kunz, T. H. & Delwart, E. 
(2010). Bat Guano Virome: Predominance of Dietary Viruses from Insects and Plants 
plus Novel Mammalian Viruses. Journal of Virology 84, 6955-6965. 
Li, Q., Yafal, A. G., Lee, Y. M., Hogle, J. & Chow, M. (1994). Poliovirus neutralization by 
antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of 
these sequences at physiological temperature. Journal of Virology 68, 3965-3970. 
Liang, Z., Kumar, A. S. M., Jones, M. S., Knowles, N. J. & Lipton, H. L. (2008). 
Phylogenetic Analysis of the Species Theilovirus: Emerging Murine and Human 
Pathogens. Journal of Virology 82, 11545-11554. 
Lindberg, A. M. & Johansson, S. (2002). Phylogenetic analysis of Ljungan virus and A-2 
plaque virus, new members of the Picornaviridae. Virus Research 85, 61-70. 
Lipton, H. L. (1975). Theiler's virus infection in mice: an unusual biphasic disease process 
leading to demyelination. Infection and Immunity 11, 1147-1155. 
Lipton, H. L. (2008). Human Vilyuisk encephalitis. Reviews in Medical Virology 18, 347-
352. 
Liu, W., Wu, S., Xiong, Y., Li, T., Wen, Z., Yan, M., Qin, K., Liu, Y. & Wu , Y. (2014). 
Co-Circulation and Genomic Recombination of Coxsackievirus A16 and Enterovirus 
71 during a Large Outbreak of Hand, Foot, and Mouth Disease in Central China. PLoS 
ONE 9, e96051. 
Lomakina, N. F., Shustova, E. Y., Strizhakova, O. M., Drexler, J. F. & Lukashev, A. N. 
(2015). Epizootic of vesicular disease in pigs caused by coxsackievirus B4 in USSR 
in 1975. Journal of General Virology. 
Love, R. J. & Grewal, A. S. (1986). Reproductive failure in pigs caused by 
encephalomyocarditis virus. Australian Veterinary Journal 63, 128-129. 
Lu, Q.-B., Wo, Y., Wang, H.-Y., Wei, M.-T., Zhang, L., Yang, H., Liu, E.-M., Li, T.-Y., 
Zhao, Z.-T., Liu, W. & Cao, W.-C. (2014). Detection of enterovirus 68 as one of the 
commonest types of enterovirus found in patients with acute respiratory tract infection 
in China. Journal of Medical Microbiology 63, 408-414. 
Lukashev, A. N. (2010). Recombination among picornaviruses. Reviews in Medical Virology 
20, 327-337. 
Lukashev, A. N., Lashkevich, V. A., Ivanova, O. E., Koroleva, G. A., Hinkkanen, A. E. 





Luo, M., He, C., Toth, K. S., Zhang, C. X. & Lipton, H. L. (1992). Three-dimensional 
structure of Theiler murine encephalomyelitis virus (BeAn strain). Proceedings of the 
National Academy of Sciences of the United States of America 89, 2409-2413. 
Mackenzie, J. (2005). Emerging zoonotic encephalitis viruses: Lessons from Southeast Asia 
and Oceania. Journal of NeuroVirology 11, 434-440. 
Mahmood, S. A. I. (2012). Impact of Climate Change in Bangladesh: The Role of Public 
Administration and Government’s Integrity. Journal of Ecology and the Natural 
Environment 4, 223-240. 
Makower, H. & Skurska, Z. (1957). Badania rad wirusami Coxsackie Dioniesiebie III, 
Izolacja virus a Coxsackie 2 mozgu lisa. Arch Immunol Ther 5, 219-224. 
Mantke, O. D., Kallies, R., Niklasson, B., Nitsche, A. & Niedrig, M. (2007). A new 
quantitative real-time reverse transcriptase PCR assay and melting curve analysis for 
detection and genotyping of Ljungan virus strains. Journal of Virological Methods 
141, 71-77. 
Martinez-Salas, E. & Ryan, M. D. (2010). Translation and protein processing. In The 
picornaviruses. Edited by E. Ehrenfeld, E. Domingo & R. Roos. Washington, DC: 
ASM Press. 
Masek-Hammerman, K. M., A. D.; Lin, K. C.; MacKey, J.; Weissenbock, H.; Gierbolini, 
L.; Burgos, A.; Perez, H.; Mansfield, K. G. (2012). Epizootic myocarditis associated 
with Encephalomyocarditis virus in a group of rhesus macaques (macaca mulatta). Vet 
Path, 386–392. 
McElroy, K., Thomas, T. & Luciani, F. (2014). Deep sequencing of evolving pathogen 
populations: applications, errors, and bioinformatic solutions. Microbial Informatics 
and Experimentation 4, 1. 
McFerran, J. B., Clarke, J. K. & Connor, T. J. (1971). The Size of Some Mammalian 
Picornaviruses. Journal of General Virology 10, 279-284. 
McFerran, J. B., Nelson, R., McCracken, J. M. & Ross, J. G. (1969). Viruses isolated from 
sheep. Nature, London 221: 194 221, 194. 
McIntyre, C., Savolainen-Kopra, C., Hovi, T. & Simmonds, P. (2013a). Recombination in 
the evolution of human rhinovirus genomes. Archives of Virology 158, 1497-1515. 
McIntyre, C. L., Knowles, N. J. & Simmonds, P. (2013b). Proposals for the classification 
of human rhinovirus species A, B and C into genotypically assigned types. The 
Journal of General Virology 94, 1791-1806. 
McLeish, N. J., Witteveldt, J., Clasper, L., McIntyre, C., McWilliam Leitch, E. C., 
Hardie, A., Bennett, S., Gunson, R., Carman, W. F., Feeney, S. A., Coyle, P. V., 
Vipond, B., Muir, P., Benschop, K., Wolthers, K., Waris, M., Osterback, R., 
Johannessen, I., Templeton, K., Harvala, H. & Simmonds, P. (2012). Development 
and Assay of RNA Transcripts of Enterovirus Species A to D, Rhinovirus Species A 
to C, and Human Parechovirus: Assessment of Assay Sensitivity and Specificity of 
Real-Time Screening and Typing Methods. Journal of Clinical Microbiology 50, 
2910-2917. 
McWilliam Leitch, E. C., Bendig, J., Cabrerizo, M., Cardosa, J., Hyypiä, T., Ivanova, O. 
E., Kelly, A., Kroes, A. C. M., Lukashev, A., MacAdam, A., McMinn, P., 
Roivainen, M., Trallero, G., Evans, D. J. & Simmonds, P. (2009). Transmission 





McWilliam Leitch, E. C., Cabrerizo, M., Cardosa, J., Harvala, H., Ivanova, O. E., Koike, 
S., Kroes, A. C. M., Lukashev, A., Perera, D., Roivainen, M., Susi, P., Trallero, 
G., Evans, D. J. & Simmonds, P. (2012). The Association of Recombination Events 
in the Founding and Emergence of Subgenogroup Evolutionary Lineages of Human 
Enterovirus 71. Journal of Virology 86, 2676-2685. 
Medappa, K. C., McLean, C. & Rueckert, R. R. (1971). On the structure of rhinovirus 1A. 
Virology 44, 259-270. 
Meerburg, B. G., Singleton, G. R. & Kijlstra, A. (2009). Rodent-borne diseases and their 
risks for public health. Critical Reviews in Microbiology 35, 221-270. 
Melnick, J. L., Shaw, E. W. & Curnen, E. C. (1949). A virus isolated from patients 
diagnosed as non-paralytic poliomyelitis or aseptic meningitis. Proc Soc Exp Biol Med 
71, 344-349. 
Mizuta, K., Yamakawa, T., Nagasawa, H., Itagaki, T., Katsushima, F., Katsushima, Y., 
Shimizu, Y., Ito, S., Aoki, Y., Ikeda, T., Abiko, C., Kuroda, M., Noda, M., 
Kimura, H. & Ahiko, T. (2013). Epidemic myalgia associated with human 
parechovirus type 3 infection among adults occurs during an outbreak among children: 
Findings from Yamagata, Japan, in 2011. Journal of Clinical Virology 58, 188-193. 
Moon, H. J., Song, D., Seon, B. H., Kim, H. K., Park, S. J., An, D. J., Kim, J. M., Kang, 
B. K. & Park, B. K. (2012). Complete Genome Analysis of Porcine Enterovirus B 
Isolated in Korea. Journal of Virology 86, 10250. 
Morse, S. S. (2004). Factors and determinants of disease emergence. Rev Sci Tech 23, 443-
451. 
Muir, P., Kämmerer, U., Korn, K., Mulders, M. N., Pöyry, T., Weissbrich, B., Kandolf, 
R., Cleator, G. M. & van Loon, A. M. (1998). Molecular Typing of Enteroviruses: 
Current Status and Future Requirements. Clinical Microbiology Reviews 11, 202-227. 
Murphy, F. A. (1998). Emerging zoonoses. Emerging infectious diseases 4, 429-435. 
Naeem, A., Hosomi, T., Nishimura, Y., Alam, M. M., Oka, T., Zaidi, S. S. Z. & Shimizu, 
H. (2014). Genetic diversity of circulating Saffold viruses in Pakistan and 
Afghanistan. Journal of General Virology 95, 1945-1957. 
Nardelli, L., Lodetti, E., Galandi, G. L., Burrows, R., Goodridge, D., Brown, F. & 
Cartwright, B. (1968). A Foot and Mouth Disease Syndrome in Pigs caused by an 
Enterovirus. Nature 219, 1275-1276. 
Nguyen, C. V., Carrique-Mas, J., Vo Be, H., An, N. N., Tue, N. T., Anh, N. L., Anh, P. 
H., Phuc, N. T., Baker, S., Voutilainen, L., Jääskeläinen, A., Huhtamo, E., 
Utriainen, M., Sironen, T., Vaheri, A., Henttonen, H., Vapalahti, O., Chaval, Y., 
Morand, S. & Bryant, J. E. (2015). Rodents and Risk in the Mekong Delta of 
Vietnam: Seroprevalence of Selected Zoonotic Viruses in Rodents and Humans. 
Vector-Borne and Zoonotic Diseases 15, 65-72. 
Nguyen, D. V., Anh, P. H., Cuong, N. V., Hoa, N. T., Carrique-Mas, J., Hien, V. B., Sharp, 
C., Rabaa, M., Berto, A., Campbell, J., Baker, S., Farrar, J., Woolhouse, M. E., 
Bryant, J. E. & Simmonds, P. (2015 [Epub ahead of print]). Large-scale screening 
and characterization of enteroviruses and kobuviruses infecting pigs in Vietnam. J 
Gen Virol. 
Nguyen, D. V., Anh, P. H., Van Cuong, N., Hoa, N. T., Carrique-Mas, J., Hien, V. B., 




P. (2014a). Prevalence, genetic diversity and recombination of species G 
enteroviruses infecting pigs in Vietnam. Journal of General Virology 95, 549-556. 
Nguyen, D. V., Harvala, H., Ngole, E. M., Delaporte, E., Woolhouse, M. E. J., Peeters, M. 
& Simmonds, P. (2014b). High Rates of Infection with Novel Enterovirus Variants 
in Wild Populations of Mandrills and Other Old World Monkey Species. Journal of 
Virology 88, 5967-5976. 
Nielsen, A. C. Y., Böttiger, B., Banner, J., Hoffmann, T. & Nielsen, L. P. (2012). Serious 
invasive Saffold virus infections in children, 2009. Emerging Infectious Diseases 18, 
7-12. 
Niklasson, B., Kinnunen, L., Hörnfeldt, B., Hörling, J., Benemar, C., Olof Hedlund, K., 
Matskova, L., Hyypiä, T. & Winberg, G. (1999). A New Picornavirus Isolated from 
Bank Voles (Clethrionomys glareolus). Virology 255, 86-93. 
Niklasson, B., Nyholm, E., Feinstein, R., Samsioe, A. & Hörnfeldt, B. (2006). Diabetes and 
myocarditis in voles and lemmings at cyclic peak densities—induced by Ljungan 
virus? Oecologia 150, 1-7. 
Nix, W. A., Jiang, B., Maher, K., Strobert, E. & Oberste, M. S. (2008). Identification of 
Enteroviruses in Naturally Infected Captive Primates. Journal of Clinical 
Microbiology 46, 2874-2878. 
O'Connor, J. R. & Morris, J. A. (1955). Recovery of Texas-1 type Coxsackie virus from 
blood of wild rabbit and from sewage contaminating rabbit's feeding ground. Am J 
Hyg 61, 314-320. 
Oberste, M. S., Feeroz, M. M., Maher, K., Nix, W. A., Engel, G. A., Begum, S., Hasan, K. 
M., Oh, G., Pallansch, M. A. & Jones-Engel, L. (2013a). Naturally Acquired 
Picornavirus Infections in Primates at the Dhaka Zoo. Journal of Virology 87, 572-
580. 
Oberste, M. S., Feeroz, M. M., Maher, K., Nix, W. A., Engel, G. A., Hasan, K. M., Begum, 
S., Oh, G., Chowdhury, A. H., Pallansch, M. A. & Jones-Engel, L. (2013b). 
Characterizing the Picornavirus Landscape among Synanthropic Nonhuman Primates 
in Bangladesh, 2007 to 2008. Journal of Virology 87, 558-571. 
Oberste, M. S., Gotuzzo, E., Blair, P., Nix, W. A., Ksiazek, T. G., Comer, J. A., Rollin, P., 
Goldsmith, C. S., Olson, J. & Kochel, T. J. (2009). Human Febrile Illness Caused 
by Encephalomyocarditis Virus Infection, Peru. Emerging Infectious Diseases 15, 
640-646. 
Oberste, M. S., Maher, K., Kilpatrick, D. R. & Pallansch, M. A. (1999). Molecular 
Evolution of the Human Enteroviruses: Correlation of Serotype with VP1 Sequence 
and Application to Picornavirus Classification. Journal of Virology 73, 1941-1948. 
Oberste, M. S., Maher, K., Nix, W. A., Michele, S. M., Uddin, M., Schnurr, D., al-
Busaidy, S., Akoua-Koffi, C. & Pallansch, M. A. (2007). Molecular identification 
of 13 new enterovirus types, EV79–88, EV97, and EV100–101, members of the 
species Human Enterovirus B. Virus Research 128, 34-42. 
Oberste, M. S., Maher, K. & Pallansch, M. A. (2002). Molecular Phylogeny and Proposed 
Classification of the Simian Picornaviruses. Journal of Virology 76, 1244-1251. 
Oberste, M. S., Maher, K. & Pallansch, M. A. (2004a). Evidence for Frequent 
Recombination within Species Human Enterovirus B Based on Complete Genomic 




Oberste, M. S., Michele, S. M., Maher, K., Schnurr, D., Cisterna, D., Junttila, N., Uddin, 
M., Chomel, J.-J., Lau, C.-S., Ridha, W., al-Busaidy, S., Norder, H., Magnius, L. 
O. & Pallansch, M. A. (2004b). Molecular identification and characterization of two 
proposed new enterovirus serotypes, EV74 and EV75. Journal of General Virology 
85, 3205-3212. 
Oberste, M. S., Peñaranda, S. & Pallansch, M. A. (2004b). RNA Recombination Plays a 
Major Role in Genomic Change during Circulation of Coxsackie B Viruses. Journal 
of Virology 78, 2948-2955. 
Oem, J.-K., Lee, M.-H., Lee, K.-K. & An, D.-J. (2014). Novel Kobuvirus species identified 
from black goat with diarrhea. Veterinary Microbiology 172, 563-567. 
Ohsawa, K., Watanabe, Y., Miyata, H. & Sato, H. (2003). Genetic Analysis of a Theiler-
like Virus Isolated from Rats. Comparative Medicine 53, 191-196. 
Okitsu, S., Khamrin, P., Thongprachum, A., Hidaka, S., Kongkaew, S., Kongkaew, A., 
Maneekarn, N., Mizuguchi, M., Hayakawa, S. & Ushijima, H. (2012). Sequence 
analysis of porcine kobuvirus VP1 region detected in pigs in Japan and Thailand. Virus 
Genes 44, 253-257. 
Oliveira, M. A., Zhao, R., Lee, W.-M., Kremer, M. J., Minor, I., Rueckert, R. R., Diana, 
G. D., Pevear, D. C., Dutko, F. J., McKinlay, M. A. & Rossmann, M. G. (1993). 
The structure of human rhinovirus 16. Structure 1, 51-68. 
Oprisan, G., Combiescu, M., Guillot, S., Caro, V., Combiescu, A., Delpeyroux, F. & 
Crainic, R. (2002). Natural genetic recombination between cocirculating heterotypic 
enteroviruses.  J. Gen. Virol., 2193–2200. 
Özbal, Y. (2010). Determinants  contributing  to  the  newly emergent viruses. Erciyes Medical 
Journal 32, 035-040. 
Pallansch, M. & Roos, R. (2007). Enteroviruses: polioviruses, coxsackieviruses, echoviruses 
and newer enteroviruses Philadelphia: Lippincott Williams & Wilkins. 
Palmenberg, A., Naeubauer, D. & Skern, T. (2010). Genome organization and encoded 
proteins. In The picornaviruses. Edited by E. Ehrenfeld, E. Domingo & R. Roos. 
Washington, DC: ASM Press. 
Pankovics, P., Boros, Á., Kiss, T. & Reuter, G. (2015). Identification and complete genome 
analysis of kobuvirus in faecal samples of European roller (Coracias garrulus): for the 
first time in a bird. Archives of Virology 160, 345-351. 
Park, S.-J., Kim, H.-K., Moon, H.-J., Song, D.-S., Rho, S.-M., Han, J.-Y., Nguyen, V.-G. 
& Park, B.-K. (2010). Molecular detection of porcine kobuviruses in pigs in Korea 
and their association with diarrhea. Archives of Virology 155, 1803-1811. 
Parody, R., Rabella, N., Martino, R., Otegui, M., del Cuerpo, M., Coll, P. & Sierra, J. 
(2007). Upper and lower respiratory tract infections by human enterovirus and 
rhinovirus in adult patients with hematological malignancies. American Journal of 
Hematology 82, 807-811. 
Parrish, C. R., Holmes, E. C., Morens, D. M., Park, E.-C., Burke, D. S., Calisher, C. H., 
Laughlin, C. A., Saif, L. J. & Daszak, P. (2008). Cross-Species Virus Transmission 
and the Emergence of New Epidemic Diseases. Microbiology and Molecular Biology 
Reviews : MMBR 72, 457-470. 
Patel, K. & Thillainayagam, A. V. (2009). Diarrhoea. Medicine 37, 23-27. 
Patz, J. A., Olson, S. H., Uejio, C. K. & Gibbs, H. K. (2008). Disease emergence from global 




Peiris, J. S. M., de Jong, M. D. & Guan, Y. (2007). Avian Influenza Virus (H5N1): a Threat 
to Human Health. Clinical Microbiology Reviews 20, 243-267. 
Pepper, I. L., Gerba, C. P. & Brusseau, M. L. (2011). Environmental and Pollution Science: 
Elsevier Science. 
Perera, D. e. a. (2010). A comparison of the VP1, VP2, and VP4 regions for molecular typing 
of Human Enteroviruses. Journal of Medical Virology 82, 649–657. 
Petruccelli, M. A., Hirasawa, K., Takeda, M., Itagaki, S. & Doi, K. (1991). Cardiac and 
pancreatic lesions in guinea pigs infected with encephalomyocarditis (EMC) virus. 
Histol Histopathol 6, 167-170. 
Pham, D. N., Hoang, L. T., Nguyen, T. K. T., Nguyen, H. T., Le, M. Q. T., Le, P. H., Le, 
T. V., Hoang, T. V., Nguyen, N. B., Phan, T. V. & Nguyen, P. M. T. (2006). Risk 
Factors for Human Infection with Avian Influenza A H5N1, Vietnam, 2004. Emerging 
Infectious Disease journal 12, 1841. 
Pham, N. K. T., Khamrin, P., Nguyen, T. A., Kanti, D. S., Phan, T. G., Okitsu, S. & 
Ushijima, H. (2007). Isolation and Molecular Characterization of Aichi Viruses from 
Fecal Specimens Collected in Japan, Bangladesh, Thailand, and Vietnam. Journal of 
Clinical Microbiology 45, 2287–2288. 
Pham, N. K. T., Trinh, Q. D., Khamrin, P., Nguyen, T. A., Dey, S. K., Phan, T. G., Hoang, 
L. P., Maneekarn, N., Okitsu, S., Mizuguchi, M. & Ushijima, H. (2008). Sequence 
analysis of the capsid gene of Aichi viruses detected from Japan, Bangladesh, 
Thailand, and Vietnam. Journal of Medical Virology 80, 1222-1227. 
Phan, T. G., Kapusinszky, B., Wang, C., Rose, R. K., Lipton, H. L. & Delwart, E. L. 
(2011). The fecal viral flora of wild rodents. PLoS Pathog 7, e1002218. 
Phan, T. G., Nguyen, T. A., Shimizu, H., Yagyu, F., Okitsu, S., Müller, W. E. G. & 
Ushijima, H. (2005). Identification of enteroviral infection among infants and 
children admitted to hospital with acute gastroentritis in Ho Chi Minh City, Vietnam. 
Journal of Medical Virology 77, 257-264. 
Phan, T. V., Nguyen, T. T. T., Perera, D., Truong, K. H., Nguyen, T. K. T., Tang, T. C., 
How, O. M., Cardosa, M. J. & McMinn, P. C. (2007). Epidemiologic and Virologic 
Investigation of Hand, Foot, and Mouth Disease, Southern Vietnam, 2005. Emerging 
Infectious Diseases 13, 1733-1741. 
Philipps, A., Dauber, M., Groth, M., Schirrmeier, H., Platzer, M., Krumbholz, A., 
Wutzler, P. & Zell, R. (2012). Isolation and molecular characterization of a second 
serotype of the encephalomyocarditis virus. Veterinary Microbiology 161, 49-57. 
Pike, B. L., Saylors, K. E., Fair, J. N., LeBreton, M., Tamoufe, U., Djoko, C. F., Rimoin, 
A. W. & Wolfe, N. D. (2010). The Origin and Prevention of Pandemics. Clinical 
infectious diseases : an official publication of the Infectious Diseases Society of 
America 50, 1636-1640. 
Pimentel, L. C. & Taylor, E. V. (2015). Surveillance for zoonotic diseases. In Concepts and 
methods in infectious disease surveillance, pp. 92-106. Edited by N. M. M'ikanatha & 
J. K. Iskander. UK: Wiley Blackwell. 
Posada, D. (2002). Evaluation of Methods for Detecting Recombination from DNA 
Sequences: Empirical Data. Molecular Biology and Evolution 19, 708-717. 
Posada, D. & Crandall, K. A. (2001). Evaluation of methods for detecting recombination 
from DNA sequences: Computer simulations. Proceedings of the National Academy 




Prodělalová, J. (2012). The survey of porcine teschoviruses, sapeloviruses and enteroviruses 
B infecting domestic pigs and wild boars in the Czech Republic between 2005 and 
2011. Infection, Genetics and Evolution 12, 1447-1451. 
Rabaa, M., Tue, N., Phuc, T., Carrique-Mas, J., Saylors, K., Cotten, M., Bryant, J., 
Nghia, H., Cuong, N., Pham, H., Berto, A., Phat, V., Dung, T., Bao, L., Hoa, N., 
Wertheim, H., Nadjm, B., Monagin, C., van Doorn, H. R., Rahman, M., Tra, M., 
Campbell, J., Boni, M., Tam, P., van der Hoek, L., Simmonds, P., Rambaut, A., 
Toan, T., Van Vinh Chau, N., Hien, T., Wolfe, N., Farrar, J., Thwaites, G., 
Kellam, P., Woolhouse, M. J. & Baker, S. (2015). The Vietnam Initiative on 
Zoonotic Infections (VIZIONS): A Strategic Approach to Studying Emerging 
Zoonotic Infectious Diseases. EcoHealth, 1-10. 
Racaniello, V. R. (2007). Picornaviridae : the viruses and their replication: Philadelphia: 
Lippincott Williams & Wilkins. 
Rakoto-Andrianarivelo, M., Gumede, N., Jegouic, S., Balanant, J., Andriamamonjy, S. 
N., Rabemanantsoa, S., Birmingham, M., Randriamanalina, B., Nkolomoni, L., 
Venter, M., Schoub, B. D., Delpeyroux, F. & Reynes, J.-M. (2008). Reemergence 
of Recombinant Vaccine-Derived Poliovirus Outbreak in Madagascar. Journal of 
Infectious Diseases 197, 1427-1435. 
Reddacliff, L. A., Kirkland, P. D., Hartley, W. J. & Reece, R. L. (1997). 
Encephalomyocarditis virus infections in an Australian zoo. J Zoo Wildl Med 28, 153-
157. 
Reisen, W. K., Fang, Y., Martinez, V.M. (2006). Effects of  temperature on the transmission 
of West Nile Virus by Culex tarsalis (Diptera: Culicidae). JOURNAL OF MEDICAL 
ENTOMOLOGY 43, 309-317. 
Ren, L., Gonzalez, R., Xiao, Y., Xu, X., Chen, L., Vernet, G., Paranhos-Baccalà, G., Jin, 
Q. & Wang, J. (2009). Saffold Cardiovirus in Children with Acute Gastroenteritis, 
Beijing, China. Emerging Infectious Diseases 15, 1509-1511. 
Ren, L., Xiao, Y., Li, J., Chen, L., Zhang, J., Vernet, G. & Wang, J. (2013). Multiple 
Genomic Recombination Events in the Evolution of Saffold Cardiovirus. PLoS ONE 
8, e74947. 
Reperant, L. A., Cornaglia, G. & Osterhaus, A. D. M. E. (2012). The Importance of 
Understanding the Human–Animal Interface From Early Hominins to Global Citizens. 
Current Topics in Microbiology and Immunology, 49–81. 
Reuter, G., Boldizsár, Á., Kiss, I. & Pankovics, P. (2008). Candidate New Species of 
Kobuvirus in Porcine Hosts Emerging Infectious Diseases 14, 1968-1970. 
Reuter, G., Boldizsár, Á., Papp, G. & Pankovics, P. (2009). Detection of Aichi virus 
shedding in a child with enteric and extraintestinal symptoms in Hungary. Archives of 
Virology 154, 1529-1532. 
Reuter, G., Boros, Á. & Pankovics, P. (2011). Kobuviruses – a comprehensive review. 
Reviews in Medical Virology 21, 32-41. 
Reuter, G., Boros, Á., Pankovics, P. & Egyed, L. (2010a). Kobuvirus in Domestic Sheep, 
Hungary. Emerging Infectious Diseases 16, 869-870. 
Reuter, G., Kecskeméti, S. & Pankovics, P. (2010b). Evolution of Porcine Kobuvirus 
Infection, Hungary. Emerging Infectious Diseases 16, 696-698. 
Reuter, G., Nemes, C., Boros, Á., Kapusinszky, B., Delwart, E. & Pankovics, P. (2013). 




Reuter, G., Pankovics, P., Knowles, N. J. & Boros, Á. (2012). Two Closely Related Novel 
Picornaviruses in Cattle and Sheep in Hungary from 2008 to 2009, Proposed as 
Members of a New Genus in the Family Picornaviridae. Journal of Virology 86, 
13295-13302. 
Rezig, D., Farhat, E. B., Touzi, H., Meddeb, Z., Salah, A. B. & Triki, H. (2015). Prevalence 
of human cosaviruses in Tunisia, North Africa. Journal of Medical Virology 87, 940-
943. 
Rezig, D., Touzi, H., Meddeb, Z. & Triki, H. (2014). Cytopathic effect of Human cosavirus 
(HCoSV) on primary cell cultures of human embryonic lung MRC5. Journal of 
Virological Methods 207, 12-15. 
Ribeiro, J., de Arruda Leme, R., Alfieri, A. F. & Alfieri, A. A. (2013). High frequency of 
Aichivirus C (porcine kobuvirus) infection in piglets from different geographic 
regions of Brazil. Tropical Animal Health & Production 45, 1757-1762. 
Robbins, F. C., Enders, J. F., Weller, T. H. & Florentino, G. L. (1951). Studies on the 
cultivation of poliomyelitis viruses in tissue culture. V. The direct isolation and 
serologic identification of virus strains in tissue culture from patients with 
nonparalytic and paralytic poliomyelitis. Am J Hyg 54, 286-293. 
Rogers, J. S. & Swofford, D. L. (1998). A fast method for approximating maximum 
likelihoods of phylogenetic trees from nucleotide sequences. Syst Biol 47, 77-89. 
Rohll, J. B., Percy, N., Ley, R., Evans, D. J., Almond, J. W. & Barclay, W. S. (1994). The 
5'-untranslated regions of picornavirus RNAs contain independent functional domains 
essential for RNA replication and translation. Journal of Virology 68, 4384-4391. 
Rossmann, M. G., Arnold, E., Erickson, J. W., Frankenberger, E. A., Griffith, J. P., 
Hecht, H.-J., Johnson, J. E., Kamer, G., Luo, M., Mosser, A. G., Rueckert, R. R., 
Sherry, B. & Vriend, G. (1985). Structure of a human common cold virus and 
functional relationship to other picornaviruses. Nature 317, 145-153. 
Rousset, D., Rakoto-Andrianarivelo, M., Razafindratsimandresy, R., Randriamanalina, 
B., Guillot, S., Balanant, J., Mauclère, P. & Delpeyroux, F. (2003). Recombinant 
Vaccine–Derived Poliovirus in Madagascar. Emerging Infectious Diseases 9, 885-
887. 
Ruan, S., Wang, W. & Levin, S. A. (2006). The effect of global travel on the spread of SARS. 
Mathematical biosciences and engineering 3. 
Rueckert, R. R. & Wimmer, E. (1984). Systematic nomenclature of picornavirus proteins. J 
Virol 50, 957-959. 
Sadeuh-Mba, S. A., Bessaud, M., Joffret, M., Endegue Zanga, M., Balanant, J., Mpoudi 
Ngole, E., Njouom, R., Reynes, J., Delpeyroux, F. & Rousset, D. (2014). 
Characterization of Enteroviruses from Non-Human Primates in Cameroon Revealed 
Virus Types Widespread in Humans along with Candidate New Types and Species. 
PLoS Neglected Tropical Diseases 8, e3052. 
Saikruang, W., Khamrin, P., Suantai, B., Ushijima, H. & Maneekarn, N. (2014). 
Molecular detection and characterization of aichivirus A in adult patients with diarrhea 
in Thailand. Journal of Medical Virology 86, 983-987. 
Salas, R., Pacheco, M. E., Ramos, B., Taibo, M. E., Jaimes, E., Vasquez, C., Querales, J., 
de Manzione, N., Godoy, O., Betancourt, A., Araoz, F., Bruzual, R., Garcia, J., 
Tesh, R. B., Rico-Hesse, R. & Shops, R. E. (1991). Venezuelan haemorrhagic fever. 




Salisbury, A.-M., Begon, M., Dove, W., Niklasson, B. & Stewart, J. (2014). Ljungan virus 
is endemic in rodents in the UK. Archives of Virology 159, 547-551. 
Sanfaçon, H., Gorbalenya, A. E., Knowles, N. J. & Chen, Y. (2011). Picornavirales. In In 
Virus Taxonomy: Classification and Nomenclature of Viruses: Ninth Report of the 
International Committee on Taxonomy of Viruses. Edited by A. M. Q. King, M. J. 
Adams, E. B. Carstens & E. Lefkowitz. San Diego: Elsevier. 
Santti, J., Hyypiä, T., Kinnunen, L. & Salminen, M. (1999). Evidence of Recombination 
among Enteroviruses. Journal of Virology 73, 8741-8749. 
Sarmanova, E. S. & Chumachenko, H. H. (1960). Study of the etiology of Viliuisk 
encephalomyelitis. I. Study of the biological characteristics of virus strains isolated 
from patients. Voprosy MeditsinskoiVirusologii 6, 211-214. 
Scheltinga, S. A., Templeton, K. E., Beersma, M. F. C. & Claas, E. C. J. (2005). Diagnosis 
of human metapneumovirus and rhinovirus in patients with respiratory tract infections 
by an internally controlled multiplex real-time RNA PCR. Journal of Clinical 
Virology 33, 306-311. 
Schober, D., Kronenberger, P., Prchla, E., Blaas, D. & Fuchs, R. (1998). Major and Minor 
Receptor Group Human Rhinoviruses Penetrate from Endosomes by Different 
Mechanisms. Journal of Virology 72, 1354-1364. 
Sdiri-Loulizi, K., Gharbi-Khélifi, H., de Rougemont, A., Chouchane, S., Sakly, N., 
Ambert-Balay, K., Hassine, M., Guédiche, M. N., Aouni, M. & Pothier, P. (2008). 
Acute Infantile Gastroenteritis Associated with Human Enteric Viruses in Tunisia. 
Journal of Clinical Microbiology 46, 1349-1355. 
Seechurn, P., Knowles, N. J. & McCauley, J. W. (1990). The complete nucleotide sequence 
of a pathogenic swine vesicular disease virus. Virus Research 16, 255-274. 
Shan, T. L., Wang, C. M., Cui, L., Delwart, E., Yuan, C. L., Zhao, W., Guo, W., Dai, X. 
Q., Yu, Y. & Hua, X. G. (2010). Human Parechovirus Infections in Monkeys with 
Diarrhea, China. Emerging Infectious Diseases 16, 1168-1169. 
Sharkey, D. J., Scalice, E. R., Christy, K. G., Atwood, S. M. & Daiss, J. L. (1994). 
Antibodies as Thermolabile Switches: High Temperature Triggering for the 
Polymerase Chain Reaction. Nat Biotech 12, 506-509. 
Sharp, J., Harrison, C. J., Puckett, K., Selvaraju, S. B., Penaranda, S., Nix, W. A., 
Oberste, M. S. & Selvarangan, R. (2013). Characteristics of Young Infants in Whom 
Human Parechovirus, Enterovirus or Neither Were Detected in Cerebrospinal Fluid 
During Sepsis Evaluations. The Pediatric Infectious Disease Journal 32, 213-216. 
She, R. C., Hymas, W. C., Taggart, E. W., Petti, C. A. & Hillyard, D. R. (2010). 
Performance of enterovirus genotyping targeting the VP1 and VP2 regions on non-
typeable isolates and patient specimens. Journal of Virological Methods 165, 46-50. 
Shimizu, H., Thorley, B., Paladin, F. J., Brussen, K. A., Stambos, V., Yuen, L., Utama, 
A., Tano, Y., Arita, M., Yoshida, H., Yoneyama, T., Benegas, A., Roesel, S., 
Pallansch, M., Kew, O. & Miyamura, T. (2004). Circulation of Type 1 Vaccine-
Derived Poliovirus in the Philippines in 2001. Journal of Virology 78, 13512-13521. 
Simmonds, P. (2006). Recombination and Selection in the Evolution of Picornaviruses and 





Simmonds, P. (2010). Recombination in the evolution of picornaviruses. In The 
Picornaviruses. Edited by E. Ehrenfeld, E. Domingo & R. Roos. Washington, DC: 
ASM Press. 
Simmonds, P. (2012). SSE: a nucleotide and amino acid sequence analysis platform. BMC 
Research Notes 5, 50-50. 
Simmonds, P. & Midgley, S. (2005). Recombination in the Genesis and Evolution of 
Hepatitis B Virus Genotypes. Journal of Virology 79, 15467-15476. 
Simmonds, P., Tuplin, A. & Evans, D. J. (2004). Detection of genome-scale ordered RNA 
structure (GORS) in genomes of positive-stranded RNA viruses: Implications for 
virus evolution and host persistence. RNA 10, 1337-1351. 
Simmonds, P. & Welch, J. (2006). Frequency and Dynamics of Recombination within 
Different Species of Human Enteroviruses. Journal of Virology 80, 483-493. 
Simon-Loriere, E. & Holmes, E. C. (2011). Why do RNA viruses recombine? Nature 
Reviews Microbiology 9, 617-626. 
Simonsson, M., Elfaitouri, A., Mohamed, N., Blomberg, J. & Ohrmalm, C. (2013). 
Foodborne viruses. In Food associated pathogens, pp. 280-315. Edited by W. Tham 
& M. Danielsson-Tham: CRC Press. 
Sisay, Z., Wang, Q., Oka, T. & Saif, L. (2013). Prevalence and molecular characterization 
of porcine enteric caliciviruses and first detection of porcine kobuviruses in US swine. 
Archives of virology 158, 1583-1588. 
Skov, M. N., Carstensen, B., Tornøe, N. & Madsen, M. (1999). Evaluation of sampling 
methods for the detection of Salmonella in broiler flocks. Journal of Applied 
Microbiology 86, 695-700. 
Smith, C. (2009). Pandemic! - Where do new viral infections come from? 
Smith, T. J., Kremer, M. J., Luo, M., Vriend, G., Arnold, E., Kamer, G., Rossmann, M. 
G., McKinlay, M. A., Diana, G. D. & Otto, M. J. (1986). The site of attachment in 
human rhinovirus 14 for antiviral agents that inhibit uncoating. Science 233, 1286–
1293. 
Smits, S. L., Raj, V. S., Oduber, M. D., Schapendonk, C. M. E., Bodewes, R., Provacia, 
L., Stittelaar, K. J., Osterhaus, A. D. M. E. & Haagmans, B. L. (2013). 
Metagenomic Analysis of the Ferret Fecal Viral Flora. PLoS ONE 8, e71595. 
Smura, T., Blomqvist, S., Vuorinen, T., Ivanova, O., Samoilovich, E., Al-Hello, H., 
Savolainen-Kopra, C., Hovi, T. & Roivainen, M. (2014). Recombination in the 
Evolution of Enterovirus C Species Sub-Group that Contains Types CVA-21, CVA-
24, EV-C95, EV-C96 and EV-C99. PLoS ONE 9, e94579. 
Smura, T. P., Junttila, N., Blomqvist, S., Norder, H., Kaijalainen, S., Paananen, A., 
Magnius, L. O., Hovi, T. & Roivainen, M. (2007). Enterovirus 94, a proposed new 
serotype in human enterovirus species D. Journal of General Virology 88, 849-858. 
Smyth, M. S. & Martin, J. H. (2002). Picornavirus uncoating. Molecular Pathology 55, 214-
219. 
Sozzi, E., Barbieri, I., Lavazza, A., Lelli, D., Moreno, A., Canelli, E., Bugnetti, M. & 
Cordioli, P. (2010). Molecular Characterization and Phylogenetic Analysis of VP1 of 
Porcine Enteric Picornaviruses Isolates in Italy. Transboundary and Emerging 
Diseases 57 434–442. 
Spickler, A. R., Roth, J. A., Galyon, J. & Lofstedt, J. (2010). Swine Vesicular Disease. In 




Spradbrow, P. B. & Chung, Y. S. (1970). Haemagglutination-Inhibition Antibodies To 
Encephalomyocarditis Virus In Queensland Cattle. Australian Veterinary Journal 46, 
126-128. 
Stanway, G., Brown, F., Christian, P., Hovi, T., Hyypiä, T., King, A. M. Q., Knowles, N. 
J., Lemon, S. M., Minor, P. D., Pallansch, M. A., Palmenberg, A. C. & Skern, T. 
(2005). Family Picornaviridae. In In: Virus Taxonomy Eighth Report of the 
International Committee on Taxonomy of Viruses, pp. 757-778. Edited by C. M. 
Fauquet, M. A. Mayo, J. Maniloff, U. Desselberger & L. A. Ball. Elsevier/Academic 
Press, London. 
Stanway, G., Joki-Korpela, P. & Hyypiä, T. (2000). Human parechoviruses – biology 
andclinical significance. Rev Med Virol 10, 57-69. 
Stanway, G., Kalkkinen, N., Roivainen, M., Ghazi, F., Khan, M., Smyth, M., Meurman, 
O. & Hyypiä, T. (1994). Molecular and biological characteristics of echovirus 22, a 
representative of a new picornavirus group. Journal of Virology 68, 8232-8238. 
Stöcker, A., Souza, B. F. d. C. D., Ribeiro, T. C. M., Netto, E. M., Araujo, L. O., Corrêa, 
J. I., Almeida, P. S., Peixoto de Mattos, A., Ribeiro, H. d. C., Pedral-Sampaio, D. 
B., Drosten, C. & Drexler, J. F. (2012). Cosavirus Infection in Persons with and 
without Gastroenteritis, Brazil. Emerging Infectious Diseases 18, 656-659. 
Suomalainen, M. & Greber, U. F. (2013). Uncoating of non-enveloped viruses. Current 
Opinion in Virology 3, 27-33. 
Swofford, D. L., Waddell, P. J., Huelsenbeck, J. P., Foster, P. G., Lewis, P. O. & Rogers, 
J. S. (2001). Bias in phylogenetic estimation and its relevance to the choice between 
parsimony and likelihood methods. Systematic Biology 50, 525-539. 
Takamatsu, Y., Uchida, L., Nga, P. T., Okamoto, K., Nabeshima, T., Thao, D. T. T., Hai, 
D. T., Tuyet, N. T., Duc, H. M., Luat, L. X., Hasebe, F. & Morita, K. (2013). An 
approach for differentiating echovirus 30 and Japanese encephalitis virus infections in 
acute meningitis/encephalitis: a retrospective study of 103 cases in Vietnam. Virology 
Journal 10, 280-280. 
Tamura, K., Peterson, D., Peterson, N., Stecher, G., Nei, M. & Kumar, S. (2011). MEGA5: 
Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary 
Distance, and Maximum Parsimony Methods. Molecular Biology and Evolution 28, 
2731-2739. 
Tamura, K., Peterson, D., Peterson, N., Stecher, G., Nei, M. & Kumar, S. (2011). MEGA5: 
molecular evolutionary genetics analysis using maximum likelihood, evolutionary 
distance, and maximum parsimony methods. Mol Biol Evol 28, 2731–2739. 
Tan, L. V., Qui, P. T., Ha, D. Q., Hue, N. B., Bao, L. Q., Cam, B. V., Khanh, T. H., Hien, 
T. T., Vinh Chau, N. V., Tram, T. T., Hien, V. M., Nga, T. V. T., Schultsz, C., 
Farrar, J., van Doorn, H. R. & de Jong, M. D. (2010). Viral Etiology of Encephalitis 
in Children in Southern Vietnam: Results of a One-Year Prospective Descriptive 
Study. PLoS Neglected Tropical Diseases 4, e854. 
Tan, L. V., Thai, L. H., Phu, N. H., Nghia, H. D. T., Chuong, L. V., Sinh, D. X., Phong, 
N. D., Mai, N. T. H., Man, D. N. H., Hien, V. M., Vinh, N. T., Day, J., Chau, N. 
V. V., Hien, T. T., Farrar, J., de Jong, M. D., Thwaites, G., van Doorn, H. R. & 
Chau, T. T. H. (2014). Viral Aetiology of Central Nervous System Infections in 
Adults Admitted to a Tertiary Referral Hospital in Southern Vietnam over 12 Years. 




Tang, J., Yoshida, H., Ding, Z., Tao, Z., Zhang, J., Tian, B., Zhao, Z. & Zhang, L. (2014). 
Molecular Epidemiology and Recombination of Human Enteroviruses from AFP 
surveillance in Yunnan, China from 2006 to 2010. Sci Rep 4. 
Tapia, G., Cinek, O., Witsø, E., Kulich, M., Rasmussen, T., Grinde, B. & Rønningen, K. 
S. (2008). Longitudinal observation of parechovirus in stool samples from Norwegian 
infants. Journal of Medical Virology 80, 1835-1842. 
Tauriainen, S., Martiskainen, M., Oikarinen, S., Lönnrot, M., Viskari, H., Ilonen, J., 
Simell, O., Knip, M. & Hyöty, H. (2007). Human parechovirus 1 infections in young 
children - no association with type 1 diabetes. Journal of Medical Virology 79, 457-
462. 
Taylor, L. H., Latham, S. M. & Woolhouse, M. E. (2001). Risk factors for human disease 
emergence. Philosophical Transactions of the Royal Society B: Biological Sciences 
356, 983-989. 
Taylor, L. H., Latham, S.M., Woolhouse, M.E. (2001). Risk Factors for Human Disease 
Emergence. Philosophical Transactions of the Royal Society B: Biological Sciences 
356, 983-989. 
Taylor, W. R., Nguyen, K., Nguyen, D., Nguyen, H., Horby, P., Nguyen, H. L., Lien, T., 
Tran, G., Tran, N., Nguyen, H. M., Nguyen, T., Nguyen, H. H., Nguyen, T., Tran, 
G., Farrar, J., de Jong, M., Schultsz, C., Tran, H., Nguyen, D., Vu, B., Le, H., 
Dao, T., Nguyen, T. & Wertheim, H. (2012). The Spectrum of Central Nervous 
System Infections in an Adult Referral Hospital in Hanoi, Vietnam. PLoS ONE 7, 
e42099. 
Tesh, R. B. & Wallace, G. D. (1978). Observations on the natural history of 
encephalomyocarditis virus. Am J Trop Med Hyg 27, 133-143. 
Theiler, M. (1934). Spontaneous encephalomyelitis of mice - a new virus disease. Science 80, 
122. 
Tisdall, P. (1981). In Search of Human Origins. Pennsylvania, US: CBC Merchandising. 
Tran, T., Chien, B. T., Papadakis, G., Druce, J., Birch, C., Chibo, D., An, T. P., Trang, 
L. T. K., Trieu, N. B., Thuy, D. T. T., Catton, M. & Mai, T. X. (2012). Respiratory 
virus laboratory pandemic planning and surveillance in central Viet Nam, 2008–2010. 
Western Pacific Surveillance and Response Journal : WPSAR 3, 49-56. 
Tsukagoshi, H., Mizuta, K., Abiko, C., Itagaki, T., Yoshizumi, M., Kobayashi, M., 
Kuroda, M., Kozawa, K., Noda, M., Ryo, A. & Kimura, H. (2011). The impact of 
Saffold cardiovirus in patients with acute respiratory infections in Yamagata, Japan. 
Scandinavian Journal Of Infectious Diseases 43, 669-671. 
Tu, L. T. P., Hoang, N. V. M., Cuong, N. V., Campbell, J., Bryant, J. E., Hoa, N. T., Kiet, 
B. T., Thompson, C., Duy, D. T., Phat, V. V., Hien, V. B., Thwaites, G., Baker, S. 
& Carrique-Mas, J. J. (2015). High levels of contamination and antimicrobial-
resistant non-typhoidal Salmonella serovars on pig and poultry farms in the Mekong 
Delta of Vietnam. Epidemiology & Infection FirstView, 1-13. 
Tuthill, T. J., Groppelli, E., Hogle, J. M. & Rowlands, D. J. (2010). Picornaviruses. Curr 
Top Microbiol Immunol 343, 43-89. 
van der Kuyl, A. C., Kuiken, C. L., Dekker, J. T. & Goudsmit, J. (1995). Phylogeny of 





van der Sanden, S., van Eek, J., Martin, D. P., van der Avoort, H., Vennema, H. & 
Koopmans, M. (2011). Detection of recombination breakpoints in the genomes of 
human enterovirus 71 strains isolated in the Netherlands in epidemic and non-
epidemic years, 1963-2010. Infection, genetics and evolution : journal of molecular 
epidemiology and evolutionary genetics in infectious diseases 11, 886-894. 
Venkataraman, S., Reddy, S. P., Loo, J., Idamakanti, N., Hallenbeck, P. L. & Reddy, V. 
S. (2008). Structure of Seneca Valley Virus-001, An oncolytic picornavirus 
representing a new genus. Structure (London, England : 1993) 16, 1555-1561. 
Verboon-Maciolek, M. A., Groenendaal, F., Hahn, C. D., Hellmann, J., van Loon, A. M., 
Boivin, G. & de Vries, L. S. (2008). Human parechovirus causes encephalitis with 
white matter injury in neonates. Annals of Neurology 64, 266-273. 
Verdaguer, N., Blaas, D. & Fita, I. (2000). Structure of human rhinovirus serotype 2 
(HRV2)1. Journal of Molecular Biology 300, 1179-1194. 
Verlinde, J. D. & Van Tangeren, H. E. (1953). Human infections with viruses of the 
Columbia-SK group. Arch Gesamte Virusforsch 5. 
Walters, B., Peñaranda, S., Nix, W.A., Oberste, M.S., Todd, K.M., Katz, B.Z., Zheng, X. 
(2011). Detection of human parechovirus (HPeV)-3 in spinal fluid specimens from 
pediatric patients in the Chicago area. Journal of Clinical Virology 52, 187-191. 
Wang, B., Tian, Z.-J., Gong, D.-Q., Li, D.-Y., Wang, Y., Chen, J.-Z., An, T.-Q., Peng, J.-
M. & Tong, G.-Z. (2010). Isolation of serotype 2 porcine teschovirus in China: 
Evidence of natural recombination. Veterinary Microbiology 146, 138-143. 
Wang, L. F. & Crameri, G. (2014). Emerging zoonotic viral diseases. OIE Revue Scientifique 
et Technique 33, 569-581. 
Wang, T. H., Donaldson, Y. K., Brettle, R. P., Bell, J. E. & Simmonds, P. (2001). 
Identification of Shared Populations of Human Immunodeficiency Virus Type 1 
Infecting Microglia and Tissue Macrophages outside the Central Nervous System. 
Journal of Virology 75, 11686-11699. 
Warren, J., Smadel, J. E. & Russ, S. B. (1949). The Family Relationship of 
Encephalomyocarditis, Columbia-SK, M. M., and Mengo Encephalomyelitis Viruses. 
The Journal of Immunology 62, 387-398. 
Wells, S. K. & Gutter, A. E. (1989). Encephalomyocarditis virus: epizootic in a zoological 
collection. J Zoo Wildl Med 20, 291-296. 
Westerhuis, B., Kolehmainen, P., Benschop, K., Nurminen, N., Koen, G., Koskiniemi, M., 
Simell, O., Knip, M., Hyöty, H., Wolthers, K. & Tauriainen, S. (2013). Human 
parechovirus seroprevalence in Finland and the Netherlands. Journal of Clinical 
Virology 58, 211-215. 
Whitton, J. L., Cornell, C. T. & Feuer, R. (2005). Host and virus determinants of 
picornavirus pathogenesis and tropism. Nat Rev Micro 3, 765-776. 
WHO (1959). World Health Organization technical report series no. 169 Geneva. 
WHO (2010). "Pandemic (H1N1) 2009 – update 100". Disease outbreak news (World Health 
Organization (WHO)). 
Wilson, M. E. (1995). Travel and the emergence of infectious diseases. Emerging Infectious 
Diseases 1, 39-46. 
Wisdom, A., Leitch, E. C. M., Gaunt, E., Harvala, H. & Simmonds, P. (2009). Screening 




Enteroviruses: Comprehensive VP4-VP2 Typing Reveals High Incidence and Genetic 
Diversity of HRV Species C. Journal of Clinical Microbiology 47, 3958-3967. 
Wolfe, N. D., Dunavan, C. P. & Diamond, J. (2007). Origins of major human infectious 
diseases. Nature 447, 279-283. 
Wolfe, N. D., Switzer, W. M., Carr, J. K., Bhullar, V. B., Shanmugam, V., Tamoufe, U., 
Prosser, A. T., Torimiro, J. N., Wright, A., Mpoudi-Ngole, E., McCutchan, F. E., 
Birx, D. L., Folks, T. M., Burke, D. S. & Heneine, W. (2004). Naturally acquired 
simian retrovirus infections in central African hunters. The Lancet 363, 932-937. 
Woolhouse, M. & Gowtage-Sequeria, S. (2005). Host Range and Emerging and Reemerging 
Pathogens. Emerging Infectious Disease journal 11, 1842. 
Woolhouse, M. E. & Gaunt, E. (2007). Ecological origins of novel human pathogens. 
Critical Reviews in Microbiology 33, 231-242. 
Worobey, M., Gemmel, M., Teuwen, D. E., Haselkorn, T., Kunstman, K., Bunce, M., 
Muyembe, J.-J., Kabongo, J.-M. M., Kalengayi, R. M., Van Marck, E., Gilbert, 
M. T. P. & Wolinsky, S. M. (2008). Direct evidence of extensive diversity of HIV-1 
in Kinshasa by 1960. Nature 455, 661-664. 
Xiang, Z., Gonzalez, R., Wang, Z., Ren, L., Xiao, Y., Li, J., Li, Y., Vernet, G., Paranhos-
Baccalà, G., Jin, Q. & Wang, J. (2012). Coxsackievirus A21, Enterovirus 68, and 
Acute Respiratory Tract Infection, China. Emerging Infectious Diseases 18, 821-824. 
Yamashita, T., Ito, M., Kabashima, Y., Tsuzuki, H., Fujiura, A. & Sakae, K. (2003). 
Isolation and characterization of a new species of kobuvirus associated with cattle. J 
Gen Virol 84, 3069–3077. 
Yamashita, T., Kobayashi, S., Sakac, K., Nakata, S., Chiba, S., Ishihara, Y. & Isomura, 
S. (1991). Isolation of Cytopathic Small Round Viruses with BS-C-l Cells from 
Patients with Gastroenteritis. Journal of Infectious Diseases 164, 954-957. 
Yamashita, T., Sakae, K., Ishihara, Y., Isomura, S. & Utagawa, E. (1993). Prevalence of 
newly isolated, cytopathic small round virus (Aichi strain) in Japan. Journal of 
Clinical Microbiology 31, 2938-2943. 
Yamashita, T., Sakae, K., Kobayashi, S., Ishihara, Y., Miyake, T., Mubina, A. & 
Isomura, S. (1995). Isolation of Cytopathic Small Round Virus (Aichi Virus) from 
Pakistani Children and Japanese Travelers from Southeast Asia. Microbiology and 
Immunology 39, 433-435. 
Yamashita, T., Sugiyama, M., Tsuzuki, H., Sakae, K., Suzuki, Y. & Miyazaki, Y. (2000). 
Application of a Reverse Transcription-PCR for Identification and Differentiation of 
Aichi Virus, a New Member of the Picornavirus Family Associated with 
Gastroenteritis in Humans. Journal of Clinical Microbiology 38, 2955-2961. 
Yang, C.-F., Naguib, T., Yang, S.-J., Nasr, E., Jorba, J., Ahmed, N., Campagnoli, R., van 
der Avoort, H., Shimizu, H., Yoneyama, T., Miyamura, T., Pallansch, M. & Kew, 
O. (2003). Circulation of Endemic Type 2 Vaccine-Derived Poliovirus in Egypt from 
1983 to 1993. Journal of Virology 77, 8366-8377. 
Yang, S., Wang, Y., Shen, Q., Zhang, W. & Hua, X. (2013). Prevalence of porcine 
enterovirus 9 in pigs in Middle and Eastern China. Virology Journal 10, 99. 
Yang, S., Zhang, W., Shen, Q., Yang, Z., Zhu, J., Cui, L. & Hua, X. (2009). Aichi Virus 





Yeo, D. S.-Y., Lian, J. E., Fernandez, C. J., Lin, Y.-N., Liaw, J. C.-W., Soh, M.-L., Lim, 
E. A.-S., Chan, K.-P., Ng, M.-L., Tan, H.-C., Oh, S., Ooi, E.-E. & Tan, B.-H. 
(2013). A highly divergent Encephalomyocarditis virus isolated from nonhuman 
primates in Singapore. Virology Journal 10, 248-248. 
Yin-Murphy, M. & Almond, J. W. (1996). Picornaviruses. In Medical Microbiology, 4th 
edn. Edited by B. S. University of Texas Medical Branch at Galveston: Galveston 
(TX). 
Yozwiak, N. L., Skewes-Cox, P., Stenglein, M. D., Balmaseda, A., Harris, E. & DeRisi, J. 
L. (2012). Virus Identification in Unknown Tropical Febrile Illness Cases Using Deep 
Sequencing. PLoS Neglected Tropical Diseases 6, e1485. 
Zell, R., Dauber, M., Krumbholz, A., Henke, A., Birch-Hirschfeld, E., Stelzner, A., 
Prager, D. & Wurm, R. (2001). Porcine Teschoviruses Comprise at Least Eleven 
Distinct Serotypes: Molecular and Evolutionary Aspects. Journal of Virology 75, 
1620-1631. 
Zhang, G., Haydon, D. T., Knowles, N. J. & McCauley, J. W. (1999). Molecular evolution 
of swine vesicular disease virus. Journal of General Virology 80, 639-651. 
Zhang, W., Yang, S., Shen, Q., Ren, L., Shan, T., Wei, J., Cui, L. & Hua, X. (2012). 
Complete Genome Sequence of a Novel Porcine Enterovirus Strain in China. Journal 
of Virology 86, 7008-7009. 
Zhang, Y., Zhu, S., Yan, D., Liu, G., Bai, R., Wang, D., Chen, L., Zhu, H., An, H., Kew, 
O. & Xu, W. (2010). Natural Type 3/Type 2 Intertypic Vaccine-Related Poliovirus 
Recombinants with the First Crossover Sites within the VP1 Capsid Coding Region. 
PLoS ONE 5, e15300. 
Zharkikh, A. & Li, W. H. (1992). Statistical properties of bootstrap estimation of 
phylogenetic variability from nucleotide sequences. I. Four taxa with a molecular 
clock. Molecular Biology and Evolution 9, 1119-1147. 
Zhou, L., Liao, Q., Dong, L., Huai, Y., Bai, T., Xiang, N., Shu, Y., Liu, W., Wang, S., Qin, 
P., Wang, M., Xing, X., Lv, J., Chen, Ray Y., Feng, Z., Yang, W., Uyeki, 
Timothy M. & Yu, H. (2009). Risk Factors for Human Illness with Avian Influenza 
A (H5N1) Virus Infection in China. Journal of Infectious Diseases 199, 1726-1734. 
Ziad, A. M., Nischay, M., Kevin, J. O., Shamsudeen, F. F., Vishal, K., Jonathan, H. E., 
Rafat, A., Abdulkareem, D., Mushabab Al, A., Ariful, I., Amit, K., Thomas, B., 
Peter, D., Abdullah, A. A. R. & Lipkin, W. I. (2013). Middle East Respiratory 
Syndrome Coronavirus in Bats, Saudi Arabia. Emerging Infectious Disease journal 
19, 1819. 
Zoll, J., Erkens Hulshof, S., Lanke, K., Verduyn Lunel, F., Melchers, W. J. G., 
Schoondermark-van de Ven, E., Roivainen, M., Galama, J. M. D. & van 
Kuppeveld, F. J. M. (2009a). Saffold Virus, a Human Theiler's-Like Cardiovirus, Is 
Ubiquitous and Causes Infection Early in Life. PLoS Pathogens 5, e1000416. 
Zoll, J., Galama, J. M. D. & van Kuppeveld, F. J. M. (2009b). Identification of Potential 
Recombination Breakpoints in Human Parechoviruses. Journal of Virology 83, 3379-
3383. 
 
